
<html lang="en"     class="pb-page"  data-request-id="2ce3c608-59e3-4c4a-a8b0-a523a92cd5f0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2008.51.issue-6;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm701095m;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity" /></meta><meta name="dc.Creator" content="Matthew W.  Martin" /></meta><meta name="dc.Creator" content="John  Newcomb" /></meta><meta name="dc.Creator" content="Joseph J.  Nunes" /></meta><meta name="dc.Creator" content="Christina  Boucher" /></meta><meta name="dc.Creator" content="Lilly  Chai" /></meta><meta name="dc.Creator" content="Linda F.  Epstein" /></meta><meta name="dc.Creator" content="Theodore  Faust" /></meta><meta name="dc.Creator" content="Sylvia  Flores" /></meta><meta name="dc.Creator" content="Paul  Gallant" /></meta><meta name="dc.Creator" content="Anu  Gore" /></meta><meta name="dc.Creator" content="Yan  Gu" /></meta><meta name="dc.Creator" content="Faye  Hsieh" /></meta><meta name="dc.Creator" content="Xin  Huang" /></meta><meta name="dc.Creator" content="Joseph L.  Kim" /></meta><meta name="dc.Creator" content="Scot  Middleton" /></meta><meta name="dc.Creator" content="Kurt  Morgenstern" /></meta><meta name="dc.Creator" content="Antonio  Oliveira-dos-Santos" /></meta><meta name="dc.Creator" content="Vinod F.  Patel" /></meta><meta name="dc.Creator" content="David  Powers" /></meta><meta name="dc.Creator" content="Paul  Rose" /></meta><meta name="dc.Creator" content="Yanyan  Tudor" /></meta><meta name="dc.Creator" content="Susan M.  Turci" /></meta><meta name="dc.Creator" content="Andrew A.  Welcher" /></meta><meta name="dc.Creator" content="Debra  Zack" /></meta><meta name="dc.Creator" content="Huilin  Zhao" /></meta><meta name="dc.Creator" content="Li  Zhu" /></meta><meta name="dc.Creator" content="Xiaotian  Zhu" /></meta><meta name="dc.Creator" content="Chiara  Ghiron" /></meta><meta name="dc.Creator" content="Monika  Ermann" /></meta><meta name="dc.Creator" content="David  Johnston" /></meta><meta name="dc.Creator" content="Carl-Gustaf Pierre  Saluste" /></meta><meta name="dc.Description" content="Lck, or lymphocyte specific kinase, is a cytoplasmic tyrosine kinase of the Src family expressed in T-cells and NK cells. Genetic evidence from knockout mice and human mutations demonstrates that L..." /></meta><meta name="Description" content="Lck, or lymphocyte specific kinase, is a cytoplasmic tyrosine kinase of the Src family expressed in T-cells and NK cells. Genetic evidence from knockout mice and human mutations demonstrates that L..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 16, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701095m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701095m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701095m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701095m" /></link>
        
    
    

<title>Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701095m" /></meta><meta property="og:title" content="Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0015.jpeg" /></meta><meta property="og:description" content=" Lck, or lymphocyte specific kinase, is a cytoplasmic tyrosine kinase of the Src family expressed in T-cells and NK cells. Genetic evidence from knockout mice and human mutations demonstrates that Lck kinase activity is critical for T-cell receptor-mediated signaling, leading to normal T-cell development and activation. A small molecule inhibitor of Lck is expected to be useful in the treatment of T-cell-mediated autoimmune and inflammatory disorders and/or organ transplant rejection. In this paper, we describe the structure-guided design, synthesis, structure–activity relationships, and pharmacological characterization of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones, a new class of compounds that are potent inhibitors of Lck. The most promising compound of this series, 6-(2,6-dimethylphenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido-[1,2-a]benzimidazol-5(6H)-one (25), exhibits potent inhibition of Lck kinase activity. This activity translates into inhibition of in vitro cell-based assays and in vivo models of T-cell activation and arthritis, respectively." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content=" Lck, or lymphocyte specific kinase, is a cytoplasmic tyrosine kinase of the Src family expressed in T-cells and NK cells. Genetic evidence from knockout mice and human mutations demonstrates that Lck kinase activity is critical for T-cell receptor-mediated signaling, leading to normal T-cell development and activation. A small molecule inhibitor of Lck is expected to be useful in the treatment of T-cell-mediated autoimmune and inflammatory disorders and/or organ transplant rejection. In this paper, we describe the structure-guided design, synthesis, structure–activity relationships, and pharmacological characterization of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones, a new class of compounds that are potent inhibitors of Lck. The most promising compound of this series, 6-(2,6-dimethylphenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido-[1,2-a]benzimidazol-5(6H)-one (25), exhibits potent inhibition of Lck kinase activity. This activity translates into inhibition of in vitro cell-based assays and in vivo models of T-cell activation and arthritis, respectively." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0015.jpeg" /></meta><meta name="twitter:title" content="Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701095m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701095m">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701095m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701095m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701095m&amp;href=/doi/10.1021/jm701095m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1637-1648</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm7010386" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701097z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+W.++Martin">Matthew W. Martin</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Newcomb">John Newcomb</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+J.++Nunes">Joseph J. Nunes</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Boucher">Christina Boucher</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lilly++Chai">Lilly Chai</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linda+F.++Epstein">Linda F. Epstein</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Theodore++Faust">Theodore Faust</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvia++Flores">Sylvia Flores</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Gallant">Paul Gallant</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anu++Gore">Anu Gore</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Gu">Yan Gu</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Faye++Hsieh">Faye Hsieh</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Huang">Xin Huang</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+L.++Kim">Joseph L. Kim</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scot++Middleton">Scot Middleton</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kurt++Morgenstern">Kurt Morgenstern</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Oliveira-dos-Santos">Antonio Oliveira-dos-Santos</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinod+F.++Patel">Vinod F. Patel</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Powers">David Powers</a></span><span class="author-xref-symbol "><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Rose">Paul Rose</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanyan++Tudor">Yanyan Tudor</a></span><span class="author-xref-symbol "><sup>◻</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+M.++Turci">Susan M. Turci</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+A.++Welcher">Andrew A. Welcher</a></span><span class="author-xref-symbol "><sup>◻</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Debra++Zack">Debra Zack</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huilin++Zhao">Huilin Zhao</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Zhu">Li Zhu</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaotian++Zhu">Xiaotian Zhu</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Ghiron">Chiara Ghiron</a></span><span class="author-xref-symbol "><sup>△</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monika++Ermann">Monika Ermann</a></span><span class="author-xref-symbol "><sup>△</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Johnston">David Johnston</a></span><span class="author-xref-symbol "><sup>△</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carl-Gustaf+Pierre++Saluste">Carl-Gustaf Pierre Saluste</a></span><span class="author-xref-symbol "><sup>△</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed: Tel.: 617-444-5013 . Fax: 617-621-3908. E-mail: <a href="/cdn-cgi/l/email-protection#214c40554c4053554861404c46444f0f424e4c"><span class="__cf_email__" data-cfemail="5c313d28313d2e28351c3d313b3932723f3331">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Department of Medicinal Chemistry.</div><div class="corresp-fn" id="afn2">‡Department of HTS and Molecular Pharmacology, Cambridge, MA.</div><div class="corresp-fn" id="afn3">§Department of Molecular Structure.</div><div class="corresp-fn" id="afn4">⊥Department of Pharmaceutics.</div><div class="corresp-fn" id="afn5">∥Department of Pharmacokinetics and Drug Metabolism.</div><div class="corresp-fn" id="afn6">#Department of Inflammation.</div><div class="corresp-fn" id="afn7">○Department of HTS and Molecular Pharmacology, Thousand Oaks, CA.</div><div class="corresp-fn" id="afn8">◻Department of Molecular Sciences.</div><div class="corresp-fn" id="afn9">△Evotec OAI.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701095m&amp;href=/doi/10.1021%2Fjm701095m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1637–1648</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 16, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 September 2007</li><li><span class="item_label"><b>Published</b> online</span>16 February 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 March 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701095m" title="DOI URL">https://doi.org/10.1021/jm701095m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1637%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BW.%2BMartin%252C%2BJohn%2BNewcomb%252C%2BJoseph%2BJ.%2BNunes%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D6%26contentID%3Djm701095m%26title%3DStructure-Based%2BDesign%2Bof%2BNovel%2B2-Amino-6-phenyl-pyrimido%255B5%25E2%2580%25B2%252C4%25E2%2580%25B2%253A5%252C6%255Dpyrimido%255B1%252C2-a%255Dbenzimidazol-5%25286H%2529-ones%2Bas%2BPotent%2Band%2BOrally%2BActive%2BInhibitors%2Bof%2BLymphocyte%2BSpecific%2BKinase%2B%2528Lck%2529%253A%2BSynthesis%252C%2BSAR%252C%2Band%2BIn%2BVivo%2BAnti-Inflammatory%2BActivity%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1648%26publicationDate%3DMarch%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701095m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2793</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701095m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;W. Martin&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Newcomb&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;J. Nunes&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Boucher&quot;},{&quot;first_name&quot;:&quot;Lilly&quot;,&quot;last_name&quot;:&quot;Chai&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;F. Epstein&quot;},{&quot;first_name&quot;:&quot;Theodore&quot;,&quot;last_name&quot;:&quot;Faust&quot;},{&quot;first_name&quot;:&quot;Sylvia&quot;,&quot;last_name&quot;:&quot;Flores&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Gallant&quot;},{&quot;first_name&quot;:&quot;Anu&quot;,&quot;last_name&quot;:&quot;Gore&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Gu&quot;},{&quot;first_name&quot;:&quot;Faye&quot;,&quot;last_name&quot;:&quot;Hsieh&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;L. Kim&quot;},{&quot;first_name&quot;:&quot;Scot&quot;,&quot;last_name&quot;:&quot;Middleton&quot;},{&quot;first_name&quot;:&quot;Kurt&quot;,&quot;last_name&quot;:&quot;Morgenstern&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Oliveira-dos-Santos&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;F. Patel&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Powers&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Rose&quot;},{&quot;first_name&quot;:&quot;Yanyan&quot;,&quot;last_name&quot;:&quot;Tudor&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;M. Turci&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;A. Welcher&quot;},{&quot;first_name&quot;:&quot;Debra&quot;,&quot;last_name&quot;:&quot;Zack&quot;},{&quot;first_name&quot;:&quot;Huilin&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Xiaotian&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Ghiron&quot;},{&quot;first_name&quot;:&quot;Monika&quot;,&quot;last_name&quot;:&quot;Ermann&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Johnston&quot;},{&quot;first_name&quot;:&quot;Carl-Gustaf&quot;,&quot;last_name&quot;:&quot;Pierre Saluste&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;1637-1648&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701095m&quot;},&quot;abstract&quot;:&quot;Lck, or lymphocyte specific kinase, is a cytoplasmic tyrosine kinase of the Src family expressed in T-cells and NK cells. Genetic evidence from knockout mice and human mutations demonstrates that Lck kinase activity is critical for T-cell receptor-mediated signaling, leading to normal T-cell development and activation. A small molecule inhibitor of Lck is expected to be useful in the treatment of T-cell-mediated autoimmune and inflammatory disorders and/or organ transplant rejection. In this paper, we describe the structure-guided design, synthesis, structure–activity relationships, and pharmacological characterization of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones, a new class of compounds that are potent inhibitors of Lck. The most promising compound of this series, 6-(2,6-dimethylphenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido-[1,2-a]benzimidazol-5(6H)-one (25), exhibits potent inhibition of Lck kinase activity. This activity translates into inhi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701095m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701095m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701095m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701095m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701095m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701095m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701095m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701095m&amp;href=/doi/10.1021/jm701095m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701095m" /></input><a href="/doi/pdf/10.1021/jm701095m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701095m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701095m%26sid%3Dliteratum%253Aachs%26pmid%3D18278858%26genre%3Darticle%26aulast%3DMartin%26date%3D2008%26atitle%3DStructure-Based%2BDesign%2Bof%2BNovel%2B2-Amino-6-phenyl-pyrimido%255B5%25E2%2580%25B2%252C4%25E2%2580%25B2%253A5%252C6%255Dpyrimido%255B1%252C2-a%255Dbenzimidazol-5%25286H%2529-ones%2Bas%2BPotent%2Band%2BOrally%2BActive%2BInhibitors%2Bof%2BLymphocyte%2BSpecific%2BKinase%2B%2528Lck%2529%253A%2BSynthesis%252C%2BSAR%252C%2Band%2BIn%2BVivo%2BAnti-Inflammatory%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D6%26spage%3D1637%26epage%3D1648%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/6" title="Go to Volume 51, Issue 6"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Volume 51, Issue 6"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Lck, or lymphocyte specific kinase, is a cytoplasmic tyrosine kinase of the Src family expressed in T-cells and NK cells. Genetic evidence from knockout mice and human mutations demonstrates that Lck kinase activity is critical for T-cell receptor-mediated signaling, leading to normal T-cell development and activation. A small molecule inhibitor of Lck is expected to be useful in the treatment of T-cell-mediated autoimmune and inflammatory disorders and/or organ transplant rejection. In this paper, we describe the structure-guided design, synthesis, structure–activity relationships, and pharmacological characterization of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones, a new class of compounds that are potent inhibitors of Lck. The most promising compound of this series, 6-(2,6-dimethylphenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido-[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (<b>25</b>), exhibits potent inhibition of Lck kinase activity. This activity translates into inhibition of in vitro cell-based assays and in vivo models of T-cell activation and arthritis, respectively.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">T-cells play a pivotal role in the adaptive immune response by acting either as potentiators (CD4+ T-helper cells) or effectors (CD8+ cytolytic T-effector cells) of immune reactions. The immune specificity of a particular T-cell is determined by the T-cell receptor (TCR<a class="ref internalNav" href="#fna" aria-label="a">a</a>) for antigen, or CD3 complex, expressed on its surface.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Signaling pathways used by the TCR have been an intense area of research toward the discovery of novel immunosuppressive agents. The goal of this research is the development of improved therapies for graft rejection and T-cell-mediated autoimmune disease. A number of protein kinases have been shown to be important for TCR signal transduction. The Src family of cytoplasmic tyrosine kinases consists of nine members: Src, Lck, Fyn, Lyn, Hck, Fgr, Blk, Yes, and Yrk.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Among the Src family, Lck and Fyn have been shown to have important roles in TCR signal transduction.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> TCR signals initiated by Lck lead to gene regulation events resulting in cytokine release, proliferation, and survival of antigen specific T-cells. Lck knockout mice and patients with Lck mutations effecting protein expression and/or catalytic activity display common phenotypes involving defects in T-cell maturation and signaling.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12">(7-12)</a> Taken together, these findings suggest that a small molecule inhibitor of Lck kinase activity might be a useful immunosuppressive agent for the treatment of graft rejection and/or T-cell-mediated autoimmune diseases. <div class="NLM_fn" id="fna"><i>a</i><p class="last">Abbreviations; Lck, lymphocyte specific kinase; TCR, T-cell receptor; IL-2, interleukin 2; PTK, protein tyrosine kinase; VEGFR-2, vascular endothelial growth factor receptor-2; KDR, kinase insert domain receptor; MAPK, mitogen-activated protein kinase; huMLR, human mixed lymphocyte reaction.</p></div></div><div class="NLM_p">As part of our ongoing efforts to identify small molecule inhibitors of Lck for the development of new therapeutic agents, we recently disclosed a number of promising chemical series.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In addition, several other groups have previously illustrated the synthesis and characterization of Lck- or Src-family kinase inhibitors.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19">(14-19)</a> Potent and bioavailable Lck/Src inhibitors have also been demonstrated to have efficacy in several in vivo models of T-cell-dependent immune responses.<a onclick="showRef(event, 'cit13a cit13b cit17f cit18d ref20'); return false;" href="javascript:void(0);" class="ref cit13a cit13b cit17f cit18d ref20">(13a, 13b, 17f, 18d, 20)</a></div><div class="NLM_p">Screening of our in-house kinase preferred collection identified aminobenzimidazole triazines, such as <i>N</i>-phenyl-1-(4-(3,4,5-trimethoxyphenylamino)-1,3,5-triazin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-amine and <i>N</i>-(2,6-dimethylphenyl)-1-(4-(3,4,5-trimethoxyphenylamino)-1,3,5-triazin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-amine (compounds <b>1</b> and <b>2</b>, respectively, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), as potent inhibitors of Lck. Unfortunately, these compounds were nonselective kinase inhibitors, exhibiting, for example, equal, low-nanomolar potency against KDR. A cocrystal structure of <b>1</b> bound to Lck revealed key interactions in the ATP-binding pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Binding to Lck is anchored by three hydrogen-bond interactions between the aminotriazine moiety of compound <b>1</b> and the kinase linker region: Met319 H-bonds through the main chain NH and carbonyl to the triazine N3 (2.8 Å) and 2-amino NH (2.8 Å), respectively, while the main chain carbonyl of Glu317 H-bonds to the CH in the 4-position of the triazines (3.1 Å).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This binding mode directs the aniline substituent of the benzimidazole core into the hydrophobic pocket adjoining the ATP-binding site in Lck. Interestingly, the cocrystal structure revealed that the N5-triazine and 2-anilinobenzimidazole nitrogens were only 4.3 and 3.8 Å, respectively, away from the γ-OH of the gatekeeper residue, Thr316.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and activity of aminobenzimidazole triazines <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure aminobenzimidazole triazine <b>1</b> bound to Lck.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We sought to exploit the proximity and hydrogen-bonding capacity of the gatekeeper threonine in Lck and take advantage of sequence differences among structurally related kinases in and around the ATP-binding pocket (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In particular, we designed the 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones, exemplified by compound <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), which possess a carbonyl oxygen that is well-positioned to accept a hydrogen bond from the γ-OH of Thr316 in the ATP-binding site of Lck (donor–acceptor distance is 2.4 Å, with an acceptor–donor−hydrogen angle of about 20 degrees).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We hypothesized that such a new interaction would increase selectivity over kinases with nonthreonine gatekeeper residues, namely, KDR.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Herein we describe the synthesis, structure–activity relationships, and pharmacological characterization of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones, a new class of compounds with potent inhibition of Lck. Lead optimization led to the discovery of compounds which demonstrated inhibition of T-cell activation in in vitro and in vivo biological assays as well as in models of rheumatoid arthritis.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Sequence Comparison at Gatekeeper Residue</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom">kinase</th><th align="center" valign="bottom">Lck</th><th align="center" valign="bottom">KDR</th><th align="center" valign="bottom">p38α</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">gatekeeper residue</td><td align="left" valign="top">Thr316</td><td align="left" valign="top">Val916</td><td align="left" valign="top">Thr106</td></tr></tbody></table></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one <b>3</b> bound to Lck.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our strategy for the construction of the 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones described in this paper is outlined in the retrosynthetic analysis shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. In this approach, we envisioned accessing tetracycles <b>4</b> via the nucleophilic addition of anilines <b>5</b> to 2-substituted tetracyclic pyrimidines <b>6</b> (X = Cl or SO<sub>2</sub>Me). Tetracyclic pyrimidines <b>6</b>, in turn, would be derived in two steps via nucleophilic attack of anilines <b>9</b> on 2-chlorobenzimidazole (<b>10</b>) followed by addition of the resulting 2-aminobenzimidazoles <b>7</b> to 2,4-disubstituted pyrimidine <b>8</b> (X = Cl or SMe, Y = Cl). This concise route would allow for rapid analoging as each variation could be introduced by simply employing the desired aniline.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0012.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthetic Analysis of 2-Amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The anilines required for the syntheses of the tetracycles shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were either obtained from commercial sources or prepared via one of the methods shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The 4-alkoxy-substituted anilines <b>14</b> were synthesized from the corresponding nitrophenols <b>11</b> via an alkylation with either 1-bromo-2-chloroethane or 1-bromo-3-chloropropane. The resulting alkylchloride <b>12</b> then underwent nucleophilic displacement with the desired amine (dimethylamine, morpholine, or <i>N</i>-methylpiperazine) to afford <i>p</i>-alkoxynitrophenyl derivative <b>13</b>. Catalytic hydrogenation with palladium on carbon afforded the corresponding aniline <b>14</b>. For 3-methoxy-4-(4-methylpiperazin-1-yl)aniline (<b>17</b>), 1-fluoro-2-methoxy-4-nitrobenzene (<b>15</b>) was heated with <i>N</i>-methylpiperazine to afford 1-(2-methoxy-4-nitrophenyl)-4-methylpiperazine (<b>16</b>). Reduction via catalytic hydrogenation with palladium on carbon afforded the desired aniline <b>17</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR: Variations of the Aniline Side Chain<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0001.gif" alt="" id="_i7" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0002.gif" alt="" id="gr6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">IC<sub>50</sub>values are the means of two or more separate determinations, in duplicate; standard deviations were generally within ±30% of the mean.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">IL-2: anti-CD3/CD28-induced T-cell IL-2 secretion assay.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">huMLR: human mixed lymphocyte reaction.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">Determined using ACD Labs 8.0.</p></div><div class="footnote" id="tbl2-fn5"><sup>e</sup><p class="last">SIF sol.: simulated intestinal fluid solubility assay.</p></div></div></div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0013.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aniline Side Chains<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux; (b) K<sub>2</sub>CO<sub>3</sub>, MeCN, 80 ºC, 57% (two steps); (c) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 16 h, 100%; (d) 100 ºC, 49%.</p></p></figure><div class="NLM_p">The synthesis of the 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones is shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. A solution of 2-chlorobenzimidazole (<b>10</b>) and the desired aniline <b>18</b> were refluxed overnight to afford the desired 2-aminobenzimidazole <b>19</b> as the hydrochloride salt. Heating of <b>19</b> with ethyl 4-chloro-2-methylthiopyrimidine-5-carboxylate (<b>20</b>) in the presence of diisopropylethylamine afforded tetracycle <b>21</b>. Activation of the sulfide via oxidation with <i>m</i>-chloroperoxybenzoic acid afforded sulfone <b>22</b>, which could be displaced with a variety of anilines to afford a series of tetracyclic pyrimidine derivatives <b>23</b>. In general, heating a solution of the sulfone and aniline in isopropanol with or without trifluoroacetic acid was used.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0014.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) reflux, 24 h, 79%; (b) (<i>i</i>-Pr)<sub>2</sub>NEt, toluene, 110 °C, 3 d, 60 %; (c) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 20 h, 97%; (d) ArNH<sub>2</sub>, <i>i</i>-PrOH, CF<sub>3</sub>CO<sub>2</sub>H, 80 °C, 5−16 h, 93%; (e) ArNH<sub>2</sub>, <i>i</i>-PrOH, 80 °C, 5 h, 58%.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Structure–Activity Relationships (SAR)</h3><div class="NLM_p">All compounds were screened for inhibitory activity against Lck in a homogeneous time-resolved fluorescent (HTRF) kinase assay. Selected compounds were tested for cellular activity by measuring the inhibition of T-cell receptor-induced IL-2 production in human T-cells as well as for the inhibition of T-cell activation in a human mixed lymphocyte reaction (huMLR).</div><div class="NLM_p">For purposes of determining kinase selectivity, the compounds were also tested against related kinases Src, p38α, and KDR. Mitogen-activated protein kinase (MAPK) p38α is a serine/threonine kinase and a key signaling protein for multiple processes that are activated in inflammation, such as the biosynthesis of pro-inflammatory cytokines TNFα and IL-1β.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The vascular endothelial growth factor receptor-2 (VEGFR-2; also referred to as the kinase insert domain receptor or KDR) is a receptor protein tyrosine kinase involved in angiogenesis, the formation of new vasculature from existing blood vessels. Aberrant angiogenesis has been associated with a variety of disorders including rheumatoid arthritis and cancer.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Thus, selectivity over p38α and KDR is important for proof of concept studies.</div><div class="NLM_p">Aminobenzimidazole triazines <b>1</b> and <b>2</b> exhibited excellent enzyme potency on Lck (6 and 1 nM, respectively) but lacked selectivity over KDR (7 and 4 nM). Our initial work focused on the hypothesis that introducing a carbonyl group to engage the Thr316 γ-OH in Lck (and clash with the Val916 γ-methyl in KDR) would provide compounds with improved selectivity while maintaining Lck potency. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compound <b>24</b>, a closely related derivative of <b>3</b> (the inhibitor modeled to examine the feasibility of this idea), served as a promising starting point. While <b>24</b> did exhibit a 30-fold loss in potency against Lck (relative to <b>2</b>), we were encouraged by the 1000-fold loss in potency against KDR. In addition, this change was coupled with a surprising >100-fold loss in potency against p38α (which also possesses a Thr gatekeeper) relative to compound <b>2</b> (p38α IC<sub>50</sub> = 78 nM). With this promising result in hand, we set out to explore whether altering the aniline side chain could increase Lck potency while maintaining the high levels of selectivity.</div><div class="NLM_p">The crystal structure of compound <b>1</b> bound to Lck (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) as well as our model of <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) revealed that substituents on the aniline at C2 should be projected toward solvent. We reasoned that the introduction of an ionizable group at the <i>para</i>-position of this ring might improve cell permeability and potency, as well as oral bioavailability. In addition, a slight boost in enzyme potency might be gained via interactions with residues along the solvent front.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, alterations to the aniline side chain were well-tolerated, with all variations affording compounds that were potent inhibitors of Lck and many exhibiting a marked improvement in solubility (>10-fold increase relative to <b>24</b>). The main area of differentiation between these compounds was their cellular activity. Replacing the methoxy groups with a tertiary amine such as the <i>N</i>-methylpiperazine in <b>25</b> and <b>26</b> resulted in compounds with a 3- to 5-fold increase in enzyme activity as well as a 10-fold increase in cell potency (huMLR data; increased potency presumably due to improved solubility and/or cell permeability). Selectivity over KDR increased to well over 500-fold, with >100-fold selectivity observed over p38α. Replacement of the <i>N</i>-methylpiperazine with 2-(dimethylamino)ethoxy or 2-(dimethylamino)propoxy groups (<b>27</b> and <b>28</b>) also improved cell potency in the huMLR by 3- to 4-fold, though the potency remained the same (relative to <b>24</b>). Replacing the dimethylamino group on the alkoxy side chain with a cyclic amine, such as piperidine (compound <b>33</b>), had little impact on potency or selectivity.</div><div class="NLM_p">We also investigated the impact of combining substituted anilines with variations on the alkoxy side chain. 3-Fluoro-substituted aniline (<b>31</b>) showed a slight improvement in KDR but with similar levels of Lck enzyme and cell potency relative to <b>24</b>. 3,5-Dimethoxy derivatives <b>30</b> and <b>35</b> showed improved enzyme and cellular potency while maintaining excellent selectivity over KDR and p38α (>500-fold for both). Replacing the <i>N</i>-methylpiperazine with a morpholine (<b>32</b>) had little impact on enzyme and cell potency, but a slight decrease in selectivity over KDR (relative to compound <b>30</b>) was observed. Overall, changes to the aniline side chain had minimal impact in terms of potency and selectivity. This is consistent with previously observed results in related series of compounds<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> and is consistent with the aniline side chain pointing toward the solvent front and having minimal interactions with the protein. Because of its excellent enzyme and cellular potency and selectivity profile, coupled with its ease of synthesis (4-(4-methylpiperazin-1-yl)aniline is commercially available), we chose to conduct subsequent SAR studies around <b>25</b>.</div><div class="NLM_p">We also explored the effect of varying the substitution on the aniline pointing into the kinase specificity pocket. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, 2,6-disubstitution affords the most potent compounds (<b>25</b>, <b>36</b>, and <b>37</b>). This is consistent with observations from previous groups,<a onclick="showRef(event, 'cit16a cit17a'); return false;" href="javascript:void(0);" class="ref cit16a cit17a">(16a, 17a)</a> as well as our own in-house studies,<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> which demonstrate that a 2,6-disubstituted aniline is the optimal substitution pattern. To avoid steric interactions, the two <i>ortho</i>-groups position the aniline orthogonal to the tetracyclic core, allowing it to easily fill the hydrophobic pocket. Compounds with monosubstitution in either the <i>para</i>- (<b>38</b>) or <i>meta</i>-positions (<b>39</b> and <b>40</b>) showed reduced potency (15- to 50-fold) relative to <b>25</b>. The loss of enzyme potency was less significant (3-fold) when the compound contained a 2,5-disubstituted aniline (<b>41</b>), but this was combined with a 20-fold loss in cell potency. Introduction of larger groups, such as the <i>p</i>-butoxy in <b>42</b>, resulted in an almost complete loss of potency against Lck (>4 µM). Because none of these alterations offered any improvement, we chose to further explore the properties of <b>25</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR:Variations of the 6-Aryl Group<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0003.gif" alt="" id="_i13" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0004.gif" alt="" id="gr9" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the means of two or more separate determinations, in duplicate; standard deviations were generally within ±30% of the mean.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">huMLR: human mixed lymphocyte reaction.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Kinase Selectivity Profile of Compound <b>25</b></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom">kinase</th><th align="center" valign="bottom" char=".">IC<sub>50</sub><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a> (µM)</th><th align="center" valign="bottom">kinase</th><th align="center" valign="bottom" char=".">IC<sub>50</sub><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a> (µM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">Lck</td><td align="char" valign="top" char=".">0.007</td><td align="left" valign="top">IGFR</td><td align="char" valign="top" char=".">2.4</td></tr><tr valign="top"><td align="left" valign="top">Src</td><td align="char" valign="top" char=".">0.042</td><td align="left" valign="top">FGFR</td><td align="char" valign="top" char=".">1.6</td></tr><tr valign="top"><td align="left" valign="top">Lyn</td><td align="char" valign="top" char=".">0.021</td><td align="left" valign="top">KDR</td><td align="char" valign="top" char=".">5.1</td></tr><tr valign="top"><td align="left" valign="top">Syk</td><td align="char" valign="top" char=".">0.20</td><td align="left" valign="top">c-Kit</td><td align="char" valign="top" char=".">0.56</td></tr><tr valign="top"><td align="left" valign="top">ZAP-70</td><td align="char" valign="top" char=".">1.5</td><td align="left" valign="top">b-Raf</td><td align="char" valign="top" char=".">0.54</td></tr><tr valign="top"><td align="left" valign="top">Tyk2</td><td align="char" valign="top" char=".">1.2</td><td align="left" valign="top">JNK2</td><td align="char" valign="top" char=".">>40</td></tr><tr valign="top"><td align="left" valign="top">JAK3</td><td align="char" valign="top" char=".">0.15</td><td align="left" valign="top">JNK3</td><td align="char" valign="top" char=".">7.3</td></tr><tr valign="top"><td align="left" valign="top">Itk</td><td align="char" valign="top" char=".">>20</td><td align="left" valign="top">p38α</td><td align="char" valign="top" char=".">>10</td></tr><tr valign="top"><td align="left" valign="top">Btk</td><td align="char" valign="top" char=".">0.41</td><td align="left" valign="top">ERK1</td><td align="char" valign="top" char=".">>100</td></tr><tr valign="top"><td align="left" valign="top">c-Met</td><td align="char" valign="top" char=".">>10</td><td align="left" valign="top">CDK5</td><td align="char" valign="top" char=".">>10</td></tr><tr valign="top"><td align="left" valign="top">Tie-2</td><td align="char" valign="top" char=".">0.75</td><td align="left" valign="top">MSK1</td><td align="char" valign="top" char=".">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the means of two or more separate determinations, in duplicate; standard deviations were generally within ±30% of the mean.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cellular Profile of Compound <b>25</b></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom">cell assay<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></th><th align="center" valign="bottom" char=".">IC<sub>50</sub><a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a> (µM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">IL-2</td><td align="char" valign="top" char=".">0.46</td></tr><tr valign="top"><td align="left" valign="top">T-cell prolif.</td><td align="char" valign="top" char=".">0.53</td></tr><tr valign="top"><td align="left" valign="top">huWB IL-2</td><td align="char" valign="top" char=".">1.2</td></tr><tr valign="top"><td align="left" valign="top">huMLR</td><td align="char" valign="top" char=".">0.047</td></tr><tr valign="top"><td align="left" valign="top">TCR ζ-chain</td><td align="char" valign="top" char=".">1.6</td></tr><tr valign="top"><td align="left" valign="top">PMA/iono</td><td align="char" valign="top" char=".">5.8</td></tr><tr valign="top"><td align="left" valign="top">JKT</td><td align="char" valign="top" char=".">0.49</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">IL-2: anti-CD3/CD28-induced T-cell IL-2 secretion assay; T-cell prolif.: anti-CD3/CD28-induced T-cell proliferation assay; huWB IL-2: anti-CD3/CD28-induced T-cell IL-2 secretion assay using human whole blood; huMLR: human mixed lymphocyte reaction; TCR ζ-chain: T-cell receptor ζ-chain phosphorylation assay; PMA/iono: anti-CD3/CD28-induced T-cell IL-2 secretion assay stimulated with phorbol myristic acid and calcium ionophore; JKT: Jurkat proliferation/survival assay. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for a description of each assay.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values are the means of two or more separate determinations, in duplicate; standard deviations were generally within ±30% of the mean.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Parameters for Compound <b>25</b> following IV Dose in Sprague–Dawley Rats<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom" char=".">dose<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a> (mg/kg)</th><th align="center" valign="bottom" char=".">AUC<sub>0→∞</sub> (ng h/mL)</th><th align="center" valign="bottom" char=".">CL (L/h/kg)</th><th align="center" valign="bottom" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th align="center" valign="bottom" char="."><i>t</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top"><td align="char" valign="top" char=".">2</td><td align="char" valign="top" char=".">1153 ± 137</td><td align="char" valign="top" char=".">1.8 ± 0.3</td><td align="char" valign="top" char=".">7.5 ± 1.4</td><td align="char" valign="top" char=".">3.12 ± 0.04</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last"><i>n</i> = 3 animals per study.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">Dosed as a solution in DMSO.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Structural Confirmation</h3><div class="NLM_p">To confirm the binding elements responsible for the observed potency and selectivity of this series of compounds, we obtained a cocrystal structure of Lck with 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one <b>25</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Consistent with findings from our previous work,<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> the aniline side chain of <b>25</b> extends to the mouth of the ATP-binding pocket, with the <i>N</i>-methylpiperazine moiety fully exposed to solvent. The 6-phenyl group is rotated 80 degrees from the tetracyclic plane due to the presence of the 2,6-substituents, which appropriately orients the aromatic ring to enter the deep hydrophobic pocket adjoining the ATP-binding site. Hydrogen bond interactions between the inhibitor <b>25</b> and the linker region of the protein are similar to those observed with compound <b>1</b> and described above. Additionally, a novel, fourth hydrogen bond is observed. As we hypothesized, the carbonyl of the tetracycle <b>25</b> accepts a hydrogen bond from the γ-OH of Thr316 (2.7 Å). This interaction with the threonine gatekeeper of Lck is most likely responsible for the observed selectivity over KDR, which possesses a valine at this position. Although p38α also contains a threonine side-chain in the gatekeeper position, the most common conformation observed for this threonine in p38α structures available through the Protein Data Bank positions the γ-OH away from the ATP-binding site where it mediates a hydrogen bond between main chain atoms from strands β4 and β5.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This side-chain conformation positions the γ-methyl of Thr106 near the ATP-binding pocket, which would yield an unfavorable interaction with the carbonyl of <b>25</b>. However, two structures of apo p38α have been reported in which the Thr106 side chain adopts a conformation similar to that seen in the Lck structures presented here.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Selectivity of this series of compounds over p38α may instead result from the presence of Ile84 on strand β4 of p38α, which places a δ-methyl group in close proximity to the tetracycle carbonyl oxygen (∼2.5 Å; model not shown). The equivalent residue in all Src-family kinases is a valine, with the γ-methyl of this valine (301) in Lck residing 3.5 Å away from the carbonyl oxygen of <b>25</b>.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray cocrystal structure of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one <b>25</b> bound to Lck.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Kinase Selectivity Profile</h3><div class="NLM_p last">To evaluate tetracyclic pyrimidine <b>25</b> in an in vivo setting, it was critical to understand the selectivity profile of this molecule. To that end, compound <b>25</b> was assayed against an extended panel of tyrosine and serine/threonine kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Within the protein tyrosine kinase (PTK) group, tetracycle <b>25</b> was selective (>100-fold) over representatives from the VEGFR, FGFR, InsR, Tie, and Met families, with a slight decrease in selectivity (20- to 50-fold) over members of the Tec, Syk, and Jak families. Greater selectivity was seen over kinases outside of the PTK group (CMGC and AGC), as <b>25</b> demonstrated >1000-fold selectivity over MAPK, CDK, and RSK family representatives. As expected, due to the close homology of Lck to other members of the Src family, little selectivity was observed against Src or Lyn.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cellular Activity</h3><div class="NLM_p last">To further characterize the cellular properties of tetracycle <b>25</b>, it was subjected to a series of functional cell assays. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, compound <b>25</b> exhibited good potency in the T-cell receptor-induced IL-2 secretion assay (IL-2) and also inhibited subsequent T-cell proliferation (T-cell prolif.) in the same human T -cells. When the IL-2 secretion assay was performed using human whole blood (huWB IL-2), there was only a 3-fold shift in potency. Tetracyclic pyrimidine <b>25</b> also inhibited a human mixed lymphocyte reaction (huMLR) with a 10-fold increase in potency as compared to the other in vitro cell assays utilizing purified human cells. This shift in potency is most likely due to the longer duration of the MLR assay as compared to the IL-2 secretion and proliferation assays. This compound also displayed inhibition of a mechanism-based biochemical cell assay probing Lck-dependent TCR ζ-chain phosphorylation (TCR ζ-chain). As expected, the compound showed a 10-fold reduction in potency when IL-2 was induced in a receptor-independent fashion by stimulating with phorbol ester and calcium ionophore (PMA/iono). In addition, the compound exhibited a similar level of potency when tested in a general proliferation assay using the human T-cell line, Jurkat (JKT), suggesting the possibility of some off-target kinase activity. With this promising in vitro data, we set out to examine the in vivo properties of <b>25</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Pharmacokinetic Profile</h3><div class="NLM_p">The pharmacokinetic properties of tetracyclic pyrimidine <b>25</b> were assessed in the rat following both intravenous (i.v.) and oral (p.o.) dosing (Tables <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, respectively). The compound displayed a moderate clearance (1.8 L/h/kg) and high volume of distribution (<i>V</i><sub>ss</sub> = 7.5 L/kg), resulting in a half-life of 3.12 h after i.v. dosing. When dosed p.o. (5 mpk administered as an aqueous suspension in 1% Tween 80 in 2% HPMC), compound <b>25</b> had a <i>t</i><sub>max</sub> of 3.0 h, with a relatively low bioavailability (17%), but was still a suitable tool for further proof of concept studies.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Parameters for Compound <b>25</b> following Oral Dose in Sprague–Dawley Rats<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom" char=".">dose<a class="ref internalNav" href="#tbl7-fn2" aria-label="b">b</a> (mg/kg)</th><th align="center" valign="bottom" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th align="center" valign="bottom" char="."><i>t</i><sub>max</sub> (h)</th><th align="center" valign="bottom" char=".">AUC<sub>0→∞</sub> (ng h/mL)</th><th align="center" valign="bottom" char=".">bioavailability, <i>F</i> (%)</th></tr></thead><tbody><tr valign="top"><td align="char" valign="top" char=".">5</td><td align="char" valign="top" char=".">82 ± 8</td><td align="char" valign="top" char=".">3.0 ± 1.0</td><td align="char" valign="top" char=".">862 ± 34</td><td align="char" valign="top" char=".">17</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last"><i>n</i> = 2 animals per study.</p></div><div class="footnote" id="tbl7-fn2"><sup>b</sup><p class="last">Dosed as an aqueous suspension in 1% Tween 80 in 2% HPMC.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Pharmacodynamic Profile</h3><div class="NLM_p">On the basis of its PK and selectivity profile, tetracyclic pyrimidine <b>25</b> was tested in a short-term T-cell receptor dependent mouse model. A single dose of <b>25</b> was administered at 3, 10, and 30 mg/kg orally to mice and evaluated for its ability to inhibit anti-CD3-mediated IL-2 secretion in serum (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The compound showed a dose-dependent inhibition of IL-2 production with an ED<sub>50</sub> estimated at 26 mg/kg.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound<b>25</b> on anti-CD3-induced IL-2 production in mice. BALB/c mice were dosed 1 h prior to challenge with compound p.o. (eight per group), as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Mice were then challenged i.v. with antimouse CD3ϵ monoclonal antibody. A total of 90 min after the challenge, IL-2 levels in serum were determined by ELISA. Data points represent the mean IL-2 levels/group ± the standard error. <i>P</i> values were determined vs vehicle control by Mann–Whitney U-test. *Indicates <i>P</i> ≤ 0.05. From this experiment, the ED<sub>50</sub> of compound <b>25</b> was estimated at 26 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Vivo Arthritis Models</h3><div class="NLM_p">Based on its promising activity in the in vivo mouse IL-2 model, compound <b>25</b> was tested in two in vivo disease models of arthritis. In the adjuvant-induced arthritis model, arthritis was induced by injection of a suspension of <i>Mycobacterium tuberculosis</i> H37Ra in paraffin oil (0.5 mg/rat) into the base of the tail of male Lewis rats, and the disease was allowed to progress for 9 days. A once daily dose of <b>25</b> was administered orally at 10, 30, and 60 mg/kg from day 9 to day 17. Paw volume was measured daily from day 9 through day 18. The compound showed a dose-dependent inhibition of arthritis, with an ED<sub>50</sub> estimated at 24 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Based on the measured plasma levels from the three dose groups, the exposure of <b>25</b> at the ED<sub>50</sub> was estimated to be 2.7 µM·h (<i>C</i><sub>max</sub> ≈ 0.7 µM). In a separate study, arthritis was induced by intradermal injection of Porcine type II collagen emulsified in IFA to female Lewis rats. Disease onset occurred 10–12 days following immunization. Compound <b>25</b> was administered orally at 0.3, 1, 3, and 10 mg/kg once daily for 7 days. The anti-inflammatory effect of <b>25</b> was determined by measuring paw diameter daily for 7 days. Compound <b>25</b> showed a dose-dependent inhibition of arthritis with an ED<sub>50</sub> estimated at 3.2 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Based on the measured plasma levels from the three dose groups, the exposure of <b>25</b> at the ED<sub>50</sub> was estimated to be 3.3 µM·h (<i>C</i><sub>max</sub> ≈ 0.5 µM).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>25</b> on adjuvant-induced arthritis in the rat. Arthritis was induced by administration of <i>Mycobacterium tuberculosis</i> H37Ra suspended in paraffin oil and injected into the base of the tail (0.5 mg/rat) on day 0 to male Lewis rats (∼250 g, obtained from CRL, Andover, MA). Compound <b>25</b> or vehicle was administered orally, once daily from day 9 to day 17. Paw volume was measured daily from day 9 through day 18. Values represent the mean ± standard error for <i>N</i> = 8 animals per group. *Indicates <i>P</i> < 0.05 vs vehicle control by Mann–Whitney U-test. From this experiment, the ED<sub>50</sub> of <b>25</b> was estimated as 24 mg/kg (AUC, 2.7 µM·h; <i>C</i><sub>max</sub>, 0.7 µM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>25</b> on collagen-induced arthritis in the rat. Arthritis was induced by intradermal injection of Porcine type II collagen emulsified in IFA to female Lewis rats. Animals were assigned to a treatment group at disease onset (study day 0), which occurred 10–12 days following immunization. Compound <b>25</b> or vehicle was administered orally, once daily for 7 days. Paw diameter was measured daily from day 0 through day 7. Values represent the mean ± standard error for <i>N</i> = 8 animals per group. *Indicates <i>P</i> < 0.05 vs vehicle control by Mann–Whitney U-test. From this experiment, the ED<sub>50</sub> of <b>25</b> was estimated as 3.2 mg/kg (AUC, 3.3 µM·h; <i>C</i><sub>max</sub>, 0.5 µM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The novel 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones have been shown to be potent and selective inhibitors of Lck. Our investigation of this series of compounds combined with structural analysis has identified the key components necessary for kinase inhibition and selectivity. Optimization efforts led to tetracyclic pyrimidine <b>25</b>, which exhibits potent and selective inhibition of Lck kinase activity. This activity translates into mechanism-based inhibition of cell-based T-cell activation in vitro and in vivo and disease modification of T-cell mediated arthritis.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. The synthesis of anilines <b>14a</b>–<b>h</b> has been previously reported.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> 4-(3-Piperidin-1-yl-propoxy)-phenylamine (<b>14i</b>) was prepared as previously reported.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> 4-(2-(Dimethylamino)ethoxy)-3-methoxyaniline was obtained from Evotec OAI, Oxon, U.K. Anhydrous solvents were obtained from Aldrich and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. All final compounds were purified to >95% purity, as determined by high-performance liquid chromatography (HPLC). Purity was measured using Agilent 1100 Series high performance liquid chromatography (HPLC) systems with UV detection at 254 nm (System A: Agilent Zorbax Eclipse XDB-C8 4.6 × 150 mm, 5 μm, 5 to 100% CH<sub>3</sub>CN in H<sub>2</sub>O, with 0.1% TFA, for 15 min at 1.5 mL/min; System B: Zorbax SB-C8, 4.6 × 75 mm, 10 to 90% CH<sub>3</sub>CN in H<sub>2</sub>O, with 0.1% formic acid, for 12 min at 1.0 mL/min). Silica gel columns were performed using either glass columns packed with silica gel (200–400 mesh, Aldrich Chemical) or prepacked silica gel cartridges (Biotage). <sup>1</sup>H NMR spectra were recorded on a Bruker AV-400 (400 MHz) spectrometer or a Varian 400 MHz spectrometer at ambient temperature. All observed protons are reported as parts per million (ppm) downfield from tetramethylsilane (TMS) or other internal reference in the appropriate solvent indicated. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and number of protons. Low-resolution mass spectral (MS) data were determined on an Agilent 1100 Series LCMS with UV detection at 254 nm and a low resonance electrospray mode (ESI). High resolution mass spectra were obtained on a high resonance electrospray time-of-flight mass spectrometer. Combustion analysis was performed by Galbraith Laboratories, Knoxville, TN, and were within 0.4% of calculated, unless otherwise noted.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(2,6-Dimethylphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-amine Hydrochloride (19a)</h3><div class="NLM_p last">A mixture of 2-chlorobenzimidazole (0.500 g, 3.28 mmol) and 2,6-dimethylaniline (2.94 g, 3.00 mL, 24.2 mmol) was heated at 100 °C for 24 h. The mixture was cooled to room temperature, and the solvent was removed under reduced pressure to afford an oily residue. Trituration with ethyl acetate afforded <i>N</i>-(2,6-dimethylphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-amine hydrochloride (<b>19a</b>; 0.707 g, 79%) as a dark purple solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.24 (s, 6 H), 7.13 – 7.56 (m, 7 H), 10.78 (s, 1 H), 12.73 (s, 2 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i> 238 (M + 1).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 6-(2,6-Dimethylphenyl)-2-methylthio-benzo[4,5]imidazolo[1,2-<i>a</i>]pyrimido[5,6-<i>e</i>]pyrimidin-5-one (21a)</h3><div class="NLM_p last">A mixture of ethyl 4-chloro-2-methylthiopyrimidine-5-carboxylate (<b>20</b>; 12.5 g, 54 mmol), <i>N</i>-(2,6-dimethylphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-amine hydrochloride (<b>19a</b>; 13.5 g, 49 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (17.6 mL, 102 mmol) in toluene (30 mL) was refluxed for 3 days. The solvent was removed under reduced pressure and the residue was partitioned between dichloromethane and 2 N HCl (aq). The organic phase was washed with additional 2 N HCl (aq) and then brine. The resulting suspension was then dissolved completely by heating and concentrated to 100 mL. The resulting suspension was filtered, and the solids were washed with dichloromethane and dried to afford 6-(2,6-dimethylphenyl)-2-methylthio-benzo[4,5]imidazolo[1,2-<i>a</i>]pyrimido[5,6-<i>e</i>]pyrimidin-5-one (<b>21a</b>; 12.5 g, 60%) as a white amorphous solid. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ ppm 2.3 (s, 6 H), 3.0 (s, 3 H), 7.2–7.3 (m, 2 H), 7.5–7.7 (m, 3 H), 7.8 (m, 1 H), 8.75 (m, 1 H), 9.5 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i> 388 (M + 1).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 6-(2,6-Dimethylphenyl)-2-methanesulphonyl-benzo[4,5]imidazolo[1,2-<i>a</i>]pyrimido[5,4-<i>e</i>]pyrimidin-5-one (22a)</h3><div class="NLM_p last">6-(2,6-Dimethylphenyl)-2-methylthio-benzo[4,5]imidazolo[1,2-<i>a</i>]pyrimido[5,6-<i>e</i>]pyrimidin-5-one (<b>21a</b>; 2.00 g, 5.16 mmol) was suspended in chloroform (50 mL), and a solution of <i>m</i>-chloroperoxybenzoic acid (70%, 2.79 g, 11.3 mmol) in chloroform (50 mL, predried over anhydrous magnesium sulfate prior to addition) was added dropwise. The mixture was stirred for 15 h, dimethylsulphoxide (1.5 mL) was added, and the mixture was stirred for 1 h. Water (10 mL) was added and the organic layer was separated and washed with water, saturated aqueous sodium bicarbonate solution (twice), and brine. The solvent was removed under reduced pressure to give 6-(2,6-dimethylphenyl)-2-methanesulphonyl-benzo[4,5]imidazolo[1,2-<i>a</i>]pyrimido[5,4-<i>e</i>]pyrimidin-5-one (<b>22a</b>; 2.10 g, 97%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ ppm 2.1 (s, 6 H), 3.5 (s, 3 H), 7.2–7.5 (m, 5 H), 7.6 (m, 1 H), 8.6 (m, 1 H), 9.6 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i> 420 (M + 1).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 6-(2,6-Dimethylphenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (25)</h3><div class="NLM_p last">A sealed tube was charged with 6-(2,6-dimethylphenyl)-2-methanesulphonyl-benzo[4,5]imidazolo[1,2-<i>a</i>]pyrimido[5,4-<i>e</i>]pyrimidin-5-one (<b>22a</b>; 3.8 g, 9.0 mmol), 4-(4-methylpiperazin-1-yl)aniline (1.8 g, 10.0 mmol), and isopropanol (75 mL). The tube was flushed with nitrogen for 2 min, fitted with a screw-cap lid, and heated at 85 °C for 15 h. The reaction mixture was cooled to room temperature and concentrated. The green residue was partitioned between dichloromethane and 1 M aqueous sodium hydroxide solution. The aqueous phase was separated and extracted with dichloromethane. The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated to give a dark green oil. This material was purified via column chromatography on silica gel (eluting with 10% methanol−dichloromethane) to afford 6-(2,6-dimethylphenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (<b>25</b>; 2.76 g, 58%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.05 (s, 6 H), 2.25 (s, 3 H), 2.45–2.54 (m, 4 H), 3.10–3.18 (m, 2 H), 3.18–3.26 (m, 2 H), 7.00 (d, <i>J</i> = 8.4 Hz, 1 H), 7.08 (d, <i>J</i> = 8.2 Hz, 1 H), 7.20–7.29 (m, 2 H), 7.30–7.43 (m, 3 H), 7.49–7.65 (m, 3 H), 8.36 (d, <i>J</i> = 7.7 Hz, 1 H), 9.08 (s, 1 H), 10.55 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 531 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 531.26153; found, 531.26176. Anal. (C<sub>31</sub>H<sub>30</sub>N<sub>8</sub>·1.5 H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-((4-((3-(Dimethylamino)propyl)oxy)phenyl)amino)-6-(2,6-dimethylphenyl)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (28)</h3><div class="NLM_p">A sealed tube was charged with 6-(2,6-dimethylphenyl)-2-methanesulphonyl-benzo[4,5]imidazolo[1,2-<i>a</i>]pyrimido[5,4-<i>e</i>]pyrimidin-5-one (<b>22a</b>; 1.0 g, 2.4 mmol), 4-(3-(dimethylamino)propoxy)aniline (0.47 g, 2.6 mmol), and isopropanol (30 mL). Trifluoroacetic acid (0.60 g, 4.8 mmol) was added, and the tube was flushed with nitrogen for 2 min, fitted with a screw-cap lid, and heated at 85 °C for 15 h. The reaction mixture was cooled to room temperature and concentrated. The green residue was partitioned between dichloromethane (30 mL) and 1 M aq sodium hydroxide solution (10 mL). The aqueous phase was separated and extracted with dichloromethane. The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated to give a yellow solid. This material was purified via column chromatography on silica gel (eluting with 5% methanol-dichloromethane) to afford 2-((4-((3-(dimethylamino)-propyl)oxy)phenyl)amino)-6-(2,6-dimethylphenyl)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (<b>28</b>; 1.2 g, 93%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.84–1.95 (m, 2 H), 2.06 (s, 6 H), 2.18 (s, 6 H), 2.34–2.45 (m, 2 H), 3.93–4.13 (m, 2 H), 6.96–7.03 (m, 1 H), 7.08 (d, <i>J</i> = 6.3 Hz, 1 H), 7.25 (s, 1 H), 7.27 (s, 1 H), 7.30–7.41 (m, 1 H), 7.32–7.36 (m, 2 H), 7.54 (d, <i>J</i> = 7.1 Hz, 1 H), 7.58–7.71 (m, 2 H), 8.32 (d, <i>J</i> = 9.3 Hz, 1 H), 9.09 (s, 1 H), 10.60 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 534 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 534.26120; found, 534.26178. Anal. (C<sub>31</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>) C, H, N.</div><div class="NLM_p last">The following compounds were synthesized according to the general procedure detailed above for compound <b>25</b>:</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 6-(2,6-Dimethylphenyl)-2-((3-(methoxy)-4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (26)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.06 (s, 6 H), 2.24 (s, 3 H), 2.44–2.56 (m, 4 H), 2.92–3.11 (m, 4 H), 3.80 (s, 3 H), 6.90–7.04 (m, 1 H), 7.14–7.24 (m, 1 H), 7.25 (s, 1 H), 7.27 (s, 1 H), 7.30–7.43 (m, 4 H), 7.55 (d, <i>J</i> = 8.2 Hz, 1 H), 8.33–8.40 (m, 1 H), 9.11 (s, 1 H), 10.60 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 561 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 561.27210; found, 561.27267. Anal. (C<sub>32</sub>H<sub>32</sub>N<sub>8</sub>O<sub>2</sub>·2 H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 6-(2,6-Dimethylphenyl)-2-((3-(methoxy)-4-((2-(4-methyl-1-piperazinyl)ethyl)oxy)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (29)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.06 (s, 6 H), 2.17 (s, 3 H), 2.30–2.43 (m, 4 H), 2.48–2.59 (m, 4 H), 2.64–2.77 (m, 2 H), 3.79 (s, 3 H), 4.02–4.17 (m, 2 H), 7.01–7.20 (m, 2 H), 7.25 (s, 1 H), 7.27 (s, 1 H), 7.31–7.44 (m, 4 H), 7.55 (d, <i>J</i> = 7.7 Hz, 1 H), 8.37 (d, <i>J</i> = 6.7 Hz, 1 H), 9.11 (s, 1 H), 10.59 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 605 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 605.29831; found, 605.29925. Anal. (C<sub>34</sub>H<sub>36</sub>N<sub>8</sub>O<sub>3</sub>·7 H<sub>2</sub>O) C. H: calcd, 6.90; found, 5.96; N: calcd, 15.33; found, 14.25.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-((3,5-Dimethoxy)-4-((2-(4-methyl-1-piperazinyl)ethyl)oxy)phenyl)amino)-6-(2,6-dimethylphenyl)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (30)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.06 (s, 6 H), 2.17 (s, 3 H), 2.29–2.41 (m, 4 H), 2.46–2.55 (m, 4 H), 2.60–2.69 (m, 2 H), 3.80 (s, 6 H), 3.93–4.04 (m, 2 H), 6.98–7.06 (m, 1 H), 7.18–7.23 (m, 1 H), 7.26 (s, 1 H), 7.28 (s, 1 H), 7.31–7.40 (m, 3 H), 7.52–7.59 (m, 1 H), 8.42 (s, 1 H), 9.14 (s, 1 H), 10.60 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 635 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 635.30888; found, 635.30868. Anal. (C<sub>35</sub>H<sub>38</sub>N<sub>8</sub>O<sub>4</sub>·1.5 H<sub>2</sub>O) C, H. N: calcd, 16.93; found:16.24.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 6-(2,6-Dimethylphenyl)-2-((3-fluoro-4-((2-(4-methyl-1-piperazinyl)ethyl)oxy)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (31)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.06 (s, 6 H), 2.16 (s, 3 H), 2.29–2.38 (m, 4 H), 2.47–2.57 (m, 4 H), 2.68–2.78 (m, 2 H), 4.07–4.29 (m, 2 H), 7.23–7.49 (m, 7 H), 7.56 (d, <i>J</i> = 8.8 Hz, 1 H), 7.67–7.87 (m, 1 H), 8.38 (d, <i>J</i> = 9.7 Hz, 1 H), 9.14 (s, 1 H), 10.74 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 593 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 593.27833; found, 593.27937. Anal. (C<sub>33</sub>H<sub>33</sub>FN<sub>8</sub>O<sub>2</sub>·1 CH<sub>3</sub>OH) C, H, N.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 6-(2,6-Dimethylphenyl)-2-((3-(methoxy)-4-((3-(4-methyl-1-piperazinyl)propyl)oxy)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (34)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.82–1.95 (m, 2 H), 2.06 (s, 6 H), 2.15 (s, 3 H), 2.24–2.48 (m, 10 H), 3.79 (s, 3 H), 3.94–4.11 (m, 2 H), 6.96–7.12 (m, 1 H), 7.13–7.24 (m, 1 H), 7.24–7.29 (m, 2 H), 7.30–7.44 (m, 4 H), 7.55 (d, <i>J</i> = 7.8 Hz, 1 H), 8.36 (d, <i>J</i> = 9.4 Hz, 1 H), 9.11 (s, 1 H), 10.58 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 619 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 619.31396; found, 619.31449. Anal. (C<sub>35</sub>H<sub>38</sub>N<sub>8</sub>O<sub>3</sub>·1.5 H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-((3,5-Dimethoxy)-4-((3-(4-methyl-1-piperazinyl)propyl)oxy)phenyl)amino)-6-(2,6-dimethylphenyl)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (35)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.74–1.88 (m, 2 H), 2.06 (s, 6 H), 2.25 (s, 3 H), 2.36–2.60 (m, 10 H), 3.79 (s, 6 H), 3.86–4.01 (m, 2 H), 7.01 (s, 1 H), 7.15–7.24 (m, 1 H), 7.24–7.30 (m, 2 H), 7.30–7.43 (m, 3 H), 7.56 (d, <i>J</i> = 8.7 Hz, 1 H), 8.39 (s, 1 H), 9.14 (s, 1 H), 10.60 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 649 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 649.32453; found, 649.32443. Anal. (C<sub>36</sub>H<sub>40</sub>N<sub>8</sub>O<sub>4</sub>·2.5 H<sub>2</sub>O) C, H, N: calcd, 16.15; found, 15.48.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-(2,6-Dichlorophenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (36)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.27 (s, 3 H), 2.48–2.58 (m, 4 H), 3.15 (d, <i>J</i> = 4.1 Hz, 2 H), 3.19–3.28 (m, 2 H), 7.00 (d, <i>J</i> = 8.4 Hz, 1 H), 7.05–7.14 (m, 1 H), 7.29 (t, <i>J</i> = 7.3 Hz, 1 H), 7.34–7.49 (m, 2 H), 7.52–7.64 (m, 2 H), 7.64–7.71 (m, 1 H), 7.75–7.83 (m, 2 H), 8.34 (d, <i>J</i> = 7.8 Hz, 1 H), 9.11 (s, 1 H), 10.70 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 571 (M + 1). HPLC purity: 100% (system A), 99% (system B). HRMS ([M + H]<sup>+</sup>) calcd, 571.15229; found, 571.15223.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-((4-(4-Methyl-1-piperazinyl)phenyl)amino)-6-(2,4,6-trichlorophenyl)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (37)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.25 (s, 3 H), 2.43–2.50 (m, 4 H), 3.09–3.18 (m, 2 H), 3.18–3.28 (m, 2 H), 7.00 (d, <i>J</i> = 8.9 Hz, 1 H), 7.09 (d, <i>J</i> = 8.8 Hz, 1 H), 7.23–7.48 (m, 2 H), 7.52–7.67 (m, 3 H), 8.06 (s, 2 H), 8.33 (d, <i>J</i> = 7.6 Hz, 1 H), 9.05–9.19 (m, 1 H), 10.71 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 605 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 605.11332; found, 605.11312. Anal. (C<sub>29</sub>H<sub>23</sub>Cl<sub>3</sub>N<sub>8</sub>O·H<sub>2</sub>O) H. C: calcd, 55.83; found, 55.25; N: calcd, 17.96; found, 16.72.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 6-(4-Methylphenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (38)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.42 (s, 3 H), 2.50 (s, 3 H), 2.52–2.65 (m, 4 H), 2.80–3.08 (m, 4 H), 6.98–7.18 (m, 3 H), 7.19–7.29 (m, 1 H), 7.30–7.41 (m, 4 H), 7.46–7.69 (m, 3 H), 8.34 (d, <i>J</i> = 7.3 Hz, 1 H), 9.04 (s, 1 H), 10.54 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 517 (M + 1). HPLC purity: 94% (system A), 95% (system B). HRMS ([M + H]<sup>+</sup>) calcd, 517.24588; found, 517.24490.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 6-(3-Methylphenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (39)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.21–2.29 (m, 3 H), 2.40 (s, 3 H), 2.45–2.57 (m, 4 H), 3.05–3.27 (m, 4 H), 6.91–7.14 (m, 2 H), 7.19–7.39 (m, 5 H), 7.43–7.67 (m, 4 H), 8.34 (d, <i>J</i> = 8.4 Hz, 1 H), 9.06 (s, 1 H), 10.51 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 517 (M + 1). HPLC purity: 96% (system A), 96% (system B). HRMS ([M + H]<sup>+</sup>) calcd, 517.24588; found, 517.24633.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-(3-(Methoxy)phenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido-[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (40)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.25 (s, 3 H), 2.44–2.55 (m, 4 H), 3.07–3.24 (m, 4 H), 3.79 (s, 3 H), 6.88–7.13 (m, 5 H), 7.20–7.39 (m, 2 H), 7.44–7.69 (m, 4 H), 8.34 (d, <i>J</i> = 7.5 Hz, 1 H), 9.06 (s, 1 H), 10.51 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 533 (M + 1). HPLC purity: 98% (system A), 99% (system B). HRMS ([M + H]<sup>+</sup>) calcd, 533.24080; found, 533.24237.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6-(5-Chloro-2-(methoxy)phenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]-benzimidazol-5(6<i>H</i>)-one (41)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.25 (s, 3 H), 2.44–2.58 (m, 4 H), 3.05–3.27 (m, 4 H), 3.74 (s, 3 H), 6.93–7.15 (m, 2 H), 7.19–7.45 (m, 4 H), 7.48–7.69 (m, 4 H), 8.33 (d, <i>J</i> = 7.9 Hz, 1 H), 9.07 (s, 1 H), 10.57 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 567 (M + 1). HPLC purity: 96% (system A), 94% (system B). HRMS ([M + H]<sup>+</sup>) calcd, 567.20183; found, 567.20314.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 6-(4-(Butoxy)phenyl)-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (42)</h3><div class="NLM_p"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.97 (t, <i>J</i> = 7.4 Hz, 3 H), 1.40–1.58 (m, 2 H), 1.66–1.84 (m, 2 H), 2.26 (s, 3 H), 2.43–2.59 (m, 4 H), 3.03–3.27 (m, 4 H), 4.07 (t, <i>J</i> = 6.5 Hz, 2 H), 6.92–7.14 (m, 4 H), 7.18–7.42 (m, 4 H), 7.43–7.69 (m, 3 H), 8.33 (d, <i>J</i> = 6.8 Hz, 1 H), 9.03 (s, 1 H), 10.49 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 575 (M + 1). HPLC purity: 98% (system A), 100% (system B). HRMS ([M + H]<sup>+</sup>) calcd, 575.28775; found, 575.28829.</div><div class="NLM_p last">The following compounds were synthesized according to the general procedure detailed above for compound <b>28</b>:</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 6-(2,6-Dimethylphenyl)-2-((3,4,5-trimethoxyphenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (24)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.06 (s, 6 H), 3.73 (s, 3 H), 3.81 (s, 6 H), 7.02 (s, 1 H), 7.21 (s, 1 H), 7.26 (s, 1 H), 7.28 (s, 1 H), 7.32–7.40 (m, 3 H), 7.56 (d, <i>J</i> = 8.2 Hz, 1 H), 8.38–8.47 (m, 1 H), 9.14 (s, 1 H), 10.60 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 523 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 523.20883; found, 523.20942. Anal.(C<sub>29</sub>H<sub>26</sub>N<sub>6</sub>O<sub>4</sub>·2.5 H<sub>2</sub>O) C, N. H: calcd, 5.51; found, 4.75.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-((4-((2-(Dimethylamino)ethyl)oxy)phenyl)amino)-6-(2,6-dimethylphenyl)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (27)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.06 (s, 6 H), 2.20 – 2.30 (m, 6 H), 2.67 (s, 2 H), 3.99 – 4.20 (m, 2 H), 6.97 – 7.05 (m, 1 H), 7.10 (d, <i>J</i> = 7.8 Hz, 1 H), 7.25 (s, 1 H), 7.27 (s, 1 H), 7.31 – 7.37 (m, 2 H), 7.36 – 7.41 (m, 1 H), 7.54 (d, <i>J</i> = 6.8 Hz, 1 H), 7.58 – 7.74 (m, 2 H), 8.33 (d, <i>J</i> = 8.5 Hz, 1 H), 9.10 (s, 1 H), 10.61 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 523 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd: 523.20883 found: 523.20942. Anal. (C<sub>30</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>· H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-((3,5-Dimethoxy)-4-((2-(4-morpholinyl)ethyl)oxy)phenyl)amino)-6-(2,6-dimethylphenyl)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (32)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.06 (s, 6 H), 2.46–2.52 (m, 4 H), 2.62–2.70 (m, 2 H), 3.55–3.62 (m, 4 H), 3.80 (s, 6 H), 3.95–4.06 (m, 2 H), 6.98–7.06 (m, 1 H), 7.17–7.24 (m, 1 H), 7.26 (s, 1 H), 7.28 (s, 1 H), 7.32–7.40 (m, 3 H), 7.56 (d, <i>J</i> = 8.4 Hz, 1 H), 8.37–8.46 (m, 1 H), 9.14 (s, 1 H), 10.61 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 622 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 622.27724; found, 622.27962. Anal. (C<sub>34</sub>H<sub>35</sub>N<sub>7</sub>O<sub>5</sub>·0.5 H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 6-(2,6-Dimethylphenyl)-2-((4-((3-(1-piperidinyl)propyl)oxy)phenyl)amino)pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one (33)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.33–1.43 (m, 2 H), 1.43–1.55 (m, 4 H), 1.83–1.97 (m, 2 H), 2.06 (s, 6 H), 2.26–2.47 (m, 6 H), 3.97–4.14 (m, 2 H), 6.95–7.03 (m, 1 H), 7.08 (d, <i>J</i> = 7.4 Hz, 1 H), 7.23–7.29 (m, 2 H), 7.30–7.43 (m, 3 H), 7.54 (d, <i>J</i> = 7.5 Hz, 1 H), 7.58–7.71 (m, 2 H), 8.28–8.39 (m, 1 H), 9.09 (s, 1 H), 10.60 (s, 1 H). MS (ESI, pos. ion) <i>m</i>/<i>z</i>: 574 (M + 1). HRMS ([M + H]<sup>+</sup>) calcd, 574.29250; found, 574.29376. Anal. (C<sub>34</sub>H<sub>35</sub>N<sub>7</sub>O<sub>2</sub>·H<sub>2</sub>O) C, H. N: calcd, 16.57; found, 15.83.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Lck Kinase Assay</h3><div class="NLM_p">The Lck HTRF kinase assay involved ATP-dependent phosphorylation of a biotinylated substrate peptide of gastrin in the presence or absence of inhibitor compound. The final concentration of gastrin was 1.2 µM. The final concentration of ATP was 0.5 µM (<i>K</i><sub>m</sub> app = 0.6 ± 0.1 µM) and the final concentration of Lck (a GST-kinase domain fusion (AA 225–509)) was 250 pM. Buffer conditions were as follows: 50 mM HEPES, pH = 7.5, 50 mM NaCl, 20 mM MgCl, 5 mM MnCl, 2 mM DTT, 0.05% BSA. The assay was quenched and stopped with 160 μL of detection reagent. Detection reagents were as follows: buffer was made of 50 mM Tris, pH = 7.5, 100 mM NaCl, 3 mM EDTA, 0.05% BSA, 0.1% Tween20. Prior to reading, <i>Streptavidin allophycocyanin</i> (SA-APC) was added at a final concentration in the assay of 0.0004 mg/mL, along with europilated antiphosphotyrosine Ab (Eu-anti-PY) at a final concentration of 0.025 nM. The assay plate was read in a Discovery fluorescence plate reader with excitation at 320 nm and emission at 615 and 655 nm.</div><div class="NLM_p last">Assays for other kinases were done in a similar way as described above, varying the concentrations of enzyme, peptide substrate, and ATP added to the reaction, depending on the specific activity of the kinase and measured <i>K</i><sub>m</sub>ʼs for the substrates.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Human Mixed Lymphocyte Reaction (huMLR)</h3><div class="NLM_p last">This assay tests the potency of T-cell activation inhibitors in an in vitro model of allogeneic T-cell stimulation. Human peripheral blood lymphocytes (hPBL; 2 × 10<sup>5</sup>/well) were incubated with mitomycin C-treated B lymphoblastoid cells (JY cell line (ATCC, Rockville, MD); 1 × 10<sup>5</sup>/well) as allogeneic stimulators in the presence or absence of dilutions of potential inhibitor compound in 96-well round-bottom tissue culture plates. These cultures were incubated at 37 °C in 5% CO<sub>2</sub> for 6 days total. The proliferative response of the hPBL was measured by <sup>3</sup>H-thymidine incorporation overnight between days 5 and 6 after initiation of culture. Cells were harvested onto glass fiber filters and <sup>3</sup>H-thymidine incorporation into DNA was analyzed by liquid scintillation counter.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Jurkat Proliferation/Survival Assay</h3><div class="NLM_p last">This assay tests the general antiproliferative/cytotoxic effect of compounds on the Jurkat human T-cell line (ATCC, Rockville, MD). Jurkat cells (1 × 10<sup>5</sup>/well) were plated in 96-well flat-bottom tissue culture plates with or without compound dilutions and cultured for 72 h at 37 °C in 5% CO<sub>2</sub>. Viable cell number was determined during the last 4 h of culture by adding 10 µL/well WST-8 dye (Alexis; San Diego, CA). WST-8 dye conversion relied on active mitochondrial electron transport for reduction of the tetrazolium dye. The dye conversion was read by OD at 450–600 nM.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Anti-CD3/CD28-Induced T-Cell IL-2 Secretion and Proliferation Assay</h3><div class="NLM_p last">This assay tests the potency of T-cell receptor (TCR; CD3) and CD28 signaling pathway inhibitors in human T-cells. T-cells were purified from human peripheral blood lymphocytes (hPBL) and preincubated with or without compound prior to stimulation with a combination of an anti-CD3 and an anti-CD28 antibody in 96-well tissue culture plates (1 × 10<sup>5</sup>T cells/well). Cells were cultured for ∼20 h at 37 °C in 5% CO<sub>2</sub>, then secreted IL-2 in the supernatants was quantified by cytokine ELISA (Pierce/Endogen, St. Louis, MO). The cells remaining in the wells were then pulsed with <sup>3</sup>H-thymidine overnight to assess the T-cell proliferative response. Cells were harvested onto glass fiber filters and <sup>3</sup>H-thymidine incorporation into DNA was analyzed by liquid scintillation counter. For comparison purposes, phorbol myristic acid (PMA) and calcium ionophore were used in combination to induce IL-2 secretion from purified T-cells. Potential inhibitor compounds were tested for inhibition of this response, as described above for anti-CD3 and anti-CD28 antibodies. Human whole-blood anti-CD3/anti-CD28-induced IL-2 secretion assays were run in a similar fashion as described above using whole blood from normal volunteers diluted 50% in tissue culture medium prior to stimulation.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> TCR ζ-Chain Phosphorylation Assay</h3><div class="NLM_p">Jurkat cells (1.25 × 10<sup>6</sup>/well) were seeded in a 96-well plate (round-bottom) in 150 µL of RPMI + 10% FCS and then preincubated with 50 µL compound or without compound (50 µL medium) at 37 °C for 30 min. For anti-CD3 stimulation, cells were cooled on ice for 15 min and then incubated with 10 µL of anti-CD3 mAb (UCHT-1) at a final concentration of 1.2 µg/mL for 30 min. A total of 20 µL of GAM-IgG<sub>1</sub> was added to cells at 30 µg/mL final and incubated for 20 min on ice. Cells were transferred to a 37 °C water bath and stimulated for 1 min. Cells were spun at speed 1000 rpm in the centrifuge for 5 min. Supernatant was aspirated and cells were lysed in 30 µL of cold lysis buffer (1% Triton X-100 in NaCl/HEPES) with phosphatase/protease inhibitors for 30 min on ice. Lysates were spun at 3000 rpm in the centrifuge for 5 min to remove nuclei before 25 µL of supernatant was transferred to new tubes for the Igen ζ-chain phosphorylation detection assay.</div><div class="NLM_p">A master mix was made containing (vol. per sample tube) 21 µL of Igen dilution buffer (PBS, 1% BSA, 0.1% tween-20; Igen/BioVeris; Gaithersburg, MD), 4 µL of the capture antibody, antihuman CD247 mAb, clone G3 (BD Coulter, San Diego, CA), coupled with Dynabeads M-280, 200 µL of the detection antibody, ruthenylated p-CD3-ζ (415.9A; Santa Cruz Biotech., Santa Cruz, CA) at 1 to 16000 dilution in Igen dilution buffer. A total of 25 µL per sample lysate was transferred from the lysate plate to a tube including the negative and positive controls. Sample tubes were shaken at room temperature overnight. Tubes then were placed in a carousel of Igen tube analyzer and analyzed. The signal-to-noise ratio was generally around 15–20.</div><div class="NLM_p last">The procedure of coupling the capture antibody, antihuman CD247 mAb, clone G3 to Dynabeads M-280 was based on the protocol provided by Dynal Biotech. The procedure of p-CD3-ζ ruthenylation is based on the protocol provided by Bio Veris.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Pharmacokinetic Studies</h3><div class="NLM_p last">Sprague–Dawley rats were administered a solution of compound in DMSO at the indicated doses i.v. For oral dosing, a suspension of the compound in 2% hydroxypropyl methylcellulose with 1% Tween-80 was administered. Samples were taken at the indicated times and analyzed for parent compound by LC-MS.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Anti-CD3-Induced IL-2 Production in Mice</h3><div class="NLM_p last">Twelve week old (20 g) BALB/c mice were dosed 1 h prior to challenge with compound p.o. (eight per group) at the indicated doses in 2% hydroxypropyl methylcellulose with 1% Tween-80. Mice were then challenged i.v. with antimouse CD3ϵ monoclonal antibody (145.2C11, BD PharMingen, San Diego, CA; 3 µg/mouse) diluted in PBS. A total of 90 min after anti-CD3 challenge, blood was collected via cardiac puncture. IL-2 levels were measured in serum by ELISA (BioSource, Camarillo, CA). Data points represent the mean IL-2 levels/group ± the standard error. <i>P</i> values were determined versus vehicle control by Mann–Whitney U-test.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Adjuvant-Induced Arthritis in Rats</h3><div class="NLM_p last">Arthritis was induced on day 0 by injection of <i>Mycobacterium tuberculosis</i> H37Ra suspended in paraffin oil (0.5 mg/rat) into the base of the tail of male Lewis rats (∼250 g, obtained from CRL, Andover, MA). The compound or vehicle (2% hydroxypropyl methylcellulose with 1% Tween-80) was administered orally, once daily from day 9 to day 17. Paw volume was measured daily from day 9 through day 18. Values represent the mean ± standard error for <i>N</i> = 8 animals per group. *<i>P</i> < 0.05 versus vehicle control by Mann–Whitney U-test.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Collagen-Induced Arthritis in Rats</h3><div class="NLM_p last">Arthritis was induced by intradermal injection of Porcine type II collagen emulsified in IFA to female Lewis rats. Animals were assigned to treatment group at disease onset (study day 0), which occurred 10–12 days following immunization. The compound or vehicle (2% hydroxypropyl methylcellulose with 1% Tween-80) was administered orally, once daily for 7 days. Paw diameter was measured daily from day 0 through day 7. Values represent the mean ± standard error for <i>N</i> = 8 animals per group. *<i>P</i> < 0.05 versus vehicle control by Mann–Whitney U-test.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> SIF Solubility Assay</h3><div class="NLM_p last">The solubility media was fasted state simulated intestinal fluid (SIF), pH 6.8, containing 5 mM sodium taurochol, 1.5 mM lecithin, 2.9 mM KH<sub>2</sub>PO<sub>4</sub>, and 0.22 M KCl. The Symyx solubility system (Santa Clara, CA) consisted of a liquid handling robot and an Agilent 1100 HPLC. An experiment template was created for solubility measurements of 24 compounds on a 96-well plate. Samples were prepared assuming a screening criterion of 200 µg/mL solubility. A stock solution was first prepared for each of the 24 compounds on a 24-well plate. A mixed solution of 50/50 CH<sub>3</sub>OH/DME (v/v) was used as the stock solvent. The weight of the solid sample (i.e., 1 mg, to the nearest 0.01 mg) was directly imported, and the appropriate volume of the stock solvent was calculated and dispensed into the 4 mL vial for each compound by the liquid handling robot to obtain a stock concentration of 500 µg/mL. From each of the 24 compound stock solutions, volumes of 200, 250, 250, and 250 µL were robotically transferred to an array of four 1 mL glass vials on a 96-well plate: one vial for the calibration standard and the other three vials for solubility samples. After evaporation of the stock solvent using a centrifugal evaporator, 500 µL of the solubility media was added to the corresponding sample vials on the 96-well plate for each compound to give a calculated concentration of 250 µg/mL. A stir bar was added to each vial using a 96-well stir bar dispenser, and the vials were sealed with a 96-well cap mat. The samples were equilibrated by stirring at 100 rpm for 24 h and subsequently left standing unstirred for an additional 24–48 h at room temperature. After equilibration, 500 µL of 50/50 CH<sub>3</sub>OH/DME was added to the corresponding standard vials on the same plate for each compound to give a calibration concentration of 200 µg/mL. Immediately before solubility measurement by HPLC, the sealed 96-well plate was centrifuged at 1650 rpm for 10 min using a plate centrifuge to allow separation of the compound supernatant from undissolved solid. The solubility samples and the calibration standards in 1 mL vials on a 96-well plate were injected directly onto the HPLC column after centrifuging. A fast gradient method was developed for HPLC throughput, starting with 100% water, containing 0.04% trifluoroacetic acid (TFA) and holding for 0.1 min, then ramping to 100% acetonitrile containing 0.04% TFA in 0.1 min and holding for 1.0 min. A Phenomenex Synergi Hydro-RP C-18 column (10 mm × 2.0 mm, 2 µm) was chosen for retention and resolution of both polar and nonpolar compounds. The injection volume was 2 µL, with a detection wavelength of 220 nm. For each compound, its solubility was quantified through individual standard peak area calibration at a concentration equal to the solubility screening criterion (i.e., 200 µg/mL).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59"><a href="/doi/suppl/10.1021/jm701095m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis and HPLC purity data for the compounds synthesized and data collection and refinement statistics for the X-ray structures of compounds <b>1</b> and <b>25</b> bound to Lck. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701095m/suppl_file/jm701095m-file002.pdf">jm701095m-file002.pdf (193.49 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701095m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew W. Martin</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e5888491888497918ca5848882808bcb868a88"><span class="__cf_email__" data-cfemail="016c60756c6073756841606c66646f2f626e6c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Newcomb</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph J. Nunes</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Boucher</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lilly Chai</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda F. Epstein</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theodore Faust</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvia Flores</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Gallant</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anu Gore</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Gu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Faye Hsieh</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Huang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph L. Kim</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scot Middleton</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kurt Morgenstern</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Oliveira-dos-Santos</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod F. Patel</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Powers</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Rose</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanyan Tudor</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan M. Turci</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew A. Welcher</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debra Zack</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huilin Zhao</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Zhu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaotian Zhu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Ghiron</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monika Ermann</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Johnston</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carl-Gustaf Pierre Saluste</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of HTS and Molecular Pharmacology, and Department of Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, Department of Inflammation, Department of Pharmaceutics, Department of Pharmacokinetics and Drug Metabolism, Department of HTS and Molecular Pharmacology, and Department of Molecular Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Evotec OAI, 151 Milton Park, Abingdon, Oxon OX14 4SD, United Kingdom</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank our colleagues Alan Cheng for the model of compound <b>3</b> in Lck; Matthew Plant for the p38α kinase assay data; Isaac Marx for the resynthesis of <b>1</b> and <b>19a</b>; and Maggie Reed for the SIF solubility assay.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kane, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Signal transduction by the TCR for antigen</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">242</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1016%2FS0952-7915%2800%2900083-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=10781399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsFeqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=242-249&author=L.+P.+Kaneauthor=J.+Linauthor=A.+Weiss&title=Signal+transduction+by+the+TCR+for+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction by the TCR for antigen</span></div><div class="casAuthors">Kane, Lawrence; Lin, Joseph; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">242-249</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 88 refs.  The past several years have seen the beginning of a shift in the way that TCR signal transduction is studied.  Although many investigators continue to identify new mols., particularly adaptor proteins, others have attempted to look at signaling events in a larger cellular context.  Thus the identification of distinct formations of signaling mols. at junctions between T cells and antigen-presenting cells, the role of the cytoskeleton and the partitioning of mols. into specialized lipid subdomains have been the subjects of many publications.  Such concepts are helping to assemble a blueprint of how the myriad adaptors and kinases fit together to effect T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JUFD7STKgLVg90H21EOLACvtfcHk0li3DnlXvVPcSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsFeqsLg%253D&md5=9f3d3db7ba29104a3d68455be77ca6ed</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2800%2900083-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252800%252900083-2%26sid%3Dliteratum%253Aachs%26aulast%3DKane%26aufirst%3DL.%2BP.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DSignal%2520transduction%2520by%2520the%2520TCR%2520for%2520antigen%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D242%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span> </span><span class="NLM_article-title">Leukocyte protein tyrosine kinases: Potential targets for drug discovery</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1146%2Fannurev.immunol.15.1.371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=9143693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK2sXisVCmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=371-404&author=J.+B.+Bolenauthor=J.+S.+Brugge&title=Leukocyte+protein+tyrosine+kinases%3A+Potential+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Leukocyte protein tyrosine kinases: potential targets for drug discovery</span></div><div class="casAuthors">Bolen, Joseph B.; Brugge, Joan S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">371-404</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 222 refs.  Intracellular signal transduction following the extracellular ligation of a wide variety of different types of surface mols. on leukocytes involves the activation of protein tyrosine kinases.  The dependence of successful intracellular signaling on the functions of the nontransmembrane class of protein tyrosine kinases coupled with the cell type-specific expression patterns for several of these enzymes makes them appealing targets for therapeutic intervention.  Development of drugs that can interfere with the catalytic functions of the nontransmembrane protein tyrosine kinases or that can disrupt crit. interactions with regulatory mols. and/or substrates should find clin. applications in the treatment of allergic diseases, autoimmunity, transplantation rejection, and cancer.  Topics discussed include src, lck, lyn, fyn, hck, blk, csk, csk, ctk, tec, btk, itk, tec, bmx, txk, fes, fer, abl, syk, and jak families of kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFmmCM9pk2ebVg90H21EOLACvtfcHk0li3DnlXvVPcSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVCmtrg%253D&md5=077f3fbee0284d0b0f2b744cecc1d5d9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.15.1.371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.15.1.371%26sid%3Dliteratum%253Aachs%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DLeukocyte%2520protein%2520tyrosine%2520kinases%253A%2520Potential%2520targets%2520for%2520drug%2520discovery%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1997%26volume%3D15%26spage%3D371%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, P.</span><span> </span><span class="NLM_article-title">Knockouts of Src-family kinases: Stiff bones, wimpy T cells, and bad memories</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1845</span><span class="NLM_x">–</span> <span class="NLM_lpage">1857</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1101%2Fgad.10.15.1845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=8756343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=1845-1857&author=C.+A.+Lowellauthor=P.+Soriano&title=Knockouts+of+Src-family+kinases%3A+Stiff+bones%2C+wimpy+T+cells%2C+and+bad+memories"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories</span></div><div class="casAuthors">Lowell, Clifford A.; Soriano, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1845-1857</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review, with 121 refs., on Src-family kinases (SFKs) in bone, neural, lymphocyte, and myeloid cell development and in keratinocyte differentiation, the regulation of SFK activity, and SFKs and tumorigenesis by polyomavirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Fr3q0woexLVg90H21EOLACvtfcHk0lgwNvw2uFGTHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGlt7s%253D&md5=b8dc93418adea84de69fb4abade22243</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fgad.10.15.1845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.10.15.1845%26sid%3Dliteratum%253Aachs%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DSoriano%26aufirst%3DP.%26atitle%3DKnockouts%2520of%2520Src-family%2520kinases%253A%2520Stiff%2520bones%252C%2520wimpy%2520T%2520cells%252C%2520and%2520bad%2520memories%26jtitle%3DGenes%2520Dev.%26date%3D1996%26volume%3D10%26spage%3D1845%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Marth, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellins, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearn, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samelson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span> </span><span class="NLM_article-title">Lymphocyte activation provokes modification of a lymphocyte specific protein tyrosine kinase (p56lck)</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">2430</span><span class="NLM_x">–</span> <span class="NLM_lpage">2437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1989&pages=2430-2437&author=J.+D.+Marthauthor=D.+B.+Lewisauthor=M.+P.+Cookeauthor=E.+D.+Mellinsauthor=M.+E.+Gearnauthor=L.+E.+Samelsonauthor=C.+B.+Wilsonauthor=A.+D.+Millerauthor=R.+M.+Perlmutter&title=Lymphocyte+activation+provokes+modification+of+a+lymphocyte+specific+protein+tyrosine+kinase+%28p56lck%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarth%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26aulast%3DMellins%26aufirst%3DE.%2BD.%26aulast%3DGearn%26aufirst%3DM.%2BE.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26aulast%3DWilson%26aufirst%3DC.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26atitle%3DLymphocyte%2520activation%2520provokes%2520modification%2520of%2520a%2520lymphocyte%2520specific%2520protein%2520tyrosine%2520kinase%2520%2528p56lck%2529%26jtitle%3DJ.%2520Immunol.%26date%3D1989%26volume%3D142%26spage%3D2430%26epage%3D2437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Groves, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidos, C. J.</span><span> </span><span class="NLM_article-title">Fyn can partially substitute for Lck in T lymphocyte development</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=417-428&author=T.+Grovesauthor=P.+Smileyauthor=M.+P.+Cookeauthor=K.+Forbushauthor=R.+M.+Perlmutterauthor=C.+J.+Guidos&title=Fyn+can+partially+substitute+for+Lck+in+T+lymphocyte+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGroves%26aufirst%3DT.%26aulast%3DSmiley%26aufirst%3DP.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26aulast%3DForbush%26aufirst%3DK.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26aulast%3DGuidos%26aufirst%3DC.%2BJ.%26atitle%3DFyn%2520can%2520partially%2520substitute%2520for%2520Lck%2520in%2520T%2520lymphocyte%2520development%26jtitle%3DImmunity%26date%3D1996%26volume%3D5%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Palacios, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7990</span><span class="NLM_x">–</span> <span class="NLM_lpage">8000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1038%2Fsj.onc.1208074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=15489916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=7990-8000&author=E.+H.+Palaciosauthor=A.+Weiss&title=Function+of+the+Src-family+kinases%2C+Lck+and+Fyn%2C+in+T-cell+development+and+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span></div><div class="casAuthors">Palacios, Emil H.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">7990-8000</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The function of the Src-family kinases (SFKs) Lck and Fyn in T cells has been intensively studied over the past 15 yr.  Animal models and cell line studies both indicate a crit. role for Lck and Fyn in proximal T-cell antigen receptor (TCR) signal transduction.  Recruited SFKs phosphorylate TCR ITAMs (immunoreceptor tyrosine-based activation motifs) in the CD3 and ζ chains, which then serve as docking sites for Syk-family kinases.  SFKs then phosphorylate and activate the recruited Syk-family kinase.  Lck and Fyn are spatially segregated in cell membranes due to differential lipid raft localization, and may undergo sequential activation.  In addn. to the CD4 and CD8 coreceptors, a recently described adaptor, Unc119, may link SFKs to the TCR.  CD45 and Csk provide pos. and neg. regulatory control of SFK functions, resp., and Csk is constitutively bound to the transmembrane adapter protein, PAG/Cbp.  TCR-based signaling is required at several stages of T-cell development, including at least pre-TCR signaling, pos. selection, peripheral maintenance of naive T cells, and lymphopenia-induced proliferation.  SFKs are required for each of these TCR-based signals, and Lck seems to be the major contributor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC2s7PGSwBibVg90H21EOLACvtfcHk0liotjd1s2EE8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyltb8%253D&md5=d9d1f2697ef4008ee8c8426ac806bd11</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208074%26sid%3Dliteratum%253Aachs%26aulast%3DPalacios%26aufirst%3DE.%2BH.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DFunction%2520of%2520the%2520Src-family%2520kinases%252C%2520Lck%2520and%2520Fyn%252C%2520in%2520T-cell%2520development%2520and%2520activation%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D7990%26epage%3D8000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Molina, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderovskid, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ewijk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narendran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, K.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Profound block in thymocyte development in mice lacking p56lck</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1992&pages=161-164&author=T.+J.+Molinaauthor=K.+Kishiharaauthor=D.+P.+Siderovskidauthor=W.+van+Ewijkauthor=A.+Narendranauthor=E.+Timmsauthor=A.+Wakehamauthor=C.+J.+Paigeauthor=K.-U.+Hartmannauthor=A.+Veilletteauthor=D.+Davidsonauthor=T.+W.+Mak&title=Profound+block+in+thymocyte+development+in+mice+lacking+p56lck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DT.%2BJ.%26aulast%3DKishihara%26aufirst%3DK.%26aulast%3DSiderovskid%26aufirst%3DD.%2BP.%26aulast%3Dvan%2BEwijk%26aufirst%3DW.%26aulast%3DNarendran%26aufirst%3DA.%26aulast%3DTimms%26aufirst%3DE.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DPaige%26aufirst%3DC.%2BJ.%26aulast%3DHartmann%26aufirst%3DK.-U.%26aulast%3DVeillette%26aufirst%3DA.%26aulast%3DDavidson%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DProfound%2520block%2520in%2520thymocyte%2520development%2520in%2520mice%2520lacking%2520p56lck%26jtitle%3DNature%26date%3D1992%26volume%3D357%26spage%3D161%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Levin, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbush, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span> </span><span class="NLM_article-title">A dominant-negative transgene defines a role for p56lck in thymopoiesis</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1671</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=1671-1680&author=S.+D.+Levinauthor=S.+J.+Andersonauthor=K.+A.+Forbushauthor=R.+M.+Perlmutter&title=A+dominant-negative+transgene+defines+a+role+for+p56lck+in+thymopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DS.%2BD.%26aulast%3DAnderson%26aufirst%3DS.%2BJ.%26aulast%3DForbush%26aufirst%3DK.%2BA.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26atitle%3DA%2520dominant-negative%2520transgene%2520defines%2520a%2520role%2520for%2520p56lck%2520in%2520thymopoiesis%26jtitle%3DEMBO%2520J.%26date%3D1993%26volume%3D12%26spage%3D1671%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Seddon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamoyska, R.</span><span> </span><span class="NLM_article-title">TCR signals mediated by Src family kinases are essential for the survival of naïve T cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">2997</span><span class="NLM_x">–</span> <span class="NLM_lpage">3005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=2997-3005&author=B.+Seddonauthor=R.+Zamoyska&title=TCR+signals+mediated+by+Src+family+kinases+are+essential+for+the+survival+of+na%C3%AFve+T+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeddon%26aufirst%3DB.%26aulast%3DZamoyska%26aufirst%3DR.%26atitle%3DTCR%2520signals%2520mediated%2520by%2520Src%2520family%2520kinases%2520are%2520essential%2520for%2520the%2520survival%2520of%2520na%25C3%25AFve%2520T%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D2997%26epage%3D3005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Straus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1992&pages=585-593&author=D.+B.+Strausauthor=A.+Weiss&title=Genetic+evidence+for+the+involvement+of+the+lck+tyrosine+kinase+in+signal+transduction+through+the+T+cell+antigen+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStraus%26aufirst%3DD.%2BB.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520the%2520involvement%2520of%2520the%2520lck%2520tyrosine%2520kinase%2520in%2520signal%2520transduction%2520through%2520the%2520T%2520cell%2520antigen%2520receptor%26jtitle%3DCell%26date%3D1992%26volume%3D70%26spage%3D585%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Goldman, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballas, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutte, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenback, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noraz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, N.</span><span> </span><span class="NLM_article-title">Defective expression of p56lck in an infant with severe combined immunodeficiency</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1172%2FJCI3205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=9664084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK1cXkslOktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=421-429&author=F.+D.+Goldmanauthor=Z.+K.+Ballasauthor=B.+C.+Schutteauthor=J.+Kempauthor=C.+Hollenbackauthor=N.+Norazauthor=N.+Taylor&title=Defective+expression+of+p56lck+in+an+infant+with+severe+combined+immunodeficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Defective expression of p56lck in an infant with severe combined immunodeficiency</span></div><div class="casAuthors">Goldman, Frederick D.; Ballas, Zuhair K.; Schutte, Brian C.; Kemp, John; Hollenback, Clay; Noraz, Nelly; Taylor, Naomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Severe combined immune deficiency (SCID) is a heterogeneous disorder characterized by profound defects in cellular and humoral immunity.  The authors report here an infant with clin. and lab. features of SCID and selective CD4 lymphopenia and lack of CD28 expression on CD8+ T cells.  T cells from this patient showed poor blastogenic responses to various mitogens and IL-2.  Other T cell antigen receptor-induced responses, including upregulation of CD69, were similarly inhibited.  However, more proximal T cell antigen receptor signaling events, such as anti-CD3 induced protein tyrosine phosphorylation, phosphorylation of mitogen-assocd. protein kinase, and calcium mobilization were intact.  Although p59fyn and ZAP-70 protein tyrosine kinases were expressed at normal levels, a marked decrease in the level of p56lck was noted.  Furthermore, this decrease was assocd. with the presence of an alternatively spliced lck transcript lacking the exon 7 kinase encoding domain.  These data suggest that a deficiency in p56lck expression can produce a SCID phenotype in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQfR5Dq3U2CbVg90H21EOLACvtfcHk0liotjd1s2EE8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkslOktLs%253D&md5=7849911b4ebf15c7c430789267b62d96</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1172%2FJCI3205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI3205%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman%26aufirst%3DF.%2BD.%26aulast%3DBallas%26aufirst%3DZ.%2BK.%26aulast%3DSchutte%26aufirst%3DB.%2BC.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DHollenback%26aufirst%3DC.%26aulast%3DNoraz%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DN.%26atitle%3DDefective%2520expression%2520of%2520p56lck%2520in%2520an%2520infant%2520with%2520severe%2520combined%2520immunodeficiency%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1998%26volume%3D102%26spage%3D421%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreirea, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seligmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenhendler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autran, B.</span><span> </span><span class="NLM_article-title">Defective p56lck activity in T cells from an adult patient with idiopathic CD4<sup>+</sup> lymphocytopenia</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1093%2Fintimm%2F12.4.449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=10744646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisl2hsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=449-457&author=P.+Hubertauthor=F.+Bergeronauthor=V.+Ferreireaauthor=M.+Seligmannauthor=E.+Oksenhendlerauthor=P.+Debreauthor=B.+Autran&title=Defective+p56lck+activity+in+T+cells+from+an+adult+patient+with+idiopathic+CD4%2B+lymphocytopenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia</span></div><div class="casAuthors">Hubert, Pascale; Bergeron, Florence; Ferreira, Valerie; Seligmann, Maxime; Oksenhendler, Eric; Debre, Patrice; Autran, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-457</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Idiopathic CD4+ lymphocytopenia (ICL) is defined by a stable loss of CD4+ T cells in the absence of any known cause of immune deficiency.  This syndrome is still of undetd. origin.  It affects adult patients, some of them displaying opportunistic infections similar to HIV-infected subjects.  The hypothesis that the cellular immune defect may be due to biochem. failures of the CD3-TCR pathway is investigated here in a patient assocg. a severe selective CD4+ lymphocytopenia with an increased CD8+ T cell count discovered in the course of a cryptococcal meningitidis.  A 40% redn. of T cell proliferation to CD3-TCR stimulation is obsd. only in the CD4+ subpopulation.  The early CD3-induced protein tyrosine phosphorylations are conserved in both CD4+ and CD8+ subsets, and the levels of the T cell protein tyrosine kinases p56Lck, p59Fyn and ZAP-70 are normal.  However, we find a 50% redn. of p56Lck kinase activity in the patient's T cells compared to a healthy control donor.  P59Fyn activity does not appear to be altered.  Nevertheless, we do not find any genetic abnormality of p56Lck.  These results thus suggest that a defect of an unknown protein regulating p56Lck activity takes place in this patient's T cells.  Taken together, these findings reveal p56Lck alteration in ICL and confirm the crit. role of this kinase in the maintenance of the peripheral CD4+ T cell subpopulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi8OArdolHqbVg90H21EOLACvtfcHk0liotjd1s2EE8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisl2hsrY%253D&md5=4db89cbd808adfb34cc71cc9050aa681</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2F12.4.449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252F12.4.449%26sid%3Dliteratum%253Aachs%26aulast%3DHubert%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DF.%26aulast%3DFerreirea%26aufirst%3DV.%26aulast%3DSeligmann%26aufirst%3DM.%26aulast%3DOksenhendler%26aufirst%3DE.%26aulast%3DDebre%26aufirst%3DP.%26aulast%3DAutran%26aufirst%3DB.%26atitle%3DDefective%2520p56lck%2520activity%2520in%2520T%2520cells%2520from%2520an%2520adult%2520patient%2520with%2520idiopathic%2520CD4%252B%2520lymphocytopenia%26jtitle%3DInt.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D449%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armistead, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouzegh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, E.</span><span> </span><span class="NLM_article-title">Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: Synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4981</span><span class="NLM_x">–</span> <span class="NLM_lpage">4991</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060435i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4981-4991&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=D.+C.+McGowanauthor=D.+M.+Armisteadauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+Bucknerauthor=L.+Chaiauthor=D.+Elbaumauthor=L.+F.+Epsteinauthor=T.+Faustauthor=S.+Flynnauthor=P.+Gallantauthor=A.+Goreauthor=Y.+Guauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=D.+Metzauthor=S.+Middletonauthor=D.+Mohnauthor=K.+Morgensternauthor=M.+J.+Morrisonauthor=P.+M.+Novakauthor=A.+Oliveira-dos-Santosauthor=D.+Powersauthor=P.+Roseauthor=S.+Schneiderauthor=S.+Sellauthor=Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=R.+D.+Whiteauthor=D.+Zackauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhuauthor=C.+Ghironauthor=P.+Amouzeghauthor=M.+Ermannauthor=J.+Jenkinsauthor=D.+Johnstonauthor=S.+Napierauthor=E.+Power&title=Novel+2-aminopyrimidine+carbamates+as+potent+and+orally+active+inhibitors+of+Lck%3A+Synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fjm060435i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060435i%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DArmistead%26aufirst%3DD.%2BM.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DNovak%26aufirst%3DP.%2BM.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSell%26aufirst%3DS.%26aulast%3DTudor%26aufirst%3DY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZack%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DAmouzegh%26aufirst%3DP.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DJenkins%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DS.%26aulast%3DPower%26aufirst%3DE.%26atitle%3DNovel%25202-aminopyrimidine%2520carbamates%2520as%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520Lck%253A%2520Synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4981%26epage%3D4991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: Synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5671</span><span class="NLM_x">–</span> <span class="NLM_lpage">5686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVChsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5671-5686&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=V.+J.+Ceeauthor=L.+Chaiauthor=H.+L.+Deakauthor=L.+F.+Epsteinauthor=T.+Faustauthor=P.+Gallantauthor=S.+D.+Geuns-Meyerauthor=A.+Goreauthor=Y.+Guauthor=B.+Henkleauthor=B.+L.+Hodousauthor=F.+Hsiehauthor=X.+Huangauthor=J.+L.+Kimauthor=J.+H.+Leeauthor=M.+W.+Martinauthor=C.+E.+Masseauthor=D.+C.+McGowanauthor=D.+Metzauthor=D.+Mohnauthor=K.+A.+Morgensternauthor=A.+Oliveira-dos-Santosauthor=V.+F.+Patelauthor=D.+Powersauthor=P.+E.+Roseauthor=S.+Schneiderauthor=S.+A.+Tomlinsonauthor=Y.-Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=R.+D.+Whiteauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhu&title=Discovery+of+aminoquinazolines+as+potent%2C+orally+bioavailable+inhibitors+of+Lck%3A+Synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity</span></div><div class="casAuthors">DiMauro, Erin F.; Newcomb, John; Nunes, Joseph J.; Bemis, Jean E.; Boucher, Christina; Buchanan, John L.; Buckner, William H.; Cee, Victor J.; Chai, Lilly; Deak, Holly L.; Epstein, Linda F.; Faust, Ted; Gallant, Paul; Geuns-Meyer, Stephanie D.; Gore, Anu; Gu, Yan; Henkle, Brad; Hodous, Brian L.; Hsieh, Faye; Huang, Xin; Kim, Joseph L.; Lee, Josie H.; Martin, Matthew W.; Masse, Craig E.; McGowan, David C.; Metz, Daniela; Mohn, Deanna; Morgenstern, Kurt A.; Oliveira-dos-Santos, Antonio; Patel, Vinod F.; Powers, David; Rose, Paul E.; Schneider, Stephen; Tomlinson, Susan A.; Tudor, Yan-Yan; Turci, Susan M.; Welcher, Andrew A.; White, Ryan D.; Zhao, Huilin; Zhu, Li; Zhu, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5671-5686</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lymphocyte-specific kinase (Lck) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and natural killer (NK) cells.  Genetic evidence in both mice and humans demonstrates that Lck kinase activity is crit. for signaling mediated by the T cell receptor (TCR), which leads to normal T cell development and activation.  Selective inhibition of Lck is expected to offer a new therapy for the treatment of T-cell-mediated autoimmune and inflammatory disease.  Screening of our kinase-preferred collection identified aminoquinazoline I as a potent, nonselective inhibitor of Lck and T cell proliferation.  In this report, we describe the synthesis and structure-activity relationships of a series of novel aminoquinazolines possessing in vitro mechanism-based potency.  Two optimized, orally bioavailable compds. exhibit antiinflammatory activity (ED50 of 22 and 11 mg/kg, resp.) in the anti-CD3-induced prodn. of interleukin-2 (IL-2) in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7qaZo8QJ6bVg90H21EOLACvtfcHk0lg31Li7n1HM8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVChsLk%253D&md5=3ed1152bf34749755fdd9c2f8f25950c</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm0605482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605482%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%2BD.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMasse%26aufirst%3DC.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DS.%2BA.%26aulast%3DTudor%26aufirst%3DY.-Y.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520aminoquinazolines%2520as%2520potent%252C%2520orally%2520bioavailable%2520inhibitors%2520of%2520Lck%253A%2520Synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5671%26epage%3D5686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of novel 2,3-diarylfuro[2,3-<i>b</i>]pyridine-4-amines as potent and selective inhibitors of Lck: Synthesis, SAR, and pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2299</span><span class="NLM_x">–</span> <span class="NLM_lpage">2304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2299-2304&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=D.+C.+McGowanauthor=R.+D.+Whiteauthor=J.+L.+Buchananauthor=E.+F.+DiMauroauthor=C.+Boucherauthor=T.+Faustauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=Discovery+of+novel+2%2C3-diarylfuro%5B2%2C3-b%5Dpyridine-4-amines+as+potent+and+selective+inhibitors+of+Lck%3A+Synthesis%2C+SAR%2C+and+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%25202%252C3-diarylfuro%255B2%252C3-b%255Dpyridine-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520Synthesis%252C%2520SAR%252C%2520and%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2299%26epage%3D2304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of 4-amino-5,6-biaryl-furo[2,3-<i>d</i>]pyrimidines as inhibitors of Lck: Development of an expedient and divergent synthetic route and preliminary SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2305-2309&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=A.+Changauthor=T.+Faustauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=T.+L.+Marshallauthor=M.+W.+Martinauthor=D.+C.+McGowanauthor=S.+Schneiderauthor=S.+M.+Turciauthor=R.+D.+Whiteauthor=X.+Zhu&title=Discovery+of+4-amino-5%2C6-biaryl-furo%5B2%2C3-d%5Dpyrimidines+as+inhibitors+of+Lck%3A+Development+of+an+expedient+and+divergent+synthetic+route+and+preliminary+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMarshall%26aufirst%3DT.%2BL.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%25204-amino-5%252C6-biaryl-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520inhibitors%2520of%2520Lck%253A%2520Development%2520of%2520an%2520expedient%2520and%2520divergent%2520synthetic%2520route%2520and%2520preliminary%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2305%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Deak, H. L.; Newcomb, J. R.; Nunes, J. J.; Boucher, C.; Cheng, A. C.; DiMauro, E. F.; Epstein, L. F.; Gallant, P.; Hodous, B. L.; Huang, X.; Lee, J. H.; Patel, V. F.; Schneider, S; Turci, S. M.; Zhu, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: Structure, synthesis, and SAR.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><div class="note"><p class="first last"> <i>18</i>, 1172–1176.</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+L.+Deak&author=J.+R.+Newcomb&author=J.+J.+Nunes&author=C.+Boucher&author=A.+C.+Cheng&author=E.+F.+DiMauro&author=L.+F.+Epstein&author=P.+Gallant&author=B.+L.+Hodous&author=X.+Huang&author=J.+H.+Lee&author=V.+F.+Patel&author=S+Schneider&author=S.+M.+Turci&author=X.+Zhu&title=N-%283-%28Phenylcarbamoyl%29arylpyrimidine%29-5-carboxamides+as+potent+and+selective+inhibitors+of+Lck%3A+Structure%2C+synthesis%2C+and+SAR."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DH.%2BL.%26atitle%3DN-%25283-%2528Phenylcarbamoyl%2529arylpyrimidine%2529-5-carboxamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520Structure%252C%2520synthesis%252C%2520and%2520SAR.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">DiMauro, E. F.; Newcomb, J.; Nunes, J. J.; Bemis, J. E.; Boucher, C.; Chai, L.; Chaffee, S. C.; Deak, H. L.; Epstein, L. F.; Faust, T.; Gallant, P.; Gore, A.; Gu, Y.; Henkle, B.; Hsieh, F.; Huang, X.; Kim, J. L.; Lee, J. H.; Martin, M. W.; McGowan, D. C.; Metz, D.; Mohn, D.; Morgenstern, K. A.; Oliveira-dos-Santos, A.; Patel, V. F.; Powers, D.; Rose, P. E.; Schneider, S.; Tomlinson, S. A.; Tudor, Y.-Y.; Turci, S. M.; Welcher, A. A.; Zhao, H.; Zhu, L.; Zhu, X.</span><span> </span><span class="NLM_article-title">Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of Lck: Synthesis, SAR, and inhibition of in vivo T-cell activation.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><div class="note"><p class="first last"> <i>51</i>, 1681–1694</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=E.+F.+DiMauro&author=J.+Newcomb&author=J.+J.+Nunes&author=J.+E.+Bemis&author=C.+Boucher&author=L.+Chai&author=S.+C.+Chaffee&author=H.+L.+Deak&author=L.+F.+Epstein&author=T.+Faust&author=P.+Gallant&author=A.+Gore&author=Y.+Gu&author=B.+Henkle&author=F.+Hsieh&author=X.+Huang&author=J.+L.+Kim&author=J.+H.+Lee&author=M.+W.+Martin&author=D.+C.+McGowan&author=D.+Metz&author=D.+Mohn&author=K.+A.+Morgenstern&author=A.+Oliveira-dos-Santos&author=V.+F.+Patel&author=D.+Powers&author=P.+E.+Rose&author=S.+Schneider&author=S.+A.+Tomlinson&author=Y.-Y.+Tudor&author=S.+M.+Turci&author=A.+A.+Welcher&author=H.+Zhao&author=L.+Zhu&author=X.+Zhu&title=Structure-guided+design+of+aminopyrimidine+amides+as+potent%2C+selective+inhibitors+of+Lck%3A+Synthesis%2C+SAR%2C+and+inhibition+of+in+vivo+T-cell+activation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DStructure-guided%2520design%2520of%2520aminopyrimidine%2520amides%2520as%2520potent%252C%2520selective%2520inhibitors%2520of%2520Lck%253A%2520Synthesis%252C%2520SAR%252C%2520and%2520inhibition%2520of%2520in%2520vivo%2520T-cell%2520activation.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hanke, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weringer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollok, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a novel, potent, and Src-family-selective tyrosine kinase inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=695-701&author=J.+H.+Hankeauthor=J.+P.+Gardnerauthor=R.+L.+Dowauthor=P.+S.+Changelianauthor=W.+H.+Brissetteauthor=E.+J.+Weringerauthor=B.+A.+Pollokauthor=P.+A.+Connelly&title=Discovery+of+a+novel%2C+potent%2C+and+Src-family-selective+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanke%26aufirst%3DJ.%2BH.%26aulast%3DGardner%26aufirst%3DJ.%2BP.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DWeringer%26aufirst%3DE.%2BJ.%26aulast%3DPollok%26aufirst%3DB.%2BA.%26aulast%3DConnelly%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520novel%252C%2520potent%252C%2520and%2520Src-family-selective%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D695%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Trevillyan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballaron, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putnam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrior, U. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollison, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faltynek, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djuric, S. W.</span><span> </span><span class="NLM_article-title">Inhibition of p56lck tyrosine kinase by isothiazoles</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=1999&pages=19-29&author=J.+M.+Trevillyanauthor=X.+G.+Chiouauthor=S.+J.+Ballaronauthor=Q.+M.+Tangauthor=A.+Bukoauthor=M.+P.+Sheetsauthor=M.+L.+Smithauthor=B.+Putnamauthor=P.+Wiedemanauthor=N.+Tuauthor=D.+Madarauthor=H.+T.+Smithauthor=E.+J.+Gubbinsauthor=U.+P.+Warriorauthor=Y.-W.+Chenauthor=K.+W.+Mollisonauthor=C.+R.+Faltynekauthor=S.+W.+Djuric&title=Inhibition+of+p56lck+tyrosine+kinase+by+isothiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DChiou%26aufirst%3DX.%2BG.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DTang%26aufirst%3DQ.%2BM.%26aulast%3DBuko%26aufirst%3DA.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DPutnam%26aufirst%3DB.%26aulast%3DWiedeman%26aufirst%3DP.%26aulast%3DTu%26aufirst%3DN.%26aulast%3DMadar%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DGubbins%26aufirst%3DE.%2BJ.%26aulast%3DWarrior%26aufirst%3DU.%2BP.%26aulast%3DChen%26aufirst%3DY.-W.%26aulast%3DMollison%26aufirst%3DK.%2BW.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DDjuric%26aufirst%3DS.%2BW.%26atitle%3DInhibition%2520of%2520p56lck%2520tyrosine%2520kinase%2520by%2520isothiazoles%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D364%26spage%3D19%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busacca, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacober, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolbert, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschantz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Discovery of 2-phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones: A new class of inhibitors of Lck kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3394</span><span class="NLM_x">–</span> <span class="NLM_lpage">3405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020113o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3394-3405&author=R.+J.+Snowauthor=M.+G.+Cardozoauthor=T.+M.+Morwickauthor=C.+A.+Busaccaauthor=Y.+Dongauthor=R.+J.+Ecknerauthor=S.+Jacoberauthor=S.+Jakesauthor=S.+Kapadiaauthor=S.+Lukasauthor=M.+Panzenbeckauthor=G.+W.+Peetauthor=J.+D.+Petersonauthor=A.+S.+Prokopowiczauthor=R.+Sellatiauthor=R.+M.+Tolbertauthor=M.+A.+Tschantzauthor=N.+Moss&title=Discovery+of+2-phenylamino-imidazo%5B4%2C5-h%5Disoquinolin-9-ones%3A+A+new+class+of+inhibitors+of+Lck+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm020113o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020113o%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DBusacca%26aufirst%3DC.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DEckner%26aufirst%3DR.%2BJ.%26aulast%3DJacober%26aufirst%3DS.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKapadia%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DPanzenbeck%26aufirst%3DM.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DPeterson%26aufirst%3DJ.%2BD.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DTolbert%26aufirst%3DR.%2BM.%26aulast%3DTschantz%26aufirst%3DM.%2BA.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25202-phenylamino-imidazo%255B4%252C5-h%255Disoquinolin-9-ones%253A%2520A%2520new%2520class%2520of%2520inhibitors%2520of%2520Lck%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3394%26epage%3D3405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschantz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Optimization of 2-phenylaminoimidazo[4,5-<i>h</i>]isoquinolin-9-ones: Orally active inhibitors of lck kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020446l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1337-1349&author=D.+R.+Goldbergauthor=T.+Butzauthor=M.+G.+Cardozoauthor=R.+J.+Ecknerauthor=A.+Hammachauthor=J.+Huangauthor=S.+Jakesauthor=S.+Kapadiaauthor=M.+Kashemauthor=S.+Lukasauthor=T.+M.+Morwickauthor=M.+Panzenbeckauthor=U.+Patelauthor=S.+Pavauthor=G.+W.+Peetauthor=J.+D.+Petersonauthor=A.+S.+Prokopowiczauthor=R.+J.+Snowauthor=R.+Sellatiauthor=H.+Takahashiauthor=J.+Tanauthor=M.+A.+Tschantzauthor=X.-J.+Wangauthor=Y.+Wangauthor=J.+Wolakauthor=P.+Xiongauthor=N.+Moss&title=Optimization+of+2-phenylaminoimidazo%5B4%2C5-h%5Disoquinolin-9-ones%3A+Orally+active+inhibitors+of+lck+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm020446l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020446l%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DButz%26aufirst%3DT.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DEckner%26aufirst%3DR.%2BJ.%26aulast%3DHammach%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKapadia%26aufirst%3DS.%26aulast%3DKashem%26aufirst%3DM.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DPanzenbeck%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DPeterson%26aufirst%3DJ.%2BD.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DTschantz%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DX.-J.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWolak%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DP.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DOptimization%2520of%25202-phenylaminoimidazo%255B4%252C5-h%255Disoquinolin-9-ones%253A%2520Orally%2520active%2520inhibitors%2520of%2520lck%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1337%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassolino, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56Lck</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1361-1364&author=P.+Chenauthor=D.+Norrisauthor=E.+J.+Iwanowiczauthor=S.+H.+Spergelauthor=J.+Linauthor=H.+H.+Guauthor=Z.+Shenauthor=J.+Wityakauthor=T.-A.+Linauthor=S.+Pangauthor=H.+de+Fexauthor=S.+Pittauthor=D.+R.+Shenauthor=A.+M.+Doweykoauthor=D.+A.+Bassolinoauthor=J.+Y.+Robergeauthor=M.+A.+Possauthor=B.-C.+Chenauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Discovery+and+initial+SAR+of+imidazoquinoxalines+as+inhibitors+of+the+Src-family+kinase+p56Lck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.-A.%26aulast%3DPang%26aufirst%3DS.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DBassolino%26aufirst%3DD.%2BA.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520and%2520initial%2520SAR%2520of%2520imidazoquinoxalines%2520as%2520inhibitors%2520of%2520the%2520Src-family%2520kinase%2520p56Lck%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1361%26epage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: Improvement of cell potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3153-3156&author=P.+Chenauthor=E.+J.+Iwanowiczauthor=D.+Norrisauthor=H.+H.+Guauthor=J.+Linauthor=R.+V.+Moquinauthor=J.+Dasauthor=J.+Wityakauthor=S.+H.+Spergelauthor=H.+de+Fexauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Synthesis+and+SAR+of+novel+imidazoquinoxaline-based+Lck+inhibitors%3A+Improvement+of+cell+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520novel%2520imidazoquinoxaline-based%2520Lck%2520inhibitors%253A%2520Improvement%2520of%2520cell%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3153%26epage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Molecular design, synthesis, and structure−activity relationships leading to the potent and selective P56lck inhibitor BMS-243117</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2145</span><span class="NLM_x">–</span> <span class="NLM_lpage">2149</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2145-2149&author=J.+Dasauthor=J.+Linauthor=R.+V.+Moquinauthor=Z.+Shenauthor=S.+H.+Spergelauthor=J.+Wityakauthor=A.+M.+Doweykoauthor=H.+F.+DeFexauthor=Q.+Fangauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Molecular+design%2C+synthesis%2C+and+structure%E2%88%92activity+relationships+leading+to+the+potent+and+selective+P56lck+inhibitor+BMS-243117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DDeFex%26aufirst%3DH.%2BF.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DMolecular%2520design%252C%2520synthesis%252C%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520leading%2520to%2520the%2520potent%2520and%2520selective%2520P56lck%2520inhibitor%2520BMS-243117%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2145%26epage%3D2149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span> </span><span class="NLM_article-title">Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56lck inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2587-2590&author=J.+Dasauthor=R.+V.+Moquinauthor=J.+Linauthor=C.+Liuauthor=A.+M.+Doweykoauthor=H.+F.+DeFexauthor=Q.+Fangauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrishauthor=J.+Wityak&title=Discovery+of+2-amino-heteroaryl-benzothiazole-6-anilides+as+potent+p56lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DDeFex%26aufirst%3DH.%2BF.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DWityak%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%25202-amino-heteroaryl-benzothiazole-6-anilides%2520as%2520potent%2520p56lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2587%26epage%3D2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Fex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56lck inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6061</span><span class="NLM_x">–</span> <span class="NLM_lpage">6066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=6061-6066&author=P.+Chenauthor=D.+Norrisauthor=J.+Dasauthor=S.+H.+Spergelauthor=J.+Wityakauthor=L.+Leithauthor=R.+Zhaoauthor=B.-C.+Chenauthor=S.+Pittauthor=S.+Pangauthor=D.+R.+Shenauthor=R.+Zhangauthor=H.+F.+De+Fexauthor=A.+M.+Doweykoauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+Behniaauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Discovery+of+novel+2-%28aminoheteroaryl%29-thiazole-5-carboxamides+as+potent+and+orally+active+Src-family+kinase+p56lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDe%2BFex%26aufirst%3DH.%2BF.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528aminoheteroaryl%2529-thiazole-5-carboxamides%2520as%2520potent%2520and%2520orally%2520active%2520Src-family%2520kinase%2520p56lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D6061%26epage%3D6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocy, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (<i>S</i>)-<i>N</i>-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4517</span><span class="NLM_x">–</span> <span class="NLM_lpage">4529</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030217e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4517-4529&author=P.+Chenauthor=A.+M.+Doweykoauthor=D.+Norrisauthor=H.+H.+Guauthor=S.+H.+Spergelauthor=J.+Dasauthor=R.+V.+Moquinauthor=J.+Linauthor=J.+Wityakauthor=E.+J.+Iwanowiczauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+Behniaauthor=S.+Chongauthor=H.+de+Fexauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=S.+Thrallauthor=P.+Stanleyauthor=O.+R.+Kocyauthor=M.+R.+Witmerauthor=S.+B.+Kannerauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Imidazoquinoxaline+Src-family+kinase+p56Lck+inhibitors%3A+SAR%2C+QSAR%2C+and+the+discovery+of+%28S%29-N-%282-chloro-6-methylphenyl%29-2-%283-methyl-1-piperazinyl%29imidazo-+%5B1%2C5-a%5Dpyrido%5B3%2C2-e%5Dpyrazin-6-amine+%28BMS-279700%29+as+a+potent+and+orally+active+inhibitor+with+excellent+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=10.1021%2Fjm030217e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030217e%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DChong%26aufirst%3DS.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DThrall%26aufirst%3DS.%26aulast%3DStanley%26aufirst%3DP.%26aulast%3DKocy%26aufirst%3DO.%2BR.%26aulast%3DWitmer%26aufirst%3DM.%2BR.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DImidazoquinoxaline%2520Src-family%2520kinase%2520p56Lck%2520inhibitors%253A%2520SAR%252C%2520QSAR%252C%2520and%2520the%2520discovery%2520of%2520%2528S%2529-N-%25282-chloro-6-methylphenyl%2529-2-%25283-methyl-1-piperazinyl%2529imidazo-%2520%255B1%252C5-a%255Dpyrido%255B3%252C2-e%255Dpyrazin-6-amine%2520%2528BMS-279700%2529%2520as%2520a%2520potent%2520and%2520orally%2520active%2520inhibitor%2520with%2520excellent%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4517%26epage%3D4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamens, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munschauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S. E.</span><span> </span><span class="NLM_article-title">Pyrrolo[2,3-<i>d</i>]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2167</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2167-2170&author=L.+D.+Arnoldauthor=D.+J.+Calderwoodauthor=R.+W.+Dixonauthor=D.+N.+Johnstonauthor=J.+S.+Kamensauthor=R.+Munschauerauthor=P.+Raffertyauthor=S.+E.+Ratnofsky&title=Pyrrolo%5B2%2C3-d%5Dpyrimidines+containing+an+extended+5-substituent+as+potent+and+selective+inhibitors+of+lck+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DJohnston%26aufirst%3DD.%2BN.%26aulast%3DKamens%26aufirst%3DJ.%2BS.%26aulast%3DMunschauer%26aufirst%3DR.%26aulast%3DRafferty%26aufirst%3DP.%26aulast%3DRatnofsky%26aufirst%3DS.%2BE.%26atitle%3DPyrrolo%255B2%252C3-d%255Dpyrimidines%2520containing%2520an%2520extended%25205-substituent%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520lck%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2167%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burchat, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, B. S.</span><span> </span><span class="NLM_article-title">Pyrazolo[3,4-<i>d</i>]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck-a selectivity insight</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1687-1690&author=A.+F.+Burchatauthor=D.+J.+Calderwoodauthor=M.+M.+Friedmanauthor=G.+C.+Hirstauthor=B.+Liauthor=P.+Raffertyauthor=K.+Ritterauthor=B.+S.+Skinner&title=Pyrazolo%5B3%2C4-d%5Dpyrimidines+containing+an+extended+3-substituent+as+potent+inhibitors+of+Lck-a+selectivity+insight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%2BF.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DFriedman%26aufirst%3DM.%2BM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DRafferty%26aufirst%3DP.%26aulast%3DRitter%26aufirst%3DK.%26aulast%3DSkinner%26aufirst%3DB.%2BS.%26atitle%3DPyrazolo%255B3%252C4-d%255Dpyrimidines%2520containing%2520an%2520extended%25203-substituent%2520as%2520potent%2520inhibitors%2520of%2520Lck-a%2520selectivity%2520insight%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1687%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waegell, W.</span><span> </span><span class="NLM_article-title">A-420983: A potent, orally active inhibitor of Lck with efficacy in a model of transplant rejection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2613</span><span class="NLM_x">–</span> <span class="NLM_lpage">2616</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2613-2616&author=D.+W.+Borhaniauthor=D.+J.+Calderwoodauthor=M.+M.+Friedmanauthor=G.+C.+Hirstauthor=B.+Liauthor=K.+W.+Leungauthor=B.+McRaeauthor=S.+Ratnofskyauthor=K.+Ritterauthor=W.+Waegell&title=A-420983%3A+A+potent%2C+orally+active+inhibitor+of+Lck+with+efficacy+in+a+model+of+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DFriedman%26aufirst%3DM.%2BM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLeung%26aufirst%3DK.%2BW.%26aulast%3DMcRae%26aufirst%3DB.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DRitter%26aufirst%3DK.%26aulast%3DWaegell%26aufirst%3DW.%26atitle%3DA-420983%253A%2520A%2520potent%252C%2520orally%2520active%2520inhibitor%2520of%2520Lck%2520with%2520efficacy%2520in%2520a%2520model%2520of%2520transplant%2520rejection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2613%26epage%3D2616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span> </span><span class="NLM_article-title">Discovery of A-770041, a src-family selective orally active Lck inhibitor that prevents organ allograft rejection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=118-122&author=A.+Burchatauthor=D.+W.+Borhaniauthor=D.+J.+Claderwoodauthor=G.+C.+Hirstauthor=B.+Liauthor=R.+F.+Stachlewitz&title=Discovery+of+A-770041%2C+a+src-family+selective+orally+active+Lck+inhibitor+that+prevents+organ+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCladerwood%26aufirst%3DD.%2BJ.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520of%2520A-770041%252C%2520a%2520src-family%2520selective%2520orally%2520active%2520Lck%2520inhibitor%2520that%2520prevents%2520organ%2520allograft%2520rejection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D118%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Abbott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrnciar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morytko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Discovery of thienopyridines as Src-family selective Lck inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1167</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1167-1171&author=L.+Abbottauthor=P.+Betschmannauthor=A.+Burchatauthor=D.+J.+Calderwoodauthor=H.+Davisauthor=P.+Hrnciarauthor=G.+C.+Hirstauthor=B.+Liauthor=M.+Morytkoauthor=K.+Mullenauthor=B.+Yang&title=Discovery+of+thienopyridines+as+Src-family+selective+Lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DL.%26aulast%3DBetschmann%26aufirst%3DP.%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DH.%26aulast%3DHrnciar%26aufirst%3DP.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMorytko%26aufirst%3DM.%26aulast%3DMullen%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520thienopyridines%2520as%2520Src-family%2520selective%2520Lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1167%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maier, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugel, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufersweiler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanRens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easwaran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, M. J.</span><span> </span><span class="NLM_article-title">Development of <i>N</i>-4,6-pyrimidine-<i>N</i>-alkyl-<i>N</i>′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3646</span><span class="NLM_x">–</span> <span class="NLM_lpage">3650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3646-3650&author=J.+A.+Maierauthor=T.+A.+Brugelauthor=M.+Sabatauthor=A.+Golebiowskiauthor=M.+J.+Laufersweilerauthor=J.+C.+VanRensauthor=C.+R.+Hopkinsauthor=B.+Deauthor=L.+C.+Hsiehauthor=K.+K.+Brownauthor=V.+Easwaranauthor=M.+J.+Janusz&title=Development+of+N-4%2C6-pyrimidine-N-alkyl-N%E2%80%B2-phenyl+ureas+as+orally+active+inhibitors+of+lymphocyte+specific+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DGolebiowski%26aufirst%3DA.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BJ.%26aulast%3DVanRens%26aufirst%3DJ.%2BC.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DEaswaran%26aufirst%3DV.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520of%2520N-4%252C6-pyrimidine-N-alkyl-N%25E2%2580%25B2-phenyl%2520ureas%2520as%2520orally%2520active%2520inhibitors%2520of%2520lymphocyte%2520specific%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3646%26epage%3D3650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanRens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugel, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufersweiler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easwaran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosegan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berberich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchanek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, M. J.</span><span> </span><span class="NLM_article-title">The development of novel 1,2-dihydro-pyrido[4,5-<i>c</i>]pyridazine based inhibitors of lymphocyte specific kinase (Lck)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4257</span><span class="NLM_x">–</span> <span class="NLM_lpage">4261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4257-4261&author=M.+Sabatauthor=J.+C.+VanRensauthor=T.+A.+Brugelauthor=J.+Maierauthor=M.+J.+Laufersweilerauthor=A.+Golebiowskiauthor=B.+Deauthor=V.+Easwaranauthor=L.+C.+Hsiehauthor=J.+Roseganauthor=S.+Berberichauthor=E.+Suchanekauthor=M.+J.+Janusz&title=The+development+of+novel+1%2C2-dihydro-pyrido%5B4%2C5-c%5Dpyridazine+based+inhibitors+of+lymphocyte+specific+kinase+%28Lck%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DVanRens%26aufirst%3DJ.%2BC.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BJ.%26aulast%3DGolebiowski%26aufirst%3DA.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DEaswaran%26aufirst%3DV.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DRosegan%26aufirst%3DJ.%26aulast%3DBerberich%26aufirst%3DS.%26aulast%3DSuchanek%26aufirst%3DE.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%2520novel%25201%252C2-dihydro-pyrido%255B4%252C5-c%255Dpyridazine%2520based%2520inhibitors%2520of%2520lymphocyte%2520specific%2520kinase%2520%2528Lck%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4257%26epage%3D4261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanRens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufersweiler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugel, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easwaran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evdokimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, M. J.</span><span> </span><span class="NLM_article-title">The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5973</span><span class="NLM_x">–</span> <span class="NLM_lpage">5977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5973-5977&author=M.+Sabatauthor=J.+C.+VanRensauthor=M.+J.+Laufersweilerauthor=T.+A.+Brugelauthor=J.+Maierauthor=A.+Golebiowskiauthor=B.+Deauthor=V.+Easwaranauthor=L.+C.+Hsiehauthor=R.+L.+Walterauthor=M.+J.+Mekelauthor=A.+Evdokimovauthor=M.+J.+Janusz&title=The+development+of+2-benzimidazole+substituted+pyrimidine+based+inhibitors+of+lymphocyte+specific+kinase+%28Lck%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DVanRens%26aufirst%3DJ.%2BC.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BJ.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DGolebiowski%26aufirst%3DA.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DEaswaran%26aufirst%3DV.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DWalter%26aufirst%3DR.%2BL.%26aulast%3DMekel%26aufirst%3DM.%2BJ.%26aulast%3DEvdokimov%26aufirst%3DA.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%25202-benzimidazole%2520substituted%2520pyrimidine%2520based%2520inhibitors%2520of%2520lymphocyte%2520specific%2520kinase%2520%2528Lck%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5973%26epage%3D5977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Waegell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babineau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span> </span><span class="NLM_article-title">A420983, a novel, small molecule inhibitor of Lck prevents allograft rejection</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1016%2FS0041-1345%2802%2902909-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=12176420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1411-1417&author=W.+Waegellauthor=M.+Babineauauthor=M.+Hartauthor=K.+Dixonauthor=B.+McRaeauthor=C.+Wallaceauthor=M.+Leachauthor=S.+Ratnofskyauthor=A.+Belangerauthor=G.+Hirstauthor=A.+Rossiniauthor=M.+Appelauthor=J.+Mordesauthor=D.+Greinerauthor=S.+Banerjee&title=A420983%2C+a+novel%2C+small+molecule+inhibitor+of+Lck+prevents+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection</span></div><div class="casAuthors">Waegell, W.; Babineau, M.; Hart, M.; Dixon, K.; McRae, B.; Wallace, C.; Leach, M.; Ratnofsky, S.; Belanger, A.; Hirst, G.; Rossini, A.; Appel, M.; Mordes, J.; Greiner, D.; Banerjee, S.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1411-1417</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A420983 is a prototypic immunosuppressive agent that selectively targets T cells receiving an activation signal.  Treatment with such an agent may allow long-term allograft survival and avoid harmful non-immune side effects common with other immunosuppressive therapies.  Lck is an attractive target for inhibition of graft rejection because it is involved in this process on several levels.  Signaling through Lck is involved in T cell cytokine prodn. and generation of cytotoxic T lymphocytes (CTL), as well as generation of T cell help required for B-cell alloantibody generation.  The present study demonstrates that the small mol. inhibitor of Lck, A420983, was able to inhibit T-cell responses in several systems.  The authors have shown that A420983 is an effective therapy for prolonging graft survival in three models of transplantation in the mouse.  In two organ transplant models, neonatal cardiac transplantation and skin transplantation.  A420983 was able to significantly prolong graft survival as compared to grafts in vehicle-treated mice.  In the islet transplant model isolated pancreatic islet cells from fully MHC-mismatched donors were protected from rejection by A420983 treatment for the entire test period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkfpFYBF9KrbVg90H21EOLACvtfcHk0ljkATeDi-m-5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlKju74%253D&md5=e2e4fbcb2a568bee9df4ad747f09d43c</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2802%2902909-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252802%252902909-3%26sid%3Dliteratum%253Aachs%26aulast%3DWaegell%26aufirst%3DW.%26aulast%3DBabineau%26aufirst%3DM.%26aulast%3DHart%26aufirst%3DM.%26aulast%3DDixon%26aufirst%3DK.%26aulast%3DMcRae%26aufirst%3DB.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DLeach%26aufirst%3DM.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DA.%26aulast%3DHirst%26aufirst%3DG.%26aulast%3DRossini%26aufirst%3DA.%26aulast%3DAppel%26aufirst%3DM.%26aulast%3DMordes%26aufirst%3DJ.%26aulast%3DGreiner%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DS.%26atitle%3DA420983%252C%2520a%2520novel%252C%2520small%2520molecule%2520inhibitor%2520of%2520Lck%2520prevents%2520allograft%2520rejection%26jtitle%3DTransplant.%2520Proc.%26date%3D2002%26volume%3D34%26spage%3D1411%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McRae, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span> </span><span class="NLM_article-title">Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1016%2Fj.intimp.2004.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=15710336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlegtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=667-677&author=B.+L.+McRaeauthor=C.+Wallaceauthor=K.+F.+Dixonauthor=A.+Rouxauthor=S.+Mohanauthor=Y.+Jiaauthor=D.+H.+Preskyauthor=D.+E.+Traceyauthor=G.+C.+Hirst&title=Suppression+of+CD4%2B+T+cell+activation+by+a+novel+inhibitor+of+Src+family+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases</span></div><div class="casAuthors">McRae, Bradford L.; Wallace, Craig; Dixon, Kathleen Fitzgerald; Roux, Alyson; Mohan, Sukumari; Jia, Yong; Presky, David H.; Tracey, Daniel E.; Hirst, Gavin C.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">667-677</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Src family kinases Lck and Fyn play an important role in T cell development and function.  We have synthesized a novel small mol., A-420983, which inhibits Lck and Fyn, as well as other Src family kinases, but has selectivity with respect to non-Src family kinases.  A-420983 completely inhibited antigen-stimulated prodn. of IFN-γ and IL-4 by mouse Th1 and Th2 cells, resp.  Antigen-induced T cell proliferation was also blocked by treatment with A-420983.  In contrast, IL-15-induced proliferation was unaffected by A-420983, suggesting that TCR-independent pathways of T cell activation were not impaired.  When mice were dosed orally, A-420983 inhibited TCR-mediated c-jun and ZAP-70 phosphorylation in CD4+ T cells and suppressed the disease course of established EAE.  Treatment with A-420983 for 7 days resulted in a block in thymocyte development at the CD4- CD8- stage, consistent with inhibition of Lck and Fyn in vivo.  These results demonstrate that a small mol. inhibitor of Lck and Fyn can block TCR-induced T cell activation in vitro and in vivo.  Furthermore, CNS demyelination mediated by activated encephalitogenic CD4+ T cells is dependent upon the kinase activity of these Src family members.  We conclude that inhibition of Src family kinases may represent a promising strategy for the treatment of T cell-mediated disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWKvht3SdgrVg90H21EOLACvtfcHk0ljkATeDi-m-5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlegtbg%253D&md5=7f1ee81f1bb64dd4a2441819e1c25478</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2004.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2004.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DMcRae%26aufirst%3DB.%2BL.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DDixon%26aufirst%3DK.%2BF.%26aulast%3DRoux%26aufirst%3DA.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DTracey%26aufirst%3DD.%2BE.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26atitle%3DSuppression%2520of%2520CD4%252B%2520T%2520cell%2520activation%2520by%2520a%2520novel%2520inhibitor%2520of%2520Src%2520family%2520kinases%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2005%26volume%3D5%26spage%3D667%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><div class="note"><p class="first last">This observation is consistent with results we have obtained from co-crystal structures of other protein−ligand systems. For a discussion of CH-O hydrogen bonds in protein−ligand complexes, see</p></div><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandretto, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span> </span><span class="NLM_article-title">Kinase inhibitors and the case for CH···O hydrogen bonds in protein−ligand binding</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=567-576&author=A.+C.+Pierceauthor=K.+L.+Sandrettoauthor=G.+W.+Bemis&title=Kinase+inhibitors+and+the+case+for+CH%C2%B7%C2%B7%C2%B7O+hydrogen+bonds+in+protein%E2%88%92ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DSandretto%26aufirst%3DK.%2BL.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26atitle%3DKinase%2520inhibitors%2520and%2520the%2520case%2520for%2520CH%25C2%25B7%25C2%25B7%25C2%25B7O%2520hydrogen%2520bonds%2520in%2520protein%25E2%2588%2592ligand%2520binding%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2002%26volume%3D49%26spage%3D567%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><div class="note"><p class="first last">The model of <b>3</b> and Lck was generated using MOE (Chemical Computing Group, Montreal, version 2006.08) based on the co-crystal structure of <b>1</b> and Lck</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+model+of+3+and+Lck+was+generated+using+MOE+%28Chemical+Computing+Group%2C+Montreal%2C+version+2006.08%29+based+on+the+co-crystal+structure+of+1+and+Lck."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">Because p38α also has threonine as its gatekeeper residue, we did not believe this would be an effective measure toward gaining selectivity over p38α</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Because+p38%CE%B1+also+has+threonine+as+its+gatekeeper+residue%2C+we+did+not+believe+this+would+be+an+effective+measure+toward+gaining+selectivity+over+p38%CE%B1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><div class="note"><p class="first last">For the synthesis of compounds containing an aniline substituted with <i>N</i>-methylpiperazine (such as <b>25</b>), it was necessary to run the reaction without acid to avoid the formation of unwanted side products.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+the+synthesis+of+compounds+containing+an+aniline+substituted+with+N-methylpiperazine+%28such+as+25%29%2C+it+was+necessary+to+run+the+reaction+without+acid+to+avoid+the+formation+of+unwanted+side+products."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2979</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.2174%2F092986705774462914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=16378500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2979-2994&author=M.+R.+Leeauthor=C.+Dominguez&title=MAP+kinase+p38+inhibitors%3A+Clinical+results+and+an+intimate+look+at+their+interactions+with+p38%CE%B1+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span></div><div class="casAuthors">Lee, Matthew R.; Dominguez, Celia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2979-2994</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes.  There are four isoforms p38α, p38β, p38γ, and p38δ.  The most thoroughly studied isoform is p38α, whose activation has been obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  Subsequently, p38α kinase has been shown to be involved in the biosynthesis of TNFα and IL-1β at the translational and transcriptional level.  MAP kinase p38α represents a point of convergence for multiple signaling processes that are activated in inflammation and thus a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and the pyridinyl-imidazole inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatment for inflammatory diseases.  Herein we provide a brief overview of recent reported clin. results for AMG 548, BIRB 796, VX 702, SCIO 469, and SCIO 323.  However, our focus will be on the binding modes of these inhibitors and other p38 inhibitors in the recent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSldsfUAO6bVg90H21EOLACvtfcHk0lhGu_OciEGqFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF&md5=eb21253fcc2df76280cd9a1812ed1015</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.2174%2F092986705774462914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774462914%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMAP%2520kinase%2520p38%2520inhibitors%253A%2520Clinical%2520results%2520and%2520an%2520intimate%2520look%2520at%2520their%2520interactions%2520with%2520p38%25CE%25B1%2520protein%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2979%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, T.</span><span> </span><span class="NLM_article-title">Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.2174%2F1568026054985939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=16178744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1017-1029&author=D.+M.+Goldsteinauthor=T.+Gabriel&title=Pathway+to+the+clinic%3A+Inhibition+of+p38+MAP+kinase.+A+review+of+ten+chemotypes+selected+for+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Pathway to the clinic: Inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span></div><div class="casAuthors">Goldstein, David M.; Gabriel, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 mitogen activated protein (MAP) kinase remains the most compelling therapeutic target for oral drug intervention for a wide range of autoimmune disorders based on the central role this enzyme plays in inflammatory cell signaling.  Efforts to discover inhibitors of p38 suitable for clin. investigation have continued to escalate in part due to the incredible diversity of unique chemotypes reported to inhibit the enzyme.  Since 1993, at least seventeen p38 inhibitors have been reported to have entered into clin. trials.  Next generation inhibitors have been disclosed with improved potency for p38 and enhanced selectivity vs. other protein kinases.  Over the last three years, there have been multiple reports of cytokine suppression in humans following oral administration of p38 inhibitors.  These results, in addn. to proof of concept studies in rheumatoid patients, have established p38 inhibition as an avenue for the future management of pro-inflammatory cytokine based diseases.  This review describes the discovery at Roche of novel p38 inhibitors which have advanced into clin. trials.  The pharmacol. of the Roche compds. is then compared with eight chem. distinct p38 inhibitors known to have entered clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve3HIFcxtSrVg90H21EOLACvtfcHk0lhGu_OciEGqFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK&md5=a4acd0c62b42c1f2eb4dafd8f8b60306</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.2174%2F1568026054985939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985939%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DT.%26atitle%3DPathway%2520to%2520the%2520clinic%253A%2520Inhibition%2520of%2520p38%2520MAP%2520kinase.%2520A%2520review%2520of%2520ten%2520chemotypes%2520selected%2520for%2520development%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1017%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Small molecule p38 inhibitors: Novel structural features and advances from 2002–2005</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.2174%2F1568026054985920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=16178741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=967-985&author=J.+Hynesauthor=K.+Leftheris&title=Small+molecule+p38+inhibitors%3A+Novel+structural+features+and+advances+from+2002%E2%80%932005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005</span></div><div class="casAuthors">Hynes, John, Jr.; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">967-985</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery and development of selective, efficacious, and safe small mol. p38 mitogen-activated protein kinase inhibitors for the treatment of inflammatory diseases remains the focus of many pharmaceutical research programs.  Advances in small mol. p38 inhibitor design in potency and oral efficacy have been accelerated with the large no. of available inhibitor-enzyme x-ray structures.  These advances have allowed for the discovery of diverse sets of inhibitors with the opportunity to map inhibitor interactions and design selective inhibitors.  This review covers recent compd. disclosures in the patent and published literature over the last three years.  Many disclosures represent new chemotypes as well as creative modifications of known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXWto2uZjwJrVg90H21EOLACvtfcHk0lhGu_OciEGqFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP&md5=e8a3966e7f270b6171b95f306d3fc341</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.2174%2F1568026054985920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985920%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSmall%2520molecule%2520p38%2520inhibitors%253A%2520Novel%2520structural%2520features%2520and%2520advances%2520from%25202002%25E2%2580%25932005%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D967%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeCouter, J.</span><span> </span><span class="NLM_article-title">The biology of VEGF and its receptor</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1038%2Fnm0603-669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=12778165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=669-676&author=N.+Ferraraauthor=H.+Gerberauthor=J.+LeCouter&title=The+biology+of+VEGF+and+its+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of VEGF and its receptors</span></div><div class="casAuthors">Ferrara, Napoleone; Gerber, Hans-Peter; LeCouter, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">669-676</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Vascular endothelial growth factor (VEGF) is a key regulator of physiol. angiogenesis during embryogenesis, skeletal growth and reproductive functions.  VEGF has also been implicated in pathol. angiogenesis assocd. with tumors, intraocular neovascular disorders and other conditions.  The biol. effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 and VEGFR-2, which differ considerably in signaling properties.  Non-signaling co-receptors also modulate VEGF RTK signaling.  Currently, several VEGF inhibitors are undergoing clin. testing in several malignancies.  VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp73RlVV-BkrVg90H21EOLACvtfcHk0lgoOIa7HTpg8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOnur4%253D&md5=7b3bc5510c26c80d75679920fbcb378e</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-669%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DGerber%26aufirst%3DH.%26aulast%3DLeCouter%26aufirst%3DJ.%26atitle%3DThe%2520biology%2520of%2520VEGF%2520and%2520its%2520receptor%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D669%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Angiogenesis in life, disease, and medicine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=932-936&author=P.+Carmeliet&title=Angiogenesis+in+life%2C+disease%2C+and+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520life%252C%2520disease%252C%2520and%2520medicine%26jtitle%3DNature%26date%3D2005%26volume%3D438%26spage%3D932%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Angiogenesis in health and disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1038%2Fnm0603-653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=12778163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=653-660&author=P.+Carmeliet&title=Angiogenesis+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in health and disease</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-660</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Blood vessels constitute the first organ in the embryo and form the largest network in our body but, sadly, are also often deadly.  When dysregulated, the formation of new blood vessels contributes to numerous malignant, ischemic, inflammatory, infectious and immune disorders.  Mol. insights into these processes are being generated at a rapidly increasing pace, offering new therapeutic opportunities that are currently being evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVe6HXO3QPLbVg90H21EOLACvtfcHk0lgoOIa7HTpg8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D&md5=501ed35c48dbcc7c9d18b804c996284a</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-653%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D653%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ahmed, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, W. P.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor (VEGF) inhibition by small molecules</span> <span class="citation_source-journal">J. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26d&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=15688612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26d&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFantb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=59-63&author=S.+I.+Ahmedauthor=A.+L.+Thomasauthor=W.+P.+Steward&title=Vascular+endothelial+growth+factor+%28VEGF%29+inhibition+by+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26dR"><div class="casContent"><span class="casTitleNuber">26d</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor (VEGF) inhibition by small molecules</span></div><div class="casAuthors">Ahmed, S. I.; Thomas, A. L.; Steward, W. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemotherapy (Firenze, Italy)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">59-63</span>CODEN:
                <span class="NLM_cas:coden">JCHEEU</span>;
        ISSN:<span class="NLM_cas:issn">1120-009X</span>.
    
            (<span class="NLM_cas:orgname">E.S.I.F.T. srl</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is essential for primary tumors to grow and metastasise, and is driven by the prodn. of pos. angiogenic factors.  The Vascular Endothelial Growth Factor (VEGF) family is central to the process of angiogenesis and comprises 5 mols. designated A, B, C, D and E.  VEGF is overexpressed in several solid malignancies.  The actions of VEGF are mediated through receptors possessing tyrosine kinase activity: VEGFR-1 (Flt-1), VEGFR-2 (Kdr/Flk-1) and VEGFR-3 (Flt-4).  Anti-VEGF strategies include the use of antibodies to VEGF or its receptors, the use of ribozymes to decrease receptor expression, and the use of inhibitors of tyrosine kinase to reduce receptor activation and downstream signalling.  The focus of this review is small mol. inhibitors of VEGF receptors which target their intrinsic tyrosine kinase activity.  The clin. development of the following agents is discussed: SU5416, SU11248, SU6668, PTK/ZK, ZD6474.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvEoRDCaYsR7Vg90H21EOLACvtfcHk0ljCVFftZ5Ob-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFantb0%253D&md5=4646b63518c4ff1234ae9771927c1e87</span></div><a href="/servlet/linkout?suffix=cit26d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BI.%26aulast%3DThomas%26aufirst%3DA.%2BL.%26aulast%3DSteward%26aufirst%3DW.%2BP.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520inhibition%2520by%2520small%2520molecules%26jtitle%3DJ.%2520Chemother.%26date%3D2004%26volume%3D16%26spage%3D59%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Paz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhenping, Z.</span><span> </span><span class="NLM_article-title">Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.2741%2F1629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=15769635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVekurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1415-1439&author=K.+Pazauthor=Z.+Zhenping&title=Development+of+angiogenesis+inhibitors+to+vascular+endothelial+growth+factor+receptor+2.+Current+status+and+future+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26eR"><div class="casContent"><span class="casTitleNuber">26e</span><div class="casTitle"><span class="NLM_cas:atitle">Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective</span></div><div class="casAuthors">Paz, Keren; Zhu, Zhenping</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1415-1439</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Angiogenesis, the recruitment of new blood vessels is a crucial mechanism required for both tumor growth and metastasis.  Advances in the understanding of the mol. mechanisms underlying the angiogenesis process have led to the discovery of a variety of pharmaceutical agents with antiangiogenic activity.  The potential application of these angiogenesis inhibitors is currently under intense clin. investigation.  Decades of investigation suggest that vascular endothelial growth factor (VEGF) and its receptors, particularly VEGF receptor 2 (VEGFR2, or kinase insert domain-contg. receptor, KDR), play a crit. role in tumor-assocd. angiogenesis.  KDR, therefore, represents a good target for therapeutic intervention.  A no. of agents designed selectively for targeting KDR are being evaluated in various phases of clin. trials in cancer patients.  This Manuscript reviews briefly the biol. of VEGF family of ligands and receptors and of KDR in particular.  The attempts to develop effective KDR antagonists, including small mols., antibodies and others, for therapeutic purposes are discussed comprehensively with special emphasis on tumor angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWzpjh84lYrVg90H21EOLACvtfcHk0ljCVFftZ5Ob-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVekurg%253D&md5=8f8bdb8650b7822f55189835489f4edc</span></div><a href="/servlet/linkout?suffix=cit26e&amp;dbid=16384&amp;doi=10.2741%2F1629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1629%26sid%3Dliteratum%253Aachs%26aulast%3DPaz%26aufirst%3DK.%26aulast%3DZhenping%26aufirst%3DZ.%26atitle%3DDevelopment%2520of%2520angiogenesis%2520inhibitors%2520to%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%25202.%2520Current%2520status%2520and%2520future%2520perspective%26jtitle%3DFront.%2520Biosci.%26date%3D2005%26volume%3D10%26spage%3D1415%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">For example, see ref <a class="ref internalNav" href="#cit13d" aria-label="13d">13d</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+example%2C+see+ref+13d."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">For examples, see</p></div><span class="NLM_contrib-group">Tamayo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2409-2413&author=N.+Tamayoauthor=L.+Liaoauthor=M.+Goldbergauthor=D.+Powersauthor=Y.-Y.+Tudorauthor=V.+Yuauthor=L.+M.+Wongauthor=B.+Henkleauthor=S.+Middletonauthor=R.+Syedauthor=T.+Harveyauthor=G.+Jangauthor=R.+Hungateauthor=C.+Dominguez&title=Design+and+synthesis+of+potent+pyridazine+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamayo%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DL.%26aulast%3DGoldberg%26aufirst%3DM.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DTudor%26aufirst%3DY.-Y.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWong%26aufirst%3DL.%2BM.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DSyed%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DT.%26aulast%3DJang%26aufirst%3DG.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520pyridazine%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2409%26epage%3D2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For examples, see</p></div><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=11896401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0li-fpi6oD-INw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkins, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulevitch, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span> </span><span class="NLM_article-title">The structure of mitogen-activated protein kinase p38 at 2.1-Å resolution</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">2327</span><span class="NLM_x">–</span> <span class="NLM_lpage">2332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1073%2Fpnas.94.6.2327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=9122194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2luro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=2327-2332&author=Z.+Wangauthor=P.+C.+Harkinsauthor=R.+J.+Ulevitchauthor=J.+Hanauthor=M.+H.+Cobbauthor=E.+J.+Goldsmith&title=The+structure+of+mitogen-activated+protein+kinase+p38+at+2.1-%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of mitogen-activated protein kinase p38 at 2.1-Å resolution</span></div><div class="casAuthors">Wang, Zhulun; Harkins, Paul C.; Ulevitch, Richard J.; Han, Jiahuai; Cobb, Melanie H.; Goldsmith, Elizabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2327-2332</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The structure of mitogen-activated protein (MAP) kinase p38 has been solved at 2.1-Å to an R factor of 21.0%, making p38 the second low activity MAP kinase solved to date.  Although p38 is topol. similar to the MAP kinase ERK2, the phosphorylation Lip (a regulatory loop near the active site) adopts a different fold in p38.  The peptide substrate binding site and the ATP binding site are also different from those of ERK2.  The results explain why MAP kinases are specific for different activating enzymes, substrates, and inhibitors.  A model presented for substrate and activator interactions has implications for the evolution of protein kinase cascades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFVQ00RJzP4bVg90H21EOLACvtfcHk0li-fpi6oD-INw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2luro%253D&md5=e437c9d7a133608665abc4f33a213790</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.6.2327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.6.2327%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHarkins%26aufirst%3DP.%2BC.%26aulast%3DUlevitch%26aufirst%3DR.%2BJ.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26atitle%3DThe%2520structure%2520of%2520mitogen-activated%2520protein%2520kinase%2520p38%2520at%25202.1-%25C3%2585%2520resolution%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D2327%26epage%3D2332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wilson, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgibbon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaffrey, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. S.</span><span> </span><span class="NLM_article-title">Crystal structure of p38 mitogen-activated protein kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">27696</span><span class="NLM_x">–</span> <span class="NLM_lpage">27700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1074%2Fjbc.271.44.27696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=8910361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK28XmvVWlur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=27696-27700&author=K.+P.+Wilsonauthor=M.+J.+Fitzgibbonauthor=P.+R.+Caronauthor=J.+P.+Griffithauthor=W.+Chenauthor=P.+G.+McCaffreyauthor=S.+P.+Chambersauthor=M.+S.+Su&title=Crystal+structure+of+p38+mitogen-activated+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of p38 mitogen-activated protein kinase</span></div><div class="casAuthors">Wilson, Keith P.; Fitzgibbon, Matthew J.; Caron, Paul R.; Griffith, James P.; Chen, Wenyong; McCaffrey, Patricia G.; Chambers, Stephen P.; Su, Michael S.-S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">27696-27700</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">MAP kinase p38 (I) is activated by environmental stress and cytokines and plays a role in transcriptional regulation and inflammatory responses.  Here, the crystal structure of unphosphorylated human apo-I was solved at 2.3 Å resoln.  The fold and topol. of I was similar to that previously reported for ERK2 kinase.  The relative orientation of the 2 domains of I was different from that obsd. in the active form of protein kinase A.  The twist resulted in a misalignment of the active site of I, suggesting that the orientation of the domains would have to change before catalysis could proceed.  The residues that were phosphorylated upon activation of I were located on a surface loop that occupied the peptide binding channel.  Occlusion of the active site by the loop, and misalignment of catalytic residues, may account for the low enzymic activity of unphosphorylated I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj36sU08J6cLVg90H21EOLACvtfcHk0lhaEkMm0n55XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVWlur4%253D&md5=eb8d3b9740f712aa829dfacda3ccf03f</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.44.27696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.44.27696%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DK.%2BP.%26aulast%3DFitzgibbon%26aufirst%3DM.%2BJ.%26aulast%3DCaron%26aufirst%3DP.%2BR.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DMcCaffrey%26aufirst%3DP.%2BG.%26aulast%3DChambers%26aufirst%3DS.%2BP.%26aulast%3DSu%26aufirst%3DM.%2BS.%26atitle%3DCrystal%2520structure%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D27696%26epage%3D27700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><div class="note"><p class="first last">All kinases were tested at their apparent <i>K</i><sub>m</sub> of ATP with respect to 1 µM of peptide substrate</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=All+kinases+were+tested+at+their+apparent+Km+of+ATP+with+respect+to+1+%C2%B5M+of+peptide+substrate."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Harmange, J. C.; Booker, S.; Buchanan, J. L.; Chaffee, S.; Novak, P. M.; van der Plas, S.; Zhu, X.</span> (Amgen, Inc.) <span> </span><span class="NLM_article-title">2,4-Disubstituted pyrimidinyl derivatives for use as anticancer agents.</span> WO 03018021,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=J.+C.+Harmange&author=S.+Booker&author=J.+L.+Buchanan&author=S.+Chaffee&author=P.+M.+Novak&author=S.+van+der+Plas&author=X.+Zhu&title=2%2C4-Disubstituted+pyrimidinyl+derivatives+for+use+as+anticancer+agents."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26atitle%3D2%252C4-Disubstituted%2520pyrimidinyl%2520derivatives%2520for%2520use%2520as%2520anticancer%2520agents.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c','cit13d','cit13e','cit13f'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e','cit17f'],'ref18':['cit18a','cit18b','cit18c','cit18d','cit18e'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c'],'ref26':['cit26a','cit26b','cit26c','cit26d','cit26e'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanli  Wang</span>, <span class="hlFld-ContribAuthor ">Yuze  Sun</span>, <span class="hlFld-ContribAuthor ">Ran  Cao</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Yuting  Xie</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Xiangbing  Qi</span>, and <span class="hlFld-ContribAuthor ">Niu  Huang</span>  . </span><span class="cited-content_cbyCitation_article-title">In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8552-8564. <a href="https://doi.org/10.1021/acs.jmedchem.7b01075" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BSilico%252BIdentification%252Bof%252Ba%252BNovel%252BHinge-Binding%252BScaffold%252Bfor%252BKinase%252BInhibitor%252BDiscovery%26aulast%3DWang%26aufirst%3DYanli%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28072017%26date%3D16102017%26date%3D26102017%26date%3D25092017%26volume%3D60%26issue%3D20%26spage%3D8552%26epage%3D8564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian G.  Lawhorn</span>, <span class="hlFld-ContribAuthor ">Joanne  Philp</span>, <span class="hlFld-ContribAuthor ">Yongdong  Zhao</span>, <span class="hlFld-ContribAuthor ">Christopher  Louer</span>, <span class="hlFld-ContribAuthor ">Marlys  Hammond</span>, <span class="hlFld-ContribAuthor ">Mui  Cheung</span>, <span class="hlFld-ContribAuthor ">Harvey  Fries</span>, <span class="hlFld-ContribAuthor ">Alan P.  Graves</span>, <span class="hlFld-ContribAuthor ">Lisa  Shewchuk</span>, <span class="hlFld-ContribAuthor ">Liping  Wang</span>, <span class="hlFld-ContribAuthor ">Joshua E.  Cottom</span>, <span class="hlFld-ContribAuthor ">Hongwei  Qi</span>, <span class="hlFld-ContribAuthor ">Huizhen  Zhao</span>, <span class="hlFld-ContribAuthor ">Rachel  Totoritis</span>, <span class="hlFld-ContribAuthor ">Guofeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Benjamin  Schwartz</span>, <span class="hlFld-ContribAuthor ">Hu  Li</span>, <span class="hlFld-ContribAuthor ">Sharon  Sweitzer</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Holt</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Gatto, Jr.</span>, and <span class="hlFld-ContribAuthor ">Lara S.  Kallander</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (18)
                                     , 7431-7448. <a href="https://doi.org/10.1021/acs.jmedchem.5b00931" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPurines%252Band%252B7-Deazapurines%252Bas%252BPotent%252Band%252BSelective%252BType%252BI%252BInhibitors%252Bof%252BTroponin%252BI-Interacting%252BKinase%252B%252528TNNI3K%252529%26aulast%3DLawhorn%26aufirst%3DBrian%2BG.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D16062015%26date%3D10092015%26date%3D24092015%26volume%3D58%26issue%3D18%26spage%3D7431%26epage%3D7448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Shan  Hsiao</span>, <span class="hlFld-ContribAuthor ">Gorakh S.  Yellol</span>, <span class="hlFld-ContribAuthor ">Li-Hsun  Chen</span>, and <span class="hlFld-ContribAuthor ">Chung-Ming  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Multidisciplinary Synthetic Approach for Rapid Combinatorial Library Synthesis of Triaza-Fluorenes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Combinatorial Chemistry</span><span> <strong>2010,</strong> <em>12 </em>
                                    (5)
                                     , 723-732. <a href="https://doi.org/10.1021/cc1000902" title="DOI URL">https://doi.org/10.1021/cc1000902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cc1000902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcc1000902%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Combinatorial%2520Chemistry%26atitle%3DMultidisciplinary%252BSynthetic%252BApproach%252Bfor%252BRapid%252BCombinatorial%252BLibrary%252BSynthesis%252Bof%252BTriaza-Fluorenes%26aulast%3DHsiao%26aufirst%3DYa-Shan%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D26%252005%25202010%26date%3D21072010%26date%3D13092010%26volume%3D12%26issue%3D5%26spage%3D723%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Sang</span>, <span class="hlFld-ContribAuthor ">Yan‐Yan  Gong</span>, <span class="hlFld-ContribAuthor ">Hua  Cheng</span>, <span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Ye  Yuan</span>, <span class="hlFld-ContribAuthor ">Guang‐Gao  Fan</span>, <span class="hlFld-ContribAuthor ">Zhi‐Qin  Wang</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Francis  Verpoort</span>. </span><span class="cited-content_cbyCitation_article-title">Transition‐Metal‐Free Base‐Controlled C−N Coupling Reactions: Selective Mono
              Versus
              Diarylation of Primary Amines with 2‐Chlorobenzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (5)
                                     , 1408-1416. <a href="https://doi.org/10.1002/adsc.202001365" title="DOI URL">https://doi.org/10.1002/adsc.202001365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001365%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DTransition%2525E2%252580%252590Metal%2525E2%252580%252590Free%252BBase%2525E2%252580%252590Controlled%252BC%2525E2%252588%252592N%252BCoupling%252BReactions%25253A%252BSelective%252BMono%252BVersus%252BDiarylation%252Bof%252BPrimary%252BAmines%252Bwith%252B2%2525E2%252580%252590Chlorobenzimidazoles%26aulast%3DSang%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D5%26spage%3D1408%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wahid M.  Basyouni</span>, <span class="hlFld-ContribAuthor ">Nagwa M.  Abdelazeem</span>, <span class="hlFld-ContribAuthor ">Samir Y.  Abbas</span>, <span class="hlFld-ContribAuthor ">Khairy A. M.  El-Bayouki</span>, <span class="hlFld-ContribAuthor ">Mohamed Y.  El-kady</span>. </span><span class="cited-content_cbyCitation_article-title">Silica Sulfuric Acid/Ethylene Glycol: An Efficient Eco-Friendly Catalyst for One-Pot Synthesis of New Benzo[4,5]imidazo[1,2-
              a
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2020,</strong> <em>52 </em>
                                    (4)
                                     , 249-260. <a href="https://doi.org/10.1080/00304948.2020.1761692" title="DOI URL">https://doi.org/10.1080/00304948.2020.1761692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304948.2020.1761692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304948.2020.1761692%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DSilica%252BSulfuric%252BAcid%25252FEthylene%252BGlycol%25253A%252BAn%252BEfficient%252BEco-Friendly%252BCatalyst%252Bfor%252BOne-Pot%252BSynthesis%252Bof%252BNew%252BBenzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyrimidines%26aulast%3DBasyouni%26aufirst%3DWahid%2BM.%26date%3D2020%26date%3D2020%26volume%3D52%26issue%3D4%26spage%3D249%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khaled M.  Elattar</span>, <span class="hlFld-ContribAuthor ">Başak Doğru  Mert</span>, <span class="hlFld-ContribAuthor ">M.  Monier</span>, <span class="hlFld-ContribAuthor ">Ahmed  El-Mekabaty</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the chemical and biological diversity of heterocyclic systems incorporating pyrimido[1,6-
              a
              ]pyrimidine and pyrimido[1,6-
              c
              ]pyrimidine scaffolds. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (26)
                                     , 15461-15492. <a href="https://doi.org/10.1039/D0RA00411A" title="DOI URL">https://doi.org/10.1039/D0RA00411A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA00411A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA00411A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAdvances%252Bin%252Bthe%252Bchemical%252Band%252Bbiological%252Bdiversity%252Bof%252Bheterocyclic%252Bsystems%252Bincorporating%252Bpyrimido%25255B1%25252C6-%252Ba%252B%25255Dpyrimidine%252Band%252Bpyrimido%25255B1%25252C6-%252Bc%252B%25255Dpyrimidine%252Bscaffolds%26aulast%3DElattar%26aufirst%3DKhaled%2BM.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D26%26spage%3D15461%26epage%3D15492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaqi  Liu</span>, <span class="hlFld-ContribAuthor ">Sarah  Morgan</span>, <span class="hlFld-ContribAuthor ">Jessica M.  Hoover</span>. </span><span class="cited-content_cbyCitation_article-title">Cobalt‐Catalyzed Aerobic Oxidative Cyclization of 2‐Aminoanilines with Isonitriles: Facile Access to 2‐Aminobenzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2020,</strong> <em>12 </em>
                                    (5)
                                     , 1297-1301. <a href="https://doi.org/10.1002/cctc.201902011" title="DOI URL">https://doi.org/10.1002/cctc.201902011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.201902011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.201902011%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DCobalt%2525E2%252580%252590Catalyzed%252BAerobic%252BOxidative%252BCyclization%252Bof%252B2%2525E2%252580%252590Aminoanilines%252Bwith%252BIsonitriles%25253A%252BFacile%252BAccess%252Bto%252B2%2525E2%252580%252590Aminobenzimidazoles%26aulast%3DLiu%26aufirst%3DJiaqi%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D5%26spage%3D1297%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caixia  Xie</span>, <span class="hlFld-ContribAuthor ">Songhua  Li</span>, <span class="hlFld-ContribAuthor ">Yunyi  Li</span>, <span class="hlFld-ContribAuthor ">Chen  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient route for the synthesis of N-(1H-benzo[d]imidazol-2-yl)benzamide derivatives promoted by CBr4 in one pot. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (9)
                                     , 130977. <a href="https://doi.org/10.1016/j.tet.2020.130977" title="DOI URL">https://doi.org/10.1016/j.tet.2020.130977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.130977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.130977%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAn%252Befficient%252Broute%252Bfor%252Bthe%252Bsynthesis%252Bof%252BN-%2525281H-benzo%25255Bd%25255Dimidazol-2-yl%252529benzamide%252Bderivatives%252Bpromoted%252Bby%252BCBr4%252Bin%252Bone%252Bpot%26aulast%3DXie%26aufirst%3DCaixia%26date%3D2020%26volume%3D76%26issue%3D9%26spage%3D130977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cassandra L.  Fleming</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Sandoz</span>, <span class="hlFld-ContribAuthor ">Tord  Inghardt</span>, <span class="hlFld-ContribAuthor ">Björn  Önfelt</span>, <span class="hlFld-ContribAuthor ">Morten  Grøtli</span>, <span class="hlFld-ContribAuthor ">Joakim  Andréasson</span>. </span><span class="cited-content_cbyCitation_article-title">A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (42)
                                     , 15142-15146. <a href="https://doi.org/10.1002/ange.201909536" title="DOI URL">https://doi.org/10.1002/ange.201909536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201909536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201909536%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DA%252BFluorescent%252BKinase%252BInhibitor%252Bthat%252BExhibits%252BDiagnostic%252BChanges%252Bin%252BEmission%252Bupon%252BBinding%26aulast%3DFleming%26aufirst%3DCassandra%2BL.%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D42%26spage%3D15142%26epage%3D15146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cassandra L.  Fleming</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Sandoz</span>, <span class="hlFld-ContribAuthor ">Tord  Inghardt</span>, <span class="hlFld-ContribAuthor ">Björn  Önfelt</span>, <span class="hlFld-ContribAuthor ">Morten  Grøtli</span>, <span class="hlFld-ContribAuthor ">Joakim  Andréasson</span>. </span><span class="cited-content_cbyCitation_article-title">A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (42)
                                     , 15000-15004. <a href="https://doi.org/10.1002/anie.201909536" title="DOI URL">https://doi.org/10.1002/anie.201909536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201909536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201909536%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DA%252BFluorescent%252BKinase%252BInhibitor%252Bthat%252BExhibits%252BDiagnostic%252BChanges%252Bin%252BEmission%252Bupon%252BBinding%26aulast%3DFleming%26aufirst%3DCassandra%2BL.%26date%3D2019%26date%3D2019%26volume%3D58%26issue%3D42%26spage%3D15000%26epage%3D15004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Monier</span>, <span class="hlFld-ContribAuthor ">Doaa  Abdel-Latif</span>, <span class="hlFld-ContribAuthor ">Ahmed  El-Mekabaty</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Elattar</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 6 + 6 systems: the chemistry of pyrimido[4,5-
              d
              ]pyrimidines and pyrimido[5,4-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (53)
                                     , 30835-30867. <a href="https://doi.org/10.1039/C9RA05687D" title="DOI URL">https://doi.org/10.1039/C9RA05687D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA05687D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA05687D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBicyclic%252B6%252B%25252B%252B6%252Bsystems%25253A%252Bthe%252Bchemistry%252Bof%252Bpyrimido%25255B4%25252C5-%252Bd%252B%25255Dpyrimidines%252Band%252Bpyrimido%25255B5%25252C4-%252Bd%252B%25255Dpyrimidines%26aulast%3DMonier%26aufirst%3DM.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D53%26spage%3D30835%26epage%3D30867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed E. M.  Mekky</span>, <span class="hlFld-ContribAuthor ">Sherif M. H.  Sanad</span>, <span class="hlFld-ContribAuthor ">Ahmed A. M.  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave Assisted Three Component One‐pot Synthesis of Bis(aminoazolo[1,5‐
              a
              ]pyrimidines) and Bis(aminoazino[1,2‐
              a
              ]benzimidazoles) Bearing Thiazole Moiety. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (33)
                                     , 9710-9715. <a href="https://doi.org/10.1002/slct.201902828" title="DOI URL">https://doi.org/10.1002/slct.201902828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902828%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DMicrowave%252BAssisted%252BThree%252BComponent%252BOne%2525E2%252580%252590pot%252BSynthesis%252Bof%252BBis%252528aminoazolo%25255B1%25252C5%2525E2%252580%252590%252Ba%252B%25255Dpyrimidines%252529%252Band%252BBis%252528aminoazino%25255B1%25252C2%2525E2%252580%252590%252Ba%252B%25255Dbenzimidazoles%252529%252BBearing%252BThiazole%252BMoiety%26aulast%3DMekky%26aufirst%3DAhmed%2BE.%2BM.%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D33%26spage%3D9710%26epage%3D9715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenguo  Xie</span>, <span class="hlFld-ContribAuthor ">Zhifang  Liu</span>, <span class="hlFld-ContribAuthor ">Danqing  Fang</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Wu</span>, <span class="hlFld-ContribAuthor ">Shaojie  Ma</span>, <span class="hlFld-ContribAuthor ">Shepei  Tan</span>, <span class="hlFld-ContribAuthor ">Kangcheng  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and molecular docking studies of aminopyrimidine derivatives as novel three-targeted Lck/Src/KDR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1185 </em>, 240-258. <a href="https://doi.org/10.1016/j.molstruc.2019.02.071" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.02.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.02.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.02.071%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3D3D-QSAR%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Baminopyrimidine%252Bderivatives%252Bas%252Bnovel%252Bthree-targeted%252BLck%25252FSrc%25252FKDR%252Binhibitors%26aulast%3DXie%26aufirst%3DWenguo%26date%3D2019%26volume%3D1185%26spage%3D240%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahdia  Hamidinasab</span>, <span class="hlFld-ContribAuthor ">Akbar  Mobinikhaledi</span>. </span><span class="cited-content_cbyCitation_article-title">Organoacid-Decorated NiFe
              2
              O
              4
              Nanoparticles: An Efficient Catalyst for Green Synthesis of 2
              H
              -Indazolo[2, 1-b]phthalazine-Triones and Pyrimido[1,2-a]benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     , 17-23. <a href="https://doi.org/10.1002/slct.201802413" title="DOI URL">https://doi.org/10.1002/slct.201802413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201802413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201802413%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DOrganoacid-Decorated%252BNiFe%252B2%252BO%252B4%252BNanoparticles%25253A%252BAn%252BEfficient%252BCatalyst%252Bfor%252BGreen%252BSynthesis%252Bof%252B2%252BH%252B-Indazolo%25255B2%25252C%252B1-b%25255Dphthalazine-Triones%252Band%252BPyrimido%25255B1%25252C2-a%25255Dbenzimidazoles%26aulast%3DHamidinasab%26aufirst%3DMahdia%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D1%26spage%3D17%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youness  El Bakri</span>, <span class="hlFld-ContribAuthor ">El Hassane  Anouar</span>, <span class="hlFld-ContribAuthor ">Youssef  Ramli</span>, <span class="hlFld-ContribAuthor ">El Mokhtar  Essassi</span>, <span class="hlFld-ContribAuthor ">Joel T.  Mague</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structure, spectroscopic characterization, Hirshfeld surface analysis, and DFT calculations of 1,4-dimethyl-2-oxo-pyrimido[1,2-a]benzimidazole hydrate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2018,</strong> <em>1152 </em>, 154-162. <a href="https://doi.org/10.1016/j.molstruc.2017.09.074" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.09.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.09.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.09.074%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructure%25252C%252Bspectroscopic%252Bcharacterization%25252C%252BHirshfeld%252Bsurface%252Banalysis%25252C%252Band%252BDFT%252Bcalculations%252Bof%252B1%25252C4-dimethyl-2-oxo-pyrimido%25255B1%25252C2-a%25255Dbenzimidazole%252Bhydrate%26aulast%3DEl%2BBakri%26aufirst%3DYouness%26date%3D2018%26volume%3D1152%26spage%3D154%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed Karam  Farag</span>, <span class="hlFld-ContribAuthor ">Ahmed  Elkamhawy</span>, <span class="hlFld-ContribAuthor ">Ashwini M.  Londhe</span>, <span class="hlFld-ContribAuthor ">Kyung-Tae  Lee</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Eun Joo  Roh</span>. </span><span class="cited-content_cbyCitation_article-title">Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>141 </em>, 657-675. <a href="https://doi.org/10.1016/j.ejmech.2017.10.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BLCK%25252FFMS%252Binhibitors%252Bbased%252Bon%252Bphenoxypyrimidine%252Bscaffold%252Bas%252Bpotential%252Btreatment%252Bfor%252Binflammatory%252Bdisorders%26aulast%3DFarag%26aufirst%3DAhmed%2BKaram%26date%3D2017%26volume%3D141%26spage%3D657%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyanka T.  Patil</span>, <span class="hlFld-ContribAuthor ">Poojali P.  Warekar</span>, <span class="hlFld-ContribAuthor ">Kirti T.  Patil</span>, <span class="hlFld-ContribAuthor ">Dattatraya K.  Jamale</span>, <span class="hlFld-ContribAuthor ">Govind B.  Kolekar</span>, <span class="hlFld-ContribAuthor ">Prashant V.  Anbhule</span>. </span><span class="cited-content_cbyCitation_article-title">Uncatalyzed synthesis of new substituted dihydro-2H-dipyrimido[1,2-a,4,5-d]pyrimidine-2,4(3H)-dione. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (7)
                                     , 4103-4114. <a href="https://doi.org/10.1007/s11164-017-2868-9" title="DOI URL">https://doi.org/10.1007/s11164-017-2868-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-017-2868-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-017-2868-9%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DUncatalyzed%252Bsynthesis%252Bof%252Bnew%252Bsubstituted%252Bdihydro-2H-dipyrimido%25255B1%25252C2-a%25252C4%25252C5-d%25255Dpyrimidine-2%25252C4%2525283H%252529-dione%26aulast%3DPatil%26aufirst%3DPriyanka%2BT.%26date%3D2017%26date%3D2017%26volume%3D43%26issue%3D7%26spage%3D4103%26epage%3D4114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mudumala Veeranarayana  Reddy</span>, <span class="hlFld-ContribAuthor ">Avuthu Vidya Sagar  Reddy</span>, <span class="hlFld-ContribAuthor ">Yeon Tae  Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Di-n-butyl ammonium chlorosulfonate ionic liquids as an efficient and recyclable catalyst for the synthesis of 1,4-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylates under solvent-free ultrasound irradiation. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2016,</strong> <em>42 </em>
                                    (5)
                                     , 4893-4906. <a href="https://doi.org/10.1007/s11164-015-2328-3" title="DOI URL">https://doi.org/10.1007/s11164-015-2328-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-015-2328-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-015-2328-3%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DDi-n-butyl%252Bammonium%252Bchlorosulfonate%252Bionic%252Bliquids%252Bas%252Ban%252Befficient%252Band%252Brecyclable%252Bcatalyst%252Bfor%252Bthe%252Bsynthesis%252Bof%252B1%25252C4-dihydrobenzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-a%25255Dpyrimidine-3-carboxylates%252Bunder%252Bsolvent-free%252Bultrasound%252Birradiation%26aulast%3DReddy%26aufirst%3DMudumala%2BVeeranarayana%26date%3D2016%26date%3D2015%26volume%3D42%26issue%3D5%26spage%3D4893%26epage%3D4906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolali  Alizadeh</span>, <span class="hlFld-ContribAuthor ">Amir Hossein  Vahabi</span>, <span class="hlFld-ContribAuthor ">Ayoob  Bazgir</span>, <span class="hlFld-ContribAuthor ">Hamid Reza  Khavasi</span>, <span class="hlFld-ContribAuthor ">Zhe  Zhu</span>, <span class="hlFld-ContribAuthor ">Long-Guan  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Determinative role of ring size and substituents in highly selective synthesis of functionalized bicyclic guanidine and tetra substituted thiophene derivatives based on salt adducts afforded by cyclic thioureas and ketene dithioacetal. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (10)
                                     , 1342-1350. <a href="https://doi.org/10.1016/j.tet.2016.01.031" title="DOI URL">https://doi.org/10.1016/j.tet.2016.01.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.01.031%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDeterminative%252Brole%252Bof%252Bring%252Bsize%252Band%252Bsubstituents%252Bin%252Bhighly%252Bselective%252Bsynthesis%252Bof%252Bfunctionalized%252Bbicyclic%252Bguanidine%252Band%252Btetra%252Bsubstituted%252Bthiophene%252Bderivatives%252Bbased%252Bon%252Bsalt%252Badducts%252Bafforded%252Bby%252Bcyclic%252Bthioureas%252Band%252Bketene%252Bdithioacetal%26aulast%3DAlizadeh%26aufirst%3DAbdolali%26date%3D2016%26volume%3D72%26issue%3D10%26spage%3D1342%26epage%3D1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binoyargha  Dam</span>, <span class="hlFld-ContribAuthor ">Amarta Kumar  Pal</span>, <span class="hlFld-ContribAuthor ">Ajay  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Nano-Fe
              3
              O
              4
              @silica sulfuric acid as a reusable and magnetically separable potent solid acid catalyst in Biginelli-type reaction for the one-pot multicomponent synthesis of fused dihydropyrimidine derivatives: A greener NOSE and SFRC approach. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2016,</strong> <em>46 </em>
                                    (3)
                                     , 275-286. <a href="https://doi.org/10.1080/00397911.2015.1135955" title="DOI URL">https://doi.org/10.1080/00397911.2015.1135955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2015.1135955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2015.1135955%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DNano-Fe%252B3%252BO%252B4%252B%252540silica%252Bsulfuric%252Bacid%252Bas%252Ba%252Breusable%252Band%252Bmagnetically%252Bseparable%252Bpotent%252Bsolid%252Bacid%252Bcatalyst%252Bin%252BBiginelli-type%252Breaction%252Bfor%252Bthe%252Bone-pot%252Bmulticomponent%252Bsynthesis%252Bof%252Bfused%252Bdihydropyrimidine%252Bderivatives%25253A%252BA%252Bgreener%252BNOSE%252Band%252BSFRC%252Bapproach%26aulast%3DDam%26aufirst%3DBinoyargha%26date%3D2016%26date%3D2016%26volume%3D46%26issue%3D3%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Guoming  Xia</span>, <span class="hlFld-ContribAuthor ">Chao  Luo</span>, <span class="hlFld-ContribAuthor ">Jianqi  Sun</span>, <span class="hlFld-ContribAuthor ">Benfei  Ye</span>, <span class="hlFld-ContribAuthor ">Yanli  Yuan</span>, <span class="hlFld-ContribAuthor ">Hongming  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">One-step synthesis of alkyl 2-chloropyrimido[1,2-a]benzimidazole-3-carboxylates under catalyst-free: combined experimental and computational studies. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (36)
                                     , 5071-5075. <a href="https://doi.org/10.1016/j.tetlet.2015.07.050" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.07.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.07.050%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DOne-step%252Bsynthesis%252Bof%252Balkyl%252B2-chloropyrimido%25255B1%25252C2-a%25255Dbenzimidazole-3-carboxylates%252Bunder%252Bcatalyst-free%25253A%252Bcombined%252Bexperimental%252Band%252Bcomputational%252Bstudies%26aulast%3DLiu%26aufirst%3DYang%26date%3D2015%26volume%3D56%26issue%3D36%26spage%3D5071%26epage%3D5075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed E.  Elshakre</span>, <span class="hlFld-ContribAuthor ">H.  Moustafa</span>, <span class="hlFld-ContribAuthor ">Huwaida. M.E.  Hassaneen</span>, <span class="hlFld-ContribAuthor ">Abdelrahim. Z.  Moussa</span>. </span><span class="cited-content_cbyCitation_article-title">Electronic spectra and DFT calculations of some pyrimido[1,2-a]benzimidazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</span><span> <strong>2015,</strong> <em>145 </em>, 1-14. <a href="https://doi.org/10.1016/j.saa.2015.02.107" title="DOI URL">https://doi.org/10.1016/j.saa.2015.02.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.saa.2015.02.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.saa.2015.02.107%26sid%3Dliteratum%253Aachs%26jtitle%3DSpectrochimica%2520Acta%2520Part%2520A%253A%2520Molecular%2520and%2520Biomolecular%2520Spectroscopy%26atitle%3DElectronic%252Bspectra%252Band%252BDFT%252Bcalculations%252Bof%252Bsome%252Bpyrimido%25255B1%25252C2-a%25255Dbenzimidazole%252Bderivatives%26aulast%3DElshakre%26aufirst%3DMohamed%2BE.%26date%3D2015%26volume%3D145%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbora  Lemrová</span>, <span class="hlFld-ContribAuthor ">Miroslav  Soural</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Strategies for Preparing Bicyclic Guanidines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (9)
                                     , 1869-1886. <a href="https://doi.org/10.1002/ejoc.201403185" title="DOI URL">https://doi.org/10.1002/ejoc.201403185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201403185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201403185%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthetic%252BStrategies%252Bfor%252BPreparing%252BBicyclic%252BGuanidines%26aulast%3DLemrov%25C3%25A1%26aufirst%3DBarbora%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D9%26spage%3D1869%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samia  M. Sayed</span>, <span class="hlFld-ContribAuthor ">Mohamed  A. Raslan</span>, <span class="hlFld-ContribAuthor ">Mohamed  A. Khalil</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Reactivity of Cyanomethyl Thiazolyl Ketone: A Facile Synthesis of Some New Azoles, Chromene, Pyridine, Thiophene, Pyrazolo[3,4-b]pyridine and Pyrimido[1,2-a]benzimidazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2015,</strong> <em>91 </em>
                                    (3)
                                     , 610. <a href="https://doi.org/10.3987/COM-15-13169" title="DOI URL">https://doi.org/10.3987/COM-15-13169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-15-13169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-15-13169%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DSynthesis%252Band%252BReactivity%252Bof%252BCyanomethyl%252BThiazolyl%252BKetone%25253A%252BA%252BFacile%252BSynthesis%252Bof%252BSome%252BNew%252BAzoles%25252C%252BChromene%25252C%252BPyridine%25252C%252BThiophene%25252C%252BPyrazolo%25255B3%25252C4-b%25255Dpyridine%252Band%252BPyrimido%25255B1%25252C2-a%25255Dbenzimidazole%252BDerivatives%26aulast%3DM.%2BSayed%26aufirst%3DSamia%26date%3D2015%26volume%3D91%26issue%3D3%26spage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxing  Liu</span>, <span class="hlFld-ContribAuthor ">Jiarong  Li</span>, <span class="hlFld-ContribAuthor ">Hongxin  Chai</span>, <span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Deli  Yang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Daxin  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient four-component one-pot strategy toward the synthesis of pyrazolo[3,4-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>11 </em>, 2125-2131. <a href="https://doi.org/10.3762/bjoc.11.229" title="DOI URL">https://doi.org/10.3762/bjoc.11.229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.11.229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.11.229%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252Bconvenient%252Bfour-component%252Bone-pot%252Bstrategy%252Btoward%252Bthe%252Bsynthesis%252Bof%252Bpyrazolo%25255B3%25252C4-%252Bd%252B%25255Dpyrimidines%26aulast%3DLiu%26aufirst%3DMingxing%26date%3D2015%26date%3D2015%26volume%3D11%26spage%3D2125%26epage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mudumala  Veeranarayana Reddy</span>, <span class="hlFld-ContribAuthor ">Jong Su  Kim</span>, <span class="hlFld-ContribAuthor ">Kwon Taek  Lim</span>, <span class="hlFld-ContribAuthor ">Yeon  Tae Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Polyethylene glycol (PEG-400): an efficient green reaction medium for the synthesis of benzo[4,5]imidazo[1,2-a]-pyrimido[4,5-d]pyrimidin-4(1H)-ones under catalyst-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (47)
                                     , 6459-6462. <a href="https://doi.org/10.1016/j.tetlet.2014.09.135" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.09.135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.09.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.09.135%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DPolyethylene%252Bglycol%252B%252528PEG-400%252529%25253A%252Ban%252Befficient%252Bgreen%252Breaction%252Bmedium%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bbenzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-a%25255D-pyrimido%25255B4%25252C5-d%25255Dpyrimidin-4%2525281H%252529-ones%252Bunder%252Bcatalyst-free%252Bconditions%26aulast%3DVeeranarayana%2BReddy%26aufirst%3DMudumala%26date%3D2014%26volume%3D55%26issue%3D47%26spage%3D6459%26epage%3D6462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Gaba</span>, <span class="hlFld-ContribAuthor ">Sarbjot  Singh</span>, <span class="hlFld-ContribAuthor ">Chander  Mohan</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>76 </em>, 494-505. <a href="https://doi.org/10.1016/j.ejmech.2014.01.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole%25253A%252BAn%252Bemerging%252Bscaffold%252Bfor%252Banalgesic%252Band%2525C2%2525A0anti-inflammatory%252Bagents%26aulast%3DGaba%26aufirst%3DMonika%26date%3D2014%26volume%3D76%26spage%3D494%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxing  Liu</span>, <span class="hlFld-ContribAuthor ">Jiarong  Li</span>, <span class="hlFld-ContribAuthor ">Shu  Chen</span>, <span class="hlFld-ContribAuthor ">Danfei  Huang</span>, <span class="hlFld-ContribAuthor ">Hongxin  Chai</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Daxin  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot NHC-assisted access to 2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (67)
                                     , 35629-35634. <a href="https://doi.org/10.1039/C4RA05346J" title="DOI URL">https://doi.org/10.1039/C4RA05346J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA05346J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA05346J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DOne-pot%252BNHC-assisted%252Baccess%252Bto%252B2%25252C3-dihydropyrimido%25255B4%25252C5-d%25255Dpyrimidin-4%2525281H%252529-ones%26aulast%3DLiu%26aufirst%3DMingxing%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D67%26spage%3D35629%26epage%3D35634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prinka  Singla</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole-biologically attractive scaffold for protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (24)
                                     , 12422. <a href="https://doi.org/10.1039/c3ra46304d" title="DOI URL">https://doi.org/10.1039/c3ra46304d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra46304d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra46304d%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBenzimidazole-biologically%252Battractive%252Bscaffold%252Bfor%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DSingla%26aufirst%3DPrinka%26date%3D2014%26volume%3D4%26issue%3D24%26spage%3D12422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogita  Bansal</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic journey of benzimidazoles: A review. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (21)
                                     , 6208-6236. <a href="https://doi.org/10.1016/j.bmc.2012.09.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.09.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.09.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Btherapeutic%252Bjourney%252Bof%252Bbenzimidazoles%25253A%252BA%252Breview%26aulast%3DBansal%26aufirst%3DYogita%26date%3D2012%26volume%3D20%26issue%3D21%26spage%3D6208%26epage%3D6236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, <span class="hlFld-ContribAuthor ">Massimo  Rocca</span>, <span class="hlFld-ContribAuthor ">Paola  Fossa</span>, <span class="hlFld-ContribAuthor ">Elena  Cichero</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Barocelli</span>, <span class="hlFld-ContribAuthor ">Vigilio  Ballabeni</span>, <span class="hlFld-ContribAuthor ">Lisa  Flammini</span>, <span class="hlFld-ContribAuthor ">Carmine  Giorgio</span>, <span class="hlFld-ContribAuthor ">Francesca  Saccani</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Domenichini</span>, <span class="hlFld-ContribAuthor ">Olga  Bruno</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (2)
                                     , 1125-1129. <a href="https://doi.org/10.1016/j.bmcl.2011.11.103" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.103%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bnew%252B5%25252C6-dihydrobenzo%25255Bh%25255Dquinazoline%252B2%25252C4-diamino%252Bsubstituted%252Band%252Bantiplatelet%25252Fantiphlogistic%252Bactivities%252Bevaluation%26aulast%3DBrullo%26aufirst%3DChiara%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D1125%26epage%3D1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junhua  Liu</span>, <span class="hlFld-ContribAuthor ">Min  Lei</span>, <span class="hlFld-ContribAuthor ">Lihong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Thiamine hydrochloride (VB1): an efficient promoter for the one-pot synthesis of benzo[4,5]imidazo[1,2-a]pyrimidine and [1,2,4]triazolo[1,5-a]pyrimidine derivatives in water medium. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2012,</strong> <em>14 </em>
                                    (3)
                                     , 840. <a href="https://doi.org/10.1039/c2gc16499j" title="DOI URL">https://doi.org/10.1039/c2gc16499j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2gc16499j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2gc16499j%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DThiamine%252Bhydrochloride%252B%252528VB1%252529%25253A%252Ban%252Befficient%252Bpromoter%252Bfor%252Bthe%252Bone-pot%252Bsynthesis%252Bof%252Bbenzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-a%25255Dpyrimidine%252Band%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bderivatives%252Bin%252Bwater%252Bmedium%26aulast%3DLiu%26aufirst%3DJunhua%26date%3D2012%26volume%3D14%26issue%3D3%26spage%3D840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junhua  Liu</span>, <span class="hlFld-ContribAuthor ">Min  Lei</span>, <span class="hlFld-ContribAuthor ">Lihong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">A catalyst-free reaction in water: synthesis of benzo[4,5]imidazo[1,2-a]pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2012,</strong> <em>14 </em>
                                    (9)
                                     , 2534. <a href="https://doi.org/10.1039/c2gc35745c" title="DOI URL">https://doi.org/10.1039/c2gc35745c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2gc35745c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2gc35745c%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DA%252Bcatalyst-free%252Breaction%252Bin%252Bwater%25253A%252Bsynthesis%252Bof%252Bbenzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-a%25255Dpyrimido%25255B4%25252C5-d%25255Dpyrimidin-4%2525281H%252529-one%252Bderivatives%26aulast%3DLiu%26aufirst%3DJunhua%26date%3D2012%26volume%3D14%26issue%3D9%26spage%3D2534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John L.  Buchanan</span>, <span class="hlFld-ContribAuthor ">John R.  Newcomb</span>, <span class="hlFld-ContribAuthor ">David P.  Carney</span>, <span class="hlFld-ContribAuthor ">Stuart C.  Chaffee</span>, <span class="hlFld-ContribAuthor ">Lilly  Chai</span>, <span class="hlFld-ContribAuthor ">Rod  Cupples</span>, <span class="hlFld-ContribAuthor ">Linda F.  Epstein</span>, <span class="hlFld-ContribAuthor ">Paul  Gallant</span>, <span class="hlFld-ContribAuthor ">Yan  Gu</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>, <span class="hlFld-ContribAuthor ">Kathy  Hodge</span>, <span class="hlFld-ContribAuthor ">Brett E.  Houk</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Janan  Jona</span>, <span class="hlFld-ContribAuthor ">Smriti  Joseph</span>, <span class="hlFld-ContribAuthor ">H. Toni  Jun</span>, <span class="hlFld-ContribAuthor ">Rakesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Chun  Li</span>, <span class="hlFld-ContribAuthor ">John  Lu</span>, <span class="hlFld-ContribAuthor ">Tom  Menges</span>, <span class="hlFld-ContribAuthor ">Michael J.  Morrison</span>, <span class="hlFld-ContribAuthor ">Perry M.  Novak</span>, <span class="hlFld-ContribAuthor ">Simon  van der Plas</span>, <span class="hlFld-ContribAuthor ">Robert  Radinsky</span>, <span class="hlFld-ContribAuthor ">Paul E.  Rose</span>, <span class="hlFld-ContribAuthor ">Satin  Sawant</span>, <span class="hlFld-ContribAuthor ">Ji-Rong  Sun</span>, <span class="hlFld-ContribAuthor ">Sekhar  Surapaneni</span>, <span class="hlFld-ContribAuthor ">Susan M.  Turci</span>, <span class="hlFld-ContribAuthor ">Keyang  Xu</span>, <span class="hlFld-ContribAuthor ">Evelyn  Yanez</span>, <span class="hlFld-ContribAuthor ">Huilin  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaotian  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (8)
                                     , 2394-2399. <a href="https://doi.org/10.1016/j.bmcl.2011.02.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.02.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.02.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.02.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2%25252C4-bis-arylamino-1%25252C3-pyrimidines%252Bas%252Binsulin-like%252Bgrowth%252Bfactor-1%252Breceptor%252B%252528IGF-1R%252529%252Binhibitors%26aulast%3DBuchanan%26aufirst%3DJohn%2BL.%26date%3D2011%26volume%3D21%26issue%3D8%26spage%3D2394%26epage%3D2399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew W  Martin</span>, <span class="hlFld-ContribAuthor ">Michelle R  Machacek</span>. </span><span class="cited-content_cbyCitation_article-title">Update on lymphocyte specific kinase inhibitors: a patent survey. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2010,</strong> <em>20 </em>
                                    (11)
                                     , 1573-1593. <a href="https://doi.org/10.1517/13543776.2010.517749" title="DOI URL">https://doi.org/10.1517/13543776.2010.517749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2010.517749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2010.517749%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DUpdate%252Bon%252Blymphocyte%252Bspecific%252Bkinase%252Binhibitors%25253A%252Ba%252Bpatent%252Bsurvey%26aulast%3DMartin%26aufirst%3DMatthew%2BW%26date%3D2010%26date%3D2010%26volume%3D20%26issue%3D11%26spage%3D1573%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Zahid  Shafiq</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Dong  Wang</span>, <span class="hlFld-ContribAuthor ">Yong-Jun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of benzimidazo[1,2-
              a
              ]pyrimidinone derivatives
              via
              catalyst-free reactions of Baylis-Hillman acetates, alcohols, and amines with 2-aminobenzimidazole. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2010,</strong> <em>9 </em>, NA-NA. <a href="https://doi.org/10.1002/jhet.324" title="DOI URL">https://doi.org/10.1002/jhet.324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.324%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bbenzimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyrimidinone%252Bderivatives%252Bvia%252Bcatalyst-free%252Breactions%252Bof%252BBaylis-Hillman%252Bacetates%25252C%252Balcohols%25252C%252Band%252Bamines%252Bwith%252B2-aminobenzimidazole%26aulast%3DWang%26aufirst%3DYan%26date%3D2010%26volume%3D9%26spage%3DNA%26epage%3DNA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tetsuo  Takayama</span>, <span class="hlFld-ContribAuthor ">Hiroki  Umemiya</span>, <span class="hlFld-ContribAuthor ">Hideaki  Amada</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Yabuuchi</span>, <span class="hlFld-ContribAuthor ">Takeshi  Koami</span>, <span class="hlFld-ContribAuthor ">Fumiyasu  Shiozawa</span>, <span class="hlFld-ContribAuthor ">Yusuke  Oka</span>, <span class="hlFld-ContribAuthor ">Akiko  Takaoka</span>, <span class="hlFld-ContribAuthor ">Akie  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Mayumi  Endo</span>, <span class="hlFld-ContribAuthor ">Masakazu  Sato</span>. </span><span class="cited-content_cbyCitation_article-title">Ring-fused pyrazole derivatives as potent inhibitors of lymphocyte-specific kinase (Lck): Structure, synthesis, and SAR. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (1)
                                     , 112-116. <a href="https://doi.org/10.1016/j.bmcl.2009.11.013" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRing-fused%252Bpyrazole%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252Blymphocyte-specific%252Bkinase%252B%252528Lck%252529%25253A%252BStructure%25252C%252Bsynthesis%25252C%252Band%252BSAR%26aulast%3DTakayama%26aufirst%3DTetsuo%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D112%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tetsuo  Takayama</span>, <span class="hlFld-ContribAuthor ">Hiroki  Umemiya</span>, <span class="hlFld-ContribAuthor ">Hideaki  Amada</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Yabuuchi</span>, <span class="hlFld-ContribAuthor ">Fumiyasu  Shiozawa</span>, <span class="hlFld-ContribAuthor ">Hironori  Katakai</span>, <span class="hlFld-ContribAuthor ">Akiko  Takaoka</span>, <span class="hlFld-ContribAuthor ">Akie  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Mayumi  Endo</span>, <span class="hlFld-ContribAuthor ">Masakazu  Sato</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrrole derivatives as potent inhibitors of lymphocyte-specific kinase: Structure, synthesis, and SAR. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (1)
                                     , 108-111. <a href="https://doi.org/10.1016/j.bmcl.2009.11.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyrrole%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252Blymphocyte-specific%252Bkinase%25253A%252BStructure%25252C%252Bsynthesis%25252C%252Band%252BSAR%26aulast%3DTakayama%26aufirst%3DTetsuo%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D108%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julianne A.  Hunt</span>, <span class="hlFld-ContribAuthor ">Richard T.  Beresis</span>, <span class="hlFld-ContribAuthor ">Joung L.  Goulet</span>, <span class="hlFld-ContribAuthor ">Mark A.  Holmes</span>, <span class="hlFld-ContribAuthor ">Xinfang J.  Hong</span>, <span class="hlFld-ContribAuthor ">Ernest  Kovacs</span>, <span class="hlFld-ContribAuthor ">Sander G.  Mills</span>, <span class="hlFld-ContribAuthor ">Rowena D.  Ruzek</span>, <span class="hlFld-ContribAuthor ">Frederick  Wong</span>, <span class="hlFld-ContribAuthor ">Jeffrey D.  Hermes</span>, <span class="hlFld-ContribAuthor ">Young-Whan  Park</span>, <span class="hlFld-ContribAuthor ">Scott P.  Salowe</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Sonatore</span>, <span class="hlFld-ContribAuthor ">Lin  Wu</span>, <span class="hlFld-ContribAuthor ">Andrea  Woods</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Zaller</span>, <span class="hlFld-ContribAuthor ">Peter J.  Sinclair</span>. </span><span class="cited-content_cbyCitation_article-title">Disubstituted pyrimidines as Lck inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (18)
                                     , 5440-5443. <a href="https://doi.org/10.1016/j.bmcl.2009.07.102" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.07.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.07.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDisubstituted%252Bpyrimidines%252Bas%252BLck%252Binhibitors%26aulast%3DHunt%26aufirst%3DJulianne%2BA.%26date%3D2009%26volume%3D19%26issue%3D18%26spage%3D5440%26epage%3D5443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gaestel</span>, <span class="hlFld-ContribAuthor ">Alexey  Kotlyarov</span>, <span class="hlFld-ContribAuthor ">Michael  Kracht</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting innate immunity protein kinase signalling in inflammation. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2009,</strong> <em>8 </em>
                                    (6)
                                     , 480-499. <a href="https://doi.org/10.1038/nrd2829" title="DOI URL">https://doi.org/10.1038/nrd2829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd2829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd2829%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTargeting%252Binnate%252Bimmunity%252Bprotein%252Bkinase%252Bsignalling%252Bin%252Binflammation%26aulast%3DGaestel%26aufirst%3DMatthias%26date%3D2009%26volume%3D8%26issue%3D6%26spage%3D480%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changsheng  Yao</span>, <span class="hlFld-ContribAuthor ">Song  Lei</span>, <span class="hlFld-ContribAuthor ">Cuihua  Wang</span>, <span class="hlFld-ContribAuthor ">Tuanjie  Li</span>, <span class="hlFld-ContribAuthor ">Chenxia  Yu</span>, <span class="hlFld-ContribAuthor ">Xiangshan  Wang</span>, <span class="hlFld-ContribAuthor ">Shujiang  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Three-component synthesis of 4-aryl-1
              H
              -pyrimido[1,2-
              a
              ]benzimidazole derivatives in ionic liquid. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2009,</strong> <em>148 </em>, NA-NA. <a href="https://doi.org/10.1002/jhet.215" title="DOI URL">https://doi.org/10.1002/jhet.215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.215%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DThree-component%252Bsynthesis%252Bof%252B4-aryl-1%252BH%252B-pyrimido%25255B1%25252C2-%252Ba%252B%25255Dbenzimidazole%252Bderivatives%252Bin%252Bionic%252Bliquid%26aulast%3DYao%26aufirst%3DChangsheng%26date%3D2009%26volume%3D148%26spage%3DNA%26epage%3DNA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and activity of aminobenzimidazole triazines <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure aminobenzimidazole triazine <b>1</b> bound to Lck.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one <b>3</b> bound to Lck.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0012.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Retrosynthetic Analysis of 2-Amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0013.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aniline Side Chains<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux; (b) K<sub>2</sub>CO<sub>3</sub>, MeCN, 80 ºC, 57% (two steps); (c) H<sub>2</sub>, 10% Pd/C, EtOH, rt, 16 h, 100%; (d) 100 ºC, 49%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0014.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) reflux, 24 h, 79%; (b) (<i>i</i>-Pr)<sub>2</sub>NEt, toluene, 110 °C, 3 d, 60 %; (c) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 20 h, 97%; (d) ArNH<sub>2</sub>, <i>i</i>-PrOH, CF<sub>3</sub>CO<sub>2</sub>H, 80 °C, 5−16 h, 93%; (e) ArNH<sub>2</sub>, <i>i</i>-PrOH, 80 °C, 5 h, 58%.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray cocrystal structure of 2-amino-6-phenylpyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-one <b>25</b> bound to Lck.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound<b>25</b> on anti-CD3-induced IL-2 production in mice. BALB/c mice were dosed 1 h prior to challenge with compound p.o. (eight per group), as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Mice were then challenged i.v. with antimouse CD3ϵ monoclonal antibody. A total of 90 min after the challenge, IL-2 levels in serum were determined by ELISA. Data points represent the mean IL-2 levels/group ± the standard error. <i>P</i> values were determined vs vehicle control by Mann–Whitney U-test. *Indicates <i>P</i> ≤ 0.05. From this experiment, the ED<sub>50</sub> of compound <b>25</b> was estimated at 26 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>25</b> on adjuvant-induced arthritis in the rat. Arthritis was induced by administration of <i>Mycobacterium tuberculosis</i> H37Ra suspended in paraffin oil and injected into the base of the tail (0.5 mg/rat) on day 0 to male Lewis rats (∼250 g, obtained from CRL, Andover, MA). Compound <b>25</b> or vehicle was administered orally, once daily from day 9 to day 17. Paw volume was measured daily from day 9 through day 18. Values represent the mean ± standard error for <i>N</i> = 8 animals per group. *Indicates <i>P</i> < 0.05 vs vehicle control by Mann–Whitney U-test. From this experiment, the ED<sub>50</sub> of <b>25</b> was estimated as 24 mg/kg (AUC, 2.7 µM·h; <i>C</i><sub>max</sub>, 0.7 µM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/medium/jm-2007-01095m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>25</b> on collagen-induced arthritis in the rat. Arthritis was induced by intradermal injection of Porcine type II collagen emulsified in IFA to female Lewis rats. Animals were assigned to a treatment group at disease onset (study day 0), which occurred 10–12 days following immunization. Compound <b>25</b> or vehicle was administered orally, once daily for 7 days. Paw diameter was measured daily from day 0 through day 7. Values represent the mean ± standard error for <i>N</i> = 8 animals per group. *Indicates <i>P</i> < 0.05 vs vehicle control by Mann–Whitney U-test. From this experiment, the ED<sub>50</sub> of <b>25</b> was estimated as 3.2 mg/kg (AUC, 3.3 µM·h; <i>C</i><sub>max</sub>, 0.5 µM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm701095m/production/images/large/jm-2007-01095m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701095m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kane, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Signal transduction by the TCR for antigen</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">242</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1016%2FS0952-7915%2800%2900083-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=10781399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjsFeqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=242-249&author=L.+P.+Kaneauthor=J.+Linauthor=A.+Weiss&title=Signal+transduction+by+the+TCR+for+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction by the TCR for antigen</span></div><div class="casAuthors">Kane, Lawrence; Lin, Joseph; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">242-249</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 88 refs.  The past several years have seen the beginning of a shift in the way that TCR signal transduction is studied.  Although many investigators continue to identify new mols., particularly adaptor proteins, others have attempted to look at signaling events in a larger cellular context.  Thus the identification of distinct formations of signaling mols. at junctions between T cells and antigen-presenting cells, the role of the cytoskeleton and the partitioning of mols. into specialized lipid subdomains have been the subjects of many publications.  Such concepts are helping to assemble a blueprint of how the myriad adaptors and kinases fit together to effect T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JUFD7STKgLVg90H21EOLACvtfcHk0lhYXJHnNVWBVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjsFeqsLg%253D&md5=9f3d3db7ba29104a3d68455be77ca6ed</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2800%2900083-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252800%252900083-2%26sid%3Dliteratum%253Aachs%26aulast%3DKane%26aufirst%3DL.%2BP.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DSignal%2520transduction%2520by%2520the%2520TCR%2520for%2520antigen%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D242%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span> </span><span class="NLM_article-title">Leukocyte protein tyrosine kinases: Potential targets for drug discovery</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1146%2Fannurev.immunol.15.1.371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=9143693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK2sXisVCmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=371-404&author=J.+B.+Bolenauthor=J.+S.+Brugge&title=Leukocyte+protein+tyrosine+kinases%3A+Potential+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Leukocyte protein tyrosine kinases: potential targets for drug discovery</span></div><div class="casAuthors">Bolen, Joseph B.; Brugge, Joan S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">371-404</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 222 refs.  Intracellular signal transduction following the extracellular ligation of a wide variety of different types of surface mols. on leukocytes involves the activation of protein tyrosine kinases.  The dependence of successful intracellular signaling on the functions of the nontransmembrane class of protein tyrosine kinases coupled with the cell type-specific expression patterns for several of these enzymes makes them appealing targets for therapeutic intervention.  Development of drugs that can interfere with the catalytic functions of the nontransmembrane protein tyrosine kinases or that can disrupt crit. interactions with regulatory mols. and/or substrates should find clin. applications in the treatment of allergic diseases, autoimmunity, transplantation rejection, and cancer.  Topics discussed include src, lck, lyn, fyn, hck, blk, csk, csk, ctk, tec, btk, itk, tec, bmx, txk, fes, fer, abl, syk, and jak families of kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFmmCM9pk2ebVg90H21EOLACvtfcHk0liu6NpJPmgdtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVCmtrg%253D&md5=077f3fbee0284d0b0f2b744cecc1d5d9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.15.1.371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.15.1.371%26sid%3Dliteratum%253Aachs%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DLeukocyte%2520protein%2520tyrosine%2520kinases%253A%2520Potential%2520targets%2520for%2520drug%2520discovery%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1997%26volume%3D15%26spage%3D371%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, P.</span><span> </span><span class="NLM_article-title">Knockouts of Src-family kinases: Stiff bones, wimpy T cells, and bad memories</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1845</span><span class="NLM_x">–</span> <span class="NLM_lpage">1857</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1101%2Fgad.10.15.1845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=8756343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=1845-1857&author=C.+A.+Lowellauthor=P.+Soriano&title=Knockouts+of+Src-family+kinases%3A+Stiff+bones%2C+wimpy+T+cells%2C+and+bad+memories"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories</span></div><div class="casAuthors">Lowell, Clifford A.; Soriano, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1845-1857</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review, with 121 refs., on Src-family kinases (SFKs) in bone, neural, lymphocyte, and myeloid cell development and in keratinocyte differentiation, the regulation of SFK activity, and SFKs and tumorigenesis by polyomavirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Fr3q0woexLVg90H21EOLACvtfcHk0liu6NpJPmgdtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGlt7s%253D&md5=b8dc93418adea84de69fb4abade22243</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fgad.10.15.1845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.10.15.1845%26sid%3Dliteratum%253Aachs%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DSoriano%26aufirst%3DP.%26atitle%3DKnockouts%2520of%2520Src-family%2520kinases%253A%2520Stiff%2520bones%252C%2520wimpy%2520T%2520cells%252C%2520and%2520bad%2520memories%26jtitle%3DGenes%2520Dev.%26date%3D1996%26volume%3D10%26spage%3D1845%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Marth, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellins, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearn, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samelson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span> </span><span class="NLM_article-title">Lymphocyte activation provokes modification of a lymphocyte specific protein tyrosine kinase (p56lck)</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">2430</span><span class="NLM_x">–</span> <span class="NLM_lpage">2437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1989&pages=2430-2437&author=J.+D.+Marthauthor=D.+B.+Lewisauthor=M.+P.+Cookeauthor=E.+D.+Mellinsauthor=M.+E.+Gearnauthor=L.+E.+Samelsonauthor=C.+B.+Wilsonauthor=A.+D.+Millerauthor=R.+M.+Perlmutter&title=Lymphocyte+activation+provokes+modification+of+a+lymphocyte+specific+protein+tyrosine+kinase+%28p56lck%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarth%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26aulast%3DMellins%26aufirst%3DE.%2BD.%26aulast%3DGearn%26aufirst%3DM.%2BE.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26aulast%3DWilson%26aufirst%3DC.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26atitle%3DLymphocyte%2520activation%2520provokes%2520modification%2520of%2520a%2520lymphocyte%2520specific%2520protein%2520tyrosine%2520kinase%2520%2528p56lck%2529%26jtitle%3DJ.%2520Immunol.%26date%3D1989%26volume%3D142%26spage%3D2430%26epage%3D2437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Groves, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidos, C. J.</span><span> </span><span class="NLM_article-title">Fyn can partially substitute for Lck in T lymphocyte development</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=417-428&author=T.+Grovesauthor=P.+Smileyauthor=M.+P.+Cookeauthor=K.+Forbushauthor=R.+M.+Perlmutterauthor=C.+J.+Guidos&title=Fyn+can+partially+substitute+for+Lck+in+T+lymphocyte+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGroves%26aufirst%3DT.%26aulast%3DSmiley%26aufirst%3DP.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26aulast%3DForbush%26aufirst%3DK.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26aulast%3DGuidos%26aufirst%3DC.%2BJ.%26atitle%3DFyn%2520can%2520partially%2520substitute%2520for%2520Lck%2520in%2520T%2520lymphocyte%2520development%26jtitle%3DImmunity%26date%3D1996%26volume%3D5%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Palacios, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7990</span><span class="NLM_x">–</span> <span class="NLM_lpage">8000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1038%2Fsj.onc.1208074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=15489916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=7990-8000&author=E.+H.+Palaciosauthor=A.+Weiss&title=Function+of+the+Src-family+kinases%2C+Lck+and+Fyn%2C+in+T-cell+development+and+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span></div><div class="casAuthors">Palacios, Emil H.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">7990-8000</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The function of the Src-family kinases (SFKs) Lck and Fyn in T cells has been intensively studied over the past 15 yr.  Animal models and cell line studies both indicate a crit. role for Lck and Fyn in proximal T-cell antigen receptor (TCR) signal transduction.  Recruited SFKs phosphorylate TCR ITAMs (immunoreceptor tyrosine-based activation motifs) in the CD3 and ζ chains, which then serve as docking sites for Syk-family kinases.  SFKs then phosphorylate and activate the recruited Syk-family kinase.  Lck and Fyn are spatially segregated in cell membranes due to differential lipid raft localization, and may undergo sequential activation.  In addn. to the CD4 and CD8 coreceptors, a recently described adaptor, Unc119, may link SFKs to the TCR.  CD45 and Csk provide pos. and neg. regulatory control of SFK functions, resp., and Csk is constitutively bound to the transmembrane adapter protein, PAG/Cbp.  TCR-based signaling is required at several stages of T-cell development, including at least pre-TCR signaling, pos. selection, peripheral maintenance of naive T cells, and lymphopenia-induced proliferation.  SFKs are required for each of these TCR-based signals, and Lck seems to be the major contributor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC2s7PGSwBibVg90H21EOLACvtfcHk0liu6NpJPmgdtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyltb8%253D&md5=d9d1f2697ef4008ee8c8426ac806bd11</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208074%26sid%3Dliteratum%253Aachs%26aulast%3DPalacios%26aufirst%3DE.%2BH.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DFunction%2520of%2520the%2520Src-family%2520kinases%252C%2520Lck%2520and%2520Fyn%252C%2520in%2520T-cell%2520development%2520and%2520activation%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D7990%26epage%3D8000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Molina, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderovskid, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ewijk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narendran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, K.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Profound block in thymocyte development in mice lacking p56lck</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1992&pages=161-164&author=T.+J.+Molinaauthor=K.+Kishiharaauthor=D.+P.+Siderovskidauthor=W.+van+Ewijkauthor=A.+Narendranauthor=E.+Timmsauthor=A.+Wakehamauthor=C.+J.+Paigeauthor=K.-U.+Hartmannauthor=A.+Veilletteauthor=D.+Davidsonauthor=T.+W.+Mak&title=Profound+block+in+thymocyte+development+in+mice+lacking+p56lck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DT.%2BJ.%26aulast%3DKishihara%26aufirst%3DK.%26aulast%3DSiderovskid%26aufirst%3DD.%2BP.%26aulast%3Dvan%2BEwijk%26aufirst%3DW.%26aulast%3DNarendran%26aufirst%3DA.%26aulast%3DTimms%26aufirst%3DE.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DPaige%26aufirst%3DC.%2BJ.%26aulast%3DHartmann%26aufirst%3DK.-U.%26aulast%3DVeillette%26aufirst%3DA.%26aulast%3DDavidson%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DProfound%2520block%2520in%2520thymocyte%2520development%2520in%2520mice%2520lacking%2520p56lck%26jtitle%3DNature%26date%3D1992%26volume%3D357%26spage%3D161%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Levin, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbush, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span> </span><span class="NLM_article-title">A dominant-negative transgene defines a role for p56lck in thymopoiesis</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1671</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=1671-1680&author=S.+D.+Levinauthor=S.+J.+Andersonauthor=K.+A.+Forbushauthor=R.+M.+Perlmutter&title=A+dominant-negative+transgene+defines+a+role+for+p56lck+in+thymopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DS.%2BD.%26aulast%3DAnderson%26aufirst%3DS.%2BJ.%26aulast%3DForbush%26aufirst%3DK.%2BA.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26atitle%3DA%2520dominant-negative%2520transgene%2520defines%2520a%2520role%2520for%2520p56lck%2520in%2520thymopoiesis%26jtitle%3DEMBO%2520J.%26date%3D1993%26volume%3D12%26spage%3D1671%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Seddon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamoyska, R.</span><span> </span><span class="NLM_article-title">TCR signals mediated by Src family kinases are essential for the survival of naïve T cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">2997</span><span class="NLM_x">–</span> <span class="NLM_lpage">3005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=2997-3005&author=B.+Seddonauthor=R.+Zamoyska&title=TCR+signals+mediated+by+Src+family+kinases+are+essential+for+the+survival+of+na%C3%AFve+T+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeddon%26aufirst%3DB.%26aulast%3DZamoyska%26aufirst%3DR.%26atitle%3DTCR%2520signals%2520mediated%2520by%2520Src%2520family%2520kinases%2520are%2520essential%2520for%2520the%2520survival%2520of%2520na%25C3%25AFve%2520T%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D2997%26epage%3D3005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Straus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1992&pages=585-593&author=D.+B.+Strausauthor=A.+Weiss&title=Genetic+evidence+for+the+involvement+of+the+lck+tyrosine+kinase+in+signal+transduction+through+the+T+cell+antigen+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStraus%26aufirst%3DD.%2BB.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520the%2520involvement%2520of%2520the%2520lck%2520tyrosine%2520kinase%2520in%2520signal%2520transduction%2520through%2520the%2520T%2520cell%2520antigen%2520receptor%26jtitle%3DCell%26date%3D1992%26volume%3D70%26spage%3D585%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Goldman, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballas, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutte, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenback, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noraz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, N.</span><span> </span><span class="NLM_article-title">Defective expression of p56lck in an infant with severe combined immunodeficiency</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1172%2FJCI3205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=9664084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK1cXkslOktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=421-429&author=F.+D.+Goldmanauthor=Z.+K.+Ballasauthor=B.+C.+Schutteauthor=J.+Kempauthor=C.+Hollenbackauthor=N.+Norazauthor=N.+Taylor&title=Defective+expression+of+p56lck+in+an+infant+with+severe+combined+immunodeficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Defective expression of p56lck in an infant with severe combined immunodeficiency</span></div><div class="casAuthors">Goldman, Frederick D.; Ballas, Zuhair K.; Schutte, Brian C.; Kemp, John; Hollenback, Clay; Noraz, Nelly; Taylor, Naomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Severe combined immune deficiency (SCID) is a heterogeneous disorder characterized by profound defects in cellular and humoral immunity.  The authors report here an infant with clin. and lab. features of SCID and selective CD4 lymphopenia and lack of CD28 expression on CD8+ T cells.  T cells from this patient showed poor blastogenic responses to various mitogens and IL-2.  Other T cell antigen receptor-induced responses, including upregulation of CD69, were similarly inhibited.  However, more proximal T cell antigen receptor signaling events, such as anti-CD3 induced protein tyrosine phosphorylation, phosphorylation of mitogen-assocd. protein kinase, and calcium mobilization were intact.  Although p59fyn and ZAP-70 protein tyrosine kinases were expressed at normal levels, a marked decrease in the level of p56lck was noted.  Furthermore, this decrease was assocd. with the presence of an alternatively spliced lck transcript lacking the exon 7 kinase encoding domain.  These data suggest that a deficiency in p56lck expression can produce a SCID phenotype in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQfR5Dq3U2CbVg90H21EOLACvtfcHk0ljO6aSKY14QLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkslOktLs%253D&md5=7849911b4ebf15c7c430789267b62d96</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1172%2FJCI3205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI3205%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman%26aufirst%3DF.%2BD.%26aulast%3DBallas%26aufirst%3DZ.%2BK.%26aulast%3DSchutte%26aufirst%3DB.%2BC.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DHollenback%26aufirst%3DC.%26aulast%3DNoraz%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DN.%26atitle%3DDefective%2520expression%2520of%2520p56lck%2520in%2520an%2520infant%2520with%2520severe%2520combined%2520immunodeficiency%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1998%26volume%3D102%26spage%3D421%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreirea, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seligmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenhendler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autran, B.</span><span> </span><span class="NLM_article-title">Defective p56lck activity in T cells from an adult patient with idiopathic CD4<sup>+</sup> lymphocytopenia</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1093%2Fintimm%2F12.4.449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=10744646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisl2hsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=449-457&author=P.+Hubertauthor=F.+Bergeronauthor=V.+Ferreireaauthor=M.+Seligmannauthor=E.+Oksenhendlerauthor=P.+Debreauthor=B.+Autran&title=Defective+p56lck+activity+in+T+cells+from+an+adult+patient+with+idiopathic+CD4%2B+lymphocytopenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia</span></div><div class="casAuthors">Hubert, Pascale; Bergeron, Florence; Ferreira, Valerie; Seligmann, Maxime; Oksenhendler, Eric; Debre, Patrice; Autran, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-457</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Idiopathic CD4+ lymphocytopenia (ICL) is defined by a stable loss of CD4+ T cells in the absence of any known cause of immune deficiency.  This syndrome is still of undetd. origin.  It affects adult patients, some of them displaying opportunistic infections similar to HIV-infected subjects.  The hypothesis that the cellular immune defect may be due to biochem. failures of the CD3-TCR pathway is investigated here in a patient assocg. a severe selective CD4+ lymphocytopenia with an increased CD8+ T cell count discovered in the course of a cryptococcal meningitidis.  A 40% redn. of T cell proliferation to CD3-TCR stimulation is obsd. only in the CD4+ subpopulation.  The early CD3-induced protein tyrosine phosphorylations are conserved in both CD4+ and CD8+ subsets, and the levels of the T cell protein tyrosine kinases p56Lck, p59Fyn and ZAP-70 are normal.  However, we find a 50% redn. of p56Lck kinase activity in the patient's T cells compared to a healthy control donor.  P59Fyn activity does not appear to be altered.  Nevertheless, we do not find any genetic abnormality of p56Lck.  These results thus suggest that a defect of an unknown protein regulating p56Lck activity takes place in this patient's T cells.  Taken together, these findings reveal p56Lck alteration in ICL and confirm the crit. role of this kinase in the maintenance of the peripheral CD4+ T cell subpopulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi8OArdolHqbVg90H21EOLACvtfcHk0ljO6aSKY14QLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisl2hsrY%253D&md5=4db89cbd808adfb34cc71cc9050aa681</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2F12.4.449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252F12.4.449%26sid%3Dliteratum%253Aachs%26aulast%3DHubert%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DF.%26aulast%3DFerreirea%26aufirst%3DV.%26aulast%3DSeligmann%26aufirst%3DM.%26aulast%3DOksenhendler%26aufirst%3DE.%26aulast%3DDebre%26aufirst%3DP.%26aulast%3DAutran%26aufirst%3DB.%26atitle%3DDefective%2520p56lck%2520activity%2520in%2520T%2520cells%2520from%2520an%2520adult%2520patient%2520with%2520idiopathic%2520CD4%252B%2520lymphocytopenia%26jtitle%3DInt.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D449%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armistead, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouzegh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, E.</span><span> </span><span class="NLM_article-title">Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: Synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4981</span><span class="NLM_x">–</span> <span class="NLM_lpage">4991</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060435i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4981-4991&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=D.+C.+McGowanauthor=D.+M.+Armisteadauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+Bucknerauthor=L.+Chaiauthor=D.+Elbaumauthor=L.+F.+Epsteinauthor=T.+Faustauthor=S.+Flynnauthor=P.+Gallantauthor=A.+Goreauthor=Y.+Guauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=D.+Metzauthor=S.+Middletonauthor=D.+Mohnauthor=K.+Morgensternauthor=M.+J.+Morrisonauthor=P.+M.+Novakauthor=A.+Oliveira-dos-Santosauthor=D.+Powersauthor=P.+Roseauthor=S.+Schneiderauthor=S.+Sellauthor=Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=R.+D.+Whiteauthor=D.+Zackauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhuauthor=C.+Ghironauthor=P.+Amouzeghauthor=M.+Ermannauthor=J.+Jenkinsauthor=D.+Johnstonauthor=S.+Napierauthor=E.+Power&title=Novel+2-aminopyrimidine+carbamates+as+potent+and+orally+active+inhibitors+of+Lck%3A+Synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fjm060435i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060435i%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DArmistead%26aufirst%3DD.%2BM.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DNovak%26aufirst%3DP.%2BM.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSell%26aufirst%3DS.%26aulast%3DTudor%26aufirst%3DY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZack%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DAmouzegh%26aufirst%3DP.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DJenkins%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DS.%26aulast%3DPower%26aufirst%3DE.%26atitle%3DNovel%25202-aminopyrimidine%2520carbamates%2520as%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520Lck%253A%2520Synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4981%26epage%3D4991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: Synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5671</span><span class="NLM_x">–</span> <span class="NLM_lpage">5686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVChsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5671-5686&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=V.+J.+Ceeauthor=L.+Chaiauthor=H.+L.+Deakauthor=L.+F.+Epsteinauthor=T.+Faustauthor=P.+Gallantauthor=S.+D.+Geuns-Meyerauthor=A.+Goreauthor=Y.+Guauthor=B.+Henkleauthor=B.+L.+Hodousauthor=F.+Hsiehauthor=X.+Huangauthor=J.+L.+Kimauthor=J.+H.+Leeauthor=M.+W.+Martinauthor=C.+E.+Masseauthor=D.+C.+McGowanauthor=D.+Metzauthor=D.+Mohnauthor=K.+A.+Morgensternauthor=A.+Oliveira-dos-Santosauthor=V.+F.+Patelauthor=D.+Powersauthor=P.+E.+Roseauthor=S.+Schneiderauthor=S.+A.+Tomlinsonauthor=Y.-Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=R.+D.+Whiteauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhu&title=Discovery+of+aminoquinazolines+as+potent%2C+orally+bioavailable+inhibitors+of+Lck%3A+Synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity</span></div><div class="casAuthors">DiMauro, Erin F.; Newcomb, John; Nunes, Joseph J.; Bemis, Jean E.; Boucher, Christina; Buchanan, John L.; Buckner, William H.; Cee, Victor J.; Chai, Lilly; Deak, Holly L.; Epstein, Linda F.; Faust, Ted; Gallant, Paul; Geuns-Meyer, Stephanie D.; Gore, Anu; Gu, Yan; Henkle, Brad; Hodous, Brian L.; Hsieh, Faye; Huang, Xin; Kim, Joseph L.; Lee, Josie H.; Martin, Matthew W.; Masse, Craig E.; McGowan, David C.; Metz, Daniela; Mohn, Deanna; Morgenstern, Kurt A.; Oliveira-dos-Santos, Antonio; Patel, Vinod F.; Powers, David; Rose, Paul E.; Schneider, Stephen; Tomlinson, Susan A.; Tudor, Yan-Yan; Turci, Susan M.; Welcher, Andrew A.; White, Ryan D.; Zhao, Huilin; Zhu, Li; Zhu, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5671-5686</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lymphocyte-specific kinase (Lck) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and natural killer (NK) cells.  Genetic evidence in both mice and humans demonstrates that Lck kinase activity is crit. for signaling mediated by the T cell receptor (TCR), which leads to normal T cell development and activation.  Selective inhibition of Lck is expected to offer a new therapy for the treatment of T-cell-mediated autoimmune and inflammatory disease.  Screening of our kinase-preferred collection identified aminoquinazoline I as a potent, nonselective inhibitor of Lck and T cell proliferation.  In this report, we describe the synthesis and structure-activity relationships of a series of novel aminoquinazolines possessing in vitro mechanism-based potency.  Two optimized, orally bioavailable compds. exhibit antiinflammatory activity (ED50 of 22 and 11 mg/kg, resp.) in the anti-CD3-induced prodn. of interleukin-2 (IL-2) in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7qaZo8QJ6bVg90H21EOLACvtfcHk0liETqFv9NC5-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVChsLk%253D&md5=3ed1152bf34749755fdd9c2f8f25950c</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm0605482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605482%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%2BD.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMasse%26aufirst%3DC.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DS.%2BA.%26aulast%3DTudor%26aufirst%3DY.-Y.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520aminoquinazolines%2520as%2520potent%252C%2520orally%2520bioavailable%2520inhibitors%2520of%2520Lck%253A%2520Synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5671%26epage%3D5686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of novel 2,3-diarylfuro[2,3-<i>b</i>]pyridine-4-amines as potent and selective inhibitors of Lck: Synthesis, SAR, and pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2299</span><span class="NLM_x">–</span> <span class="NLM_lpage">2304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2299-2304&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=D.+C.+McGowanauthor=R.+D.+Whiteauthor=J.+L.+Buchananauthor=E.+F.+DiMauroauthor=C.+Boucherauthor=T.+Faustauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=Discovery+of+novel+2%2C3-diarylfuro%5B2%2C3-b%5Dpyridine-4-amines+as+potent+and+selective+inhibitors+of+Lck%3A+Synthesis%2C+SAR%2C+and+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%25202%252C3-diarylfuro%255B2%252C3-b%255Dpyridine-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520Synthesis%252C%2520SAR%252C%2520and%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2299%26epage%3D2304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of 4-amino-5,6-biaryl-furo[2,3-<i>d</i>]pyrimidines as inhibitors of Lck: Development of an expedient and divergent synthetic route and preliminary SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2305-2309&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=A.+Changauthor=T.+Faustauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=T.+L.+Marshallauthor=M.+W.+Martinauthor=D.+C.+McGowanauthor=S.+Schneiderauthor=S.+M.+Turciauthor=R.+D.+Whiteauthor=X.+Zhu&title=Discovery+of+4-amino-5%2C6-biaryl-furo%5B2%2C3-d%5Dpyrimidines+as+inhibitors+of+Lck%3A+Development+of+an+expedient+and+divergent+synthetic+route+and+preliminary+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMarshall%26aufirst%3DT.%2BL.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%25204-amino-5%252C6-biaryl-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520inhibitors%2520of%2520Lck%253A%2520Development%2520of%2520an%2520expedient%2520and%2520divergent%2520synthetic%2520route%2520and%2520preliminary%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2305%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Deak, H. L.; Newcomb, J. R.; Nunes, J. J.; Boucher, C.; Cheng, A. C.; DiMauro, E. F.; Epstein, L. F.; Gallant, P.; Hodous, B. L.; Huang, X.; Lee, J. H.; Patel, V. F.; Schneider, S; Turci, S. M.; Zhu, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: Structure, synthesis, and SAR.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><div class="note"><p class="first last"> <i>18</i>, 1172–1176.</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+L.+Deak&author=J.+R.+Newcomb&author=J.+J.+Nunes&author=C.+Boucher&author=A.+C.+Cheng&author=E.+F.+DiMauro&author=L.+F.+Epstein&author=P.+Gallant&author=B.+L.+Hodous&author=X.+Huang&author=J.+H.+Lee&author=V.+F.+Patel&author=S+Schneider&author=S.+M.+Turci&author=X.+Zhu&title=N-%283-%28Phenylcarbamoyl%29arylpyrimidine%29-5-carboxamides+as+potent+and+selective+inhibitors+of+Lck%3A+Structure%2C+synthesis%2C+and+SAR."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DH.%2BL.%26atitle%3DN-%25283-%2528Phenylcarbamoyl%2529arylpyrimidine%2529-5-carboxamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520Structure%252C%2520synthesis%252C%2520and%2520SAR.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">DiMauro, E. F.; Newcomb, J.; Nunes, J. J.; Bemis, J. E.; Boucher, C.; Chai, L.; Chaffee, S. C.; Deak, H. L.; Epstein, L. F.; Faust, T.; Gallant, P.; Gore, A.; Gu, Y.; Henkle, B.; Hsieh, F.; Huang, X.; Kim, J. L.; Lee, J. H.; Martin, M. W.; McGowan, D. C.; Metz, D.; Mohn, D.; Morgenstern, K. A.; Oliveira-dos-Santos, A.; Patel, V. F.; Powers, D.; Rose, P. E.; Schneider, S.; Tomlinson, S. A.; Tudor, Y.-Y.; Turci, S. M.; Welcher, A. A.; Zhao, H.; Zhu, L.; Zhu, X.</span><span> </span><span class="NLM_article-title">Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of Lck: Synthesis, SAR, and inhibition of in vivo T-cell activation.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span><div class="note"><p class="first last"> <i>51</i>, 1681–1694</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=E.+F.+DiMauro&author=J.+Newcomb&author=J.+J.+Nunes&author=J.+E.+Bemis&author=C.+Boucher&author=L.+Chai&author=S.+C.+Chaffee&author=H.+L.+Deak&author=L.+F.+Epstein&author=T.+Faust&author=P.+Gallant&author=A.+Gore&author=Y.+Gu&author=B.+Henkle&author=F.+Hsieh&author=X.+Huang&author=J.+L.+Kim&author=J.+H.+Lee&author=M.+W.+Martin&author=D.+C.+McGowan&author=D.+Metz&author=D.+Mohn&author=K.+A.+Morgenstern&author=A.+Oliveira-dos-Santos&author=V.+F.+Patel&author=D.+Powers&author=P.+E.+Rose&author=S.+Schneider&author=S.+A.+Tomlinson&author=Y.-Y.+Tudor&author=S.+M.+Turci&author=A.+A.+Welcher&author=H.+Zhao&author=L.+Zhu&author=X.+Zhu&title=Structure-guided+design+of+aminopyrimidine+amides+as+potent%2C+selective+inhibitors+of+Lck%3A+Synthesis%2C+SAR%2C+and+inhibition+of+in+vivo+T-cell+activation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DStructure-guided%2520design%2520of%2520aminopyrimidine%2520amides%2520as%2520potent%252C%2520selective%2520inhibitors%2520of%2520Lck%253A%2520Synthesis%252C%2520SAR%252C%2520and%2520inhibition%2520of%2520in%2520vivo%2520T-cell%2520activation.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hanke, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weringer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollok, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a novel, potent, and Src-family-selective tyrosine kinase inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=695-701&author=J.+H.+Hankeauthor=J.+P.+Gardnerauthor=R.+L.+Dowauthor=P.+S.+Changelianauthor=W.+H.+Brissetteauthor=E.+J.+Weringerauthor=B.+A.+Pollokauthor=P.+A.+Connelly&title=Discovery+of+a+novel%2C+potent%2C+and+Src-family-selective+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanke%26aufirst%3DJ.%2BH.%26aulast%3DGardner%26aufirst%3DJ.%2BP.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DWeringer%26aufirst%3DE.%2BJ.%26aulast%3DPollok%26aufirst%3DB.%2BA.%26aulast%3DConnelly%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520novel%252C%2520potent%252C%2520and%2520Src-family-selective%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D695%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Trevillyan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballaron, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putnam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrior, U. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollison, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faltynek, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djuric, S. W.</span><span> </span><span class="NLM_article-title">Inhibition of p56lck tyrosine kinase by isothiazoles</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=1999&pages=19-29&author=J.+M.+Trevillyanauthor=X.+G.+Chiouauthor=S.+J.+Ballaronauthor=Q.+M.+Tangauthor=A.+Bukoauthor=M.+P.+Sheetsauthor=M.+L.+Smithauthor=B.+Putnamauthor=P.+Wiedemanauthor=N.+Tuauthor=D.+Madarauthor=H.+T.+Smithauthor=E.+J.+Gubbinsauthor=U.+P.+Warriorauthor=Y.-W.+Chenauthor=K.+W.+Mollisonauthor=C.+R.+Faltynekauthor=S.+W.+Djuric&title=Inhibition+of+p56lck+tyrosine+kinase+by+isothiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DChiou%26aufirst%3DX.%2BG.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DTang%26aufirst%3DQ.%2BM.%26aulast%3DBuko%26aufirst%3DA.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DPutnam%26aufirst%3DB.%26aulast%3DWiedeman%26aufirst%3DP.%26aulast%3DTu%26aufirst%3DN.%26aulast%3DMadar%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DGubbins%26aufirst%3DE.%2BJ.%26aulast%3DWarrior%26aufirst%3DU.%2BP.%26aulast%3DChen%26aufirst%3DY.-W.%26aulast%3DMollison%26aufirst%3DK.%2BW.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DDjuric%26aufirst%3DS.%2BW.%26atitle%3DInhibition%2520of%2520p56lck%2520tyrosine%2520kinase%2520by%2520isothiazoles%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D364%26spage%3D19%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busacca, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacober, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolbert, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschantz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Discovery of 2-phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones: A new class of inhibitors of Lck kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3394</span><span class="NLM_x">–</span> <span class="NLM_lpage">3405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020113o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3394-3405&author=R.+J.+Snowauthor=M.+G.+Cardozoauthor=T.+M.+Morwickauthor=C.+A.+Busaccaauthor=Y.+Dongauthor=R.+J.+Ecknerauthor=S.+Jacoberauthor=S.+Jakesauthor=S.+Kapadiaauthor=S.+Lukasauthor=M.+Panzenbeckauthor=G.+W.+Peetauthor=J.+D.+Petersonauthor=A.+S.+Prokopowiczauthor=R.+Sellatiauthor=R.+M.+Tolbertauthor=M.+A.+Tschantzauthor=N.+Moss&title=Discovery+of+2-phenylamino-imidazo%5B4%2C5-h%5Disoquinolin-9-ones%3A+A+new+class+of+inhibitors+of+Lck+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm020113o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020113o%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DBusacca%26aufirst%3DC.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DEckner%26aufirst%3DR.%2BJ.%26aulast%3DJacober%26aufirst%3DS.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKapadia%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DPanzenbeck%26aufirst%3DM.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DPeterson%26aufirst%3DJ.%2BD.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DTolbert%26aufirst%3DR.%2BM.%26aulast%3DTschantz%26aufirst%3DM.%2BA.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25202-phenylamino-imidazo%255B4%252C5-h%255Disoquinolin-9-ones%253A%2520A%2520new%2520class%2520of%2520inhibitors%2520of%2520Lck%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3394%26epage%3D3405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschantz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Optimization of 2-phenylaminoimidazo[4,5-<i>h</i>]isoquinolin-9-ones: Orally active inhibitors of lck kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020446l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1337-1349&author=D.+R.+Goldbergauthor=T.+Butzauthor=M.+G.+Cardozoauthor=R.+J.+Ecknerauthor=A.+Hammachauthor=J.+Huangauthor=S.+Jakesauthor=S.+Kapadiaauthor=M.+Kashemauthor=S.+Lukasauthor=T.+M.+Morwickauthor=M.+Panzenbeckauthor=U.+Patelauthor=S.+Pavauthor=G.+W.+Peetauthor=J.+D.+Petersonauthor=A.+S.+Prokopowiczauthor=R.+J.+Snowauthor=R.+Sellatiauthor=H.+Takahashiauthor=J.+Tanauthor=M.+A.+Tschantzauthor=X.-J.+Wangauthor=Y.+Wangauthor=J.+Wolakauthor=P.+Xiongauthor=N.+Moss&title=Optimization+of+2-phenylaminoimidazo%5B4%2C5-h%5Disoquinolin-9-ones%3A+Orally+active+inhibitors+of+lck+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm020446l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020446l%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DButz%26aufirst%3DT.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DEckner%26aufirst%3DR.%2BJ.%26aulast%3DHammach%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKapadia%26aufirst%3DS.%26aulast%3DKashem%26aufirst%3DM.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DPanzenbeck%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DPeterson%26aufirst%3DJ.%2BD.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DTschantz%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DX.-J.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWolak%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DP.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DOptimization%2520of%25202-phenylaminoimidazo%255B4%252C5-h%255Disoquinolin-9-ones%253A%2520Orally%2520active%2520inhibitors%2520of%2520lck%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1337%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassolino, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56Lck</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1364</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1361-1364&author=P.+Chenauthor=D.+Norrisauthor=E.+J.+Iwanowiczauthor=S.+H.+Spergelauthor=J.+Linauthor=H.+H.+Guauthor=Z.+Shenauthor=J.+Wityakauthor=T.-A.+Linauthor=S.+Pangauthor=H.+de+Fexauthor=S.+Pittauthor=D.+R.+Shenauthor=A.+M.+Doweykoauthor=D.+A.+Bassolinoauthor=J.+Y.+Robergeauthor=M.+A.+Possauthor=B.-C.+Chenauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Discovery+and+initial+SAR+of+imidazoquinoxalines+as+inhibitors+of+the+Src-family+kinase+p56Lck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.-A.%26aulast%3DPang%26aufirst%3DS.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DBassolino%26aufirst%3DD.%2BA.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520and%2520initial%2520SAR%2520of%2520imidazoquinoxalines%2520as%2520inhibitors%2520of%2520the%2520Src-family%2520kinase%2520p56Lck%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1361%26epage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: Improvement of cell potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3153-3156&author=P.+Chenauthor=E.+J.+Iwanowiczauthor=D.+Norrisauthor=H.+H.+Guauthor=J.+Linauthor=R.+V.+Moquinauthor=J.+Dasauthor=J.+Wityakauthor=S.+H.+Spergelauthor=H.+de+Fexauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Synthesis+and+SAR+of+novel+imidazoquinoxaline-based+Lck+inhibitors%3A+Improvement+of+cell+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520novel%2520imidazoquinoxaline-based%2520Lck%2520inhibitors%253A%2520Improvement%2520of%2520cell%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3153%26epage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Molecular design, synthesis, and structure−activity relationships leading to the potent and selective P56lck inhibitor BMS-243117</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2145</span><span class="NLM_x">–</span> <span class="NLM_lpage">2149</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2145-2149&author=J.+Dasauthor=J.+Linauthor=R.+V.+Moquinauthor=Z.+Shenauthor=S.+H.+Spergelauthor=J.+Wityakauthor=A.+M.+Doweykoauthor=H.+F.+DeFexauthor=Q.+Fangauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Molecular+design%2C+synthesis%2C+and+structure%E2%88%92activity+relationships+leading+to+the+potent+and+selective+P56lck+inhibitor+BMS-243117"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DDeFex%26aufirst%3DH.%2BF.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DMolecular%2520design%252C%2520synthesis%252C%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520leading%2520to%2520the%2520potent%2520and%2520selective%2520P56lck%2520inhibitor%2520BMS-243117%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2145%26epage%3D2149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span> </span><span class="NLM_article-title">Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56lck inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2587-2590&author=J.+Dasauthor=R.+V.+Moquinauthor=J.+Linauthor=C.+Liuauthor=A.+M.+Doweykoauthor=H.+F.+DeFexauthor=Q.+Fangauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrishauthor=J.+Wityak&title=Discovery+of+2-amino-heteroaryl-benzothiazole-6-anilides+as+potent+p56lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DDeFex%26aufirst%3DH.%2BF.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DWityak%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%25202-amino-heteroaryl-benzothiazole-6-anilides%2520as%2520potent%2520p56lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2587%26epage%3D2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Fex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56lck inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6061</span><span class="NLM_x">–</span> <span class="NLM_lpage">6066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=6061-6066&author=P.+Chenauthor=D.+Norrisauthor=J.+Dasauthor=S.+H.+Spergelauthor=J.+Wityakauthor=L.+Leithauthor=R.+Zhaoauthor=B.-C.+Chenauthor=S.+Pittauthor=S.+Pangauthor=D.+R.+Shenauthor=R.+Zhangauthor=H.+F.+De+Fexauthor=A.+M.+Doweykoauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+Behniaauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Discovery+of+novel+2-%28aminoheteroaryl%29-thiazole-5-carboxamides+as+potent+and+orally+active+Src-family+kinase+p56lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDe%2BFex%26aufirst%3DH.%2BF.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528aminoheteroaryl%2529-thiazole-5-carboxamides%2520as%2520potent%2520and%2520orally%2520active%2520Src-family%2520kinase%2520p56lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D6061%26epage%3D6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocy, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (<i>S</i>)-<i>N</i>-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4517</span><span class="NLM_x">–</span> <span class="NLM_lpage">4529</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030217e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4517-4529&author=P.+Chenauthor=A.+M.+Doweykoauthor=D.+Norrisauthor=H.+H.+Guauthor=S.+H.+Spergelauthor=J.+Dasauthor=R.+V.+Moquinauthor=J.+Linauthor=J.+Wityakauthor=E.+J.+Iwanowiczauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+Behniaauthor=S.+Chongauthor=H.+de+Fexauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=S.+Thrallauthor=P.+Stanleyauthor=O.+R.+Kocyauthor=M.+R.+Witmerauthor=S.+B.+Kannerauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Imidazoquinoxaline+Src-family+kinase+p56Lck+inhibitors%3A+SAR%2C+QSAR%2C+and+the+discovery+of+%28S%29-N-%282-chloro-6-methylphenyl%29-2-%283-methyl-1-piperazinyl%29imidazo-+%5B1%2C5-a%5Dpyrido%5B3%2C2-e%5Dpyrazin-6-amine+%28BMS-279700%29+as+a+potent+and+orally+active+inhibitor+with+excellent+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=10.1021%2Fjm030217e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030217e%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DChong%26aufirst%3DS.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DThrall%26aufirst%3DS.%26aulast%3DStanley%26aufirst%3DP.%26aulast%3DKocy%26aufirst%3DO.%2BR.%26aulast%3DWitmer%26aufirst%3DM.%2BR.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DImidazoquinoxaline%2520Src-family%2520kinase%2520p56Lck%2520inhibitors%253A%2520SAR%252C%2520QSAR%252C%2520and%2520the%2520discovery%2520of%2520%2528S%2529-N-%25282-chloro-6-methylphenyl%2529-2-%25283-methyl-1-piperazinyl%2529imidazo-%2520%255B1%252C5-a%255Dpyrido%255B3%252C2-e%255Dpyrazin-6-amine%2520%2528BMS-279700%2529%2520as%2520a%2520potent%2520and%2520orally%2520active%2520inhibitor%2520with%2520excellent%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4517%26epage%3D4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamens, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munschauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S. E.</span><span> </span><span class="NLM_article-title">Pyrrolo[2,3-<i>d</i>]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2167</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2167-2170&author=L.+D.+Arnoldauthor=D.+J.+Calderwoodauthor=R.+W.+Dixonauthor=D.+N.+Johnstonauthor=J.+S.+Kamensauthor=R.+Munschauerauthor=P.+Raffertyauthor=S.+E.+Ratnofsky&title=Pyrrolo%5B2%2C3-d%5Dpyrimidines+containing+an+extended+5-substituent+as+potent+and+selective+inhibitors+of+lck+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DJohnston%26aufirst%3DD.%2BN.%26aulast%3DKamens%26aufirst%3DJ.%2BS.%26aulast%3DMunschauer%26aufirst%3DR.%26aulast%3DRafferty%26aufirst%3DP.%26aulast%3DRatnofsky%26aufirst%3DS.%2BE.%26atitle%3DPyrrolo%255B2%252C3-d%255Dpyrimidines%2520containing%2520an%2520extended%25205-substituent%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520lck%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2167%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burchat, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, B. S.</span><span> </span><span class="NLM_article-title">Pyrazolo[3,4-<i>d</i>]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck-a selectivity insight</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1687-1690&author=A.+F.+Burchatauthor=D.+J.+Calderwoodauthor=M.+M.+Friedmanauthor=G.+C.+Hirstauthor=B.+Liauthor=P.+Raffertyauthor=K.+Ritterauthor=B.+S.+Skinner&title=Pyrazolo%5B3%2C4-d%5Dpyrimidines+containing+an+extended+3-substituent+as+potent+inhibitors+of+Lck-a+selectivity+insight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%2BF.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DFriedman%26aufirst%3DM.%2BM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DRafferty%26aufirst%3DP.%26aulast%3DRitter%26aufirst%3DK.%26aulast%3DSkinner%26aufirst%3DB.%2BS.%26atitle%3DPyrazolo%255B3%252C4-d%255Dpyrimidines%2520containing%2520an%2520extended%25203-substituent%2520as%2520potent%2520inhibitors%2520of%2520Lck-a%2520selectivity%2520insight%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1687%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waegell, W.</span><span> </span><span class="NLM_article-title">A-420983: A potent, orally active inhibitor of Lck with efficacy in a model of transplant rejection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2613</span><span class="NLM_x">–</span> <span class="NLM_lpage">2616</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2613-2616&author=D.+W.+Borhaniauthor=D.+J.+Calderwoodauthor=M.+M.+Friedmanauthor=G.+C.+Hirstauthor=B.+Liauthor=K.+W.+Leungauthor=B.+McRaeauthor=S.+Ratnofskyauthor=K.+Ritterauthor=W.+Waegell&title=A-420983%3A+A+potent%2C+orally+active+inhibitor+of+Lck+with+efficacy+in+a+model+of+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DFriedman%26aufirst%3DM.%2BM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLeung%26aufirst%3DK.%2BW.%26aulast%3DMcRae%26aufirst%3DB.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DRitter%26aufirst%3DK.%26aulast%3DWaegell%26aufirst%3DW.%26atitle%3DA-420983%253A%2520A%2520potent%252C%2520orally%2520active%2520inhibitor%2520of%2520Lck%2520with%2520efficacy%2520in%2520a%2520model%2520of%2520transplant%2520rejection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2613%26epage%3D2616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span> </span><span class="NLM_article-title">Discovery of A-770041, a src-family selective orally active Lck inhibitor that prevents organ allograft rejection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=118-122&author=A.+Burchatauthor=D.+W.+Borhaniauthor=D.+J.+Claderwoodauthor=G.+C.+Hirstauthor=B.+Liauthor=R.+F.+Stachlewitz&title=Discovery+of+A-770041%2C+a+src-family+selective+orally+active+Lck+inhibitor+that+prevents+organ+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCladerwood%26aufirst%3DD.%2BJ.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520of%2520A-770041%252C%2520a%2520src-family%2520selective%2520orally%2520active%2520Lck%2520inhibitor%2520that%2520prevents%2520organ%2520allograft%2520rejection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D118%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Abbott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrnciar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morytko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Discovery of thienopyridines as Src-family selective Lck inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1167</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1167-1171&author=L.+Abbottauthor=P.+Betschmannauthor=A.+Burchatauthor=D.+J.+Calderwoodauthor=H.+Davisauthor=P.+Hrnciarauthor=G.+C.+Hirstauthor=B.+Liauthor=M.+Morytkoauthor=K.+Mullenauthor=B.+Yang&title=Discovery+of+thienopyridines+as+Src-family+selective+Lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DL.%26aulast%3DBetschmann%26aufirst%3DP.%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DH.%26aulast%3DHrnciar%26aufirst%3DP.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMorytko%26aufirst%3DM.%26aulast%3DMullen%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520thienopyridines%2520as%2520Src-family%2520selective%2520Lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1167%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maier, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugel, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufersweiler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanRens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easwaran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, M. J.</span><span> </span><span class="NLM_article-title">Development of <i>N</i>-4,6-pyrimidine-<i>N</i>-alkyl-<i>N</i>′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3646</span><span class="NLM_x">–</span> <span class="NLM_lpage">3650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3646-3650&author=J.+A.+Maierauthor=T.+A.+Brugelauthor=M.+Sabatauthor=A.+Golebiowskiauthor=M.+J.+Laufersweilerauthor=J.+C.+VanRensauthor=C.+R.+Hopkinsauthor=B.+Deauthor=L.+C.+Hsiehauthor=K.+K.+Brownauthor=V.+Easwaranauthor=M.+J.+Janusz&title=Development+of+N-4%2C6-pyrimidine-N-alkyl-N%E2%80%B2-phenyl+ureas+as+orally+active+inhibitors+of+lymphocyte+specific+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DGolebiowski%26aufirst%3DA.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BJ.%26aulast%3DVanRens%26aufirst%3DJ.%2BC.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DEaswaran%26aufirst%3DV.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520of%2520N-4%252C6-pyrimidine-N-alkyl-N%25E2%2580%25B2-phenyl%2520ureas%2520as%2520orally%2520active%2520inhibitors%2520of%2520lymphocyte%2520specific%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3646%26epage%3D3650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanRens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugel, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufersweiler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easwaran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosegan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berberich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchanek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, M. J.</span><span> </span><span class="NLM_article-title">The development of novel 1,2-dihydro-pyrido[4,5-<i>c</i>]pyridazine based inhibitors of lymphocyte specific kinase (Lck)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4257</span><span class="NLM_x">–</span> <span class="NLM_lpage">4261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4257-4261&author=M.+Sabatauthor=J.+C.+VanRensauthor=T.+A.+Brugelauthor=J.+Maierauthor=M.+J.+Laufersweilerauthor=A.+Golebiowskiauthor=B.+Deauthor=V.+Easwaranauthor=L.+C.+Hsiehauthor=J.+Roseganauthor=S.+Berberichauthor=E.+Suchanekauthor=M.+J.+Janusz&title=The+development+of+novel+1%2C2-dihydro-pyrido%5B4%2C5-c%5Dpyridazine+based+inhibitors+of+lymphocyte+specific+kinase+%28Lck%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DVanRens%26aufirst%3DJ.%2BC.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BJ.%26aulast%3DGolebiowski%26aufirst%3DA.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DEaswaran%26aufirst%3DV.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DRosegan%26aufirst%3DJ.%26aulast%3DBerberich%26aufirst%3DS.%26aulast%3DSuchanek%26aufirst%3DE.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%2520novel%25201%252C2-dihydro-pyrido%255B4%252C5-c%255Dpyridazine%2520based%2520inhibitors%2520of%2520lymphocyte%2520specific%2520kinase%2520%2528Lck%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4257%26epage%3D4261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanRens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufersweiler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugel, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easwaran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evdokimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, M. J.</span><span> </span><span class="NLM_article-title">The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5973</span><span class="NLM_x">–</span> <span class="NLM_lpage">5977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5973-5977&author=M.+Sabatauthor=J.+C.+VanRensauthor=M.+J.+Laufersweilerauthor=T.+A.+Brugelauthor=J.+Maierauthor=A.+Golebiowskiauthor=B.+Deauthor=V.+Easwaranauthor=L.+C.+Hsiehauthor=R.+L.+Walterauthor=M.+J.+Mekelauthor=A.+Evdokimovauthor=M.+J.+Janusz&title=The+development+of+2-benzimidazole+substituted+pyrimidine+based+inhibitors+of+lymphocyte+specific+kinase+%28Lck%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DVanRens%26aufirst%3DJ.%2BC.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BJ.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DGolebiowski%26aufirst%3DA.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DEaswaran%26aufirst%3DV.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DWalter%26aufirst%3DR.%2BL.%26aulast%3DMekel%26aufirst%3DM.%2BJ.%26aulast%3DEvdokimov%26aufirst%3DA.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%25202-benzimidazole%2520substituted%2520pyrimidine%2520based%2520inhibitors%2520of%2520lymphocyte%2520specific%2520kinase%2520%2528Lck%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5973%26epage%3D5977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Waegell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babineau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span> </span><span class="NLM_article-title">A420983, a novel, small molecule inhibitor of Lck prevents allograft rejection</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1016%2FS0041-1345%2802%2902909-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=12176420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1411-1417&author=W.+Waegellauthor=M.+Babineauauthor=M.+Hartauthor=K.+Dixonauthor=B.+McRaeauthor=C.+Wallaceauthor=M.+Leachauthor=S.+Ratnofskyauthor=A.+Belangerauthor=G.+Hirstauthor=A.+Rossiniauthor=M.+Appelauthor=J.+Mordesauthor=D.+Greinerauthor=S.+Banerjee&title=A420983%2C+a+novel%2C+small+molecule+inhibitor+of+Lck+prevents+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection</span></div><div class="casAuthors">Waegell, W.; Babineau, M.; Hart, M.; Dixon, K.; McRae, B.; Wallace, C.; Leach, M.; Ratnofsky, S.; Belanger, A.; Hirst, G.; Rossini, A.; Appel, M.; Mordes, J.; Greiner, D.; Banerjee, S.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1411-1417</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A420983 is a prototypic immunosuppressive agent that selectively targets T cells receiving an activation signal.  Treatment with such an agent may allow long-term allograft survival and avoid harmful non-immune side effects common with other immunosuppressive therapies.  Lck is an attractive target for inhibition of graft rejection because it is involved in this process on several levels.  Signaling through Lck is involved in T cell cytokine prodn. and generation of cytotoxic T lymphocytes (CTL), as well as generation of T cell help required for B-cell alloantibody generation.  The present study demonstrates that the small mol. inhibitor of Lck, A420983, was able to inhibit T-cell responses in several systems.  The authors have shown that A420983 is an effective therapy for prolonging graft survival in three models of transplantation in the mouse.  In two organ transplant models, neonatal cardiac transplantation and skin transplantation.  A420983 was able to significantly prolong graft survival as compared to grafts in vehicle-treated mice.  In the islet transplant model isolated pancreatic islet cells from fully MHC-mismatched donors were protected from rejection by A420983 treatment for the entire test period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkfpFYBF9KrbVg90H21EOLACvtfcHk0ljmwsL_-qF3Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlKju74%253D&md5=e2e4fbcb2a568bee9df4ad747f09d43c</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2802%2902909-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252802%252902909-3%26sid%3Dliteratum%253Aachs%26aulast%3DWaegell%26aufirst%3DW.%26aulast%3DBabineau%26aufirst%3DM.%26aulast%3DHart%26aufirst%3DM.%26aulast%3DDixon%26aufirst%3DK.%26aulast%3DMcRae%26aufirst%3DB.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DLeach%26aufirst%3DM.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DA.%26aulast%3DHirst%26aufirst%3DG.%26aulast%3DRossini%26aufirst%3DA.%26aulast%3DAppel%26aufirst%3DM.%26aulast%3DMordes%26aufirst%3DJ.%26aulast%3DGreiner%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DS.%26atitle%3DA420983%252C%2520a%2520novel%252C%2520small%2520molecule%2520inhibitor%2520of%2520Lck%2520prevents%2520allograft%2520rejection%26jtitle%3DTransplant.%2520Proc.%26date%3D2002%26volume%3D34%26spage%3D1411%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">McRae, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span> </span><span class="NLM_article-title">Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1016%2Fj.intimp.2004.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=15710336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlegtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=667-677&author=B.+L.+McRaeauthor=C.+Wallaceauthor=K.+F.+Dixonauthor=A.+Rouxauthor=S.+Mohanauthor=Y.+Jiaauthor=D.+H.+Preskyauthor=D.+E.+Traceyauthor=G.+C.+Hirst&title=Suppression+of+CD4%2B+T+cell+activation+by+a+novel+inhibitor+of+Src+family+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases</span></div><div class="casAuthors">McRae, Bradford L.; Wallace, Craig; Dixon, Kathleen Fitzgerald; Roux, Alyson; Mohan, Sukumari; Jia, Yong; Presky, David H.; Tracey, Daniel E.; Hirst, Gavin C.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">667-677</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Src family kinases Lck and Fyn play an important role in T cell development and function.  We have synthesized a novel small mol., A-420983, which inhibits Lck and Fyn, as well as other Src family kinases, but has selectivity with respect to non-Src family kinases.  A-420983 completely inhibited antigen-stimulated prodn. of IFN-γ and IL-4 by mouse Th1 and Th2 cells, resp.  Antigen-induced T cell proliferation was also blocked by treatment with A-420983.  In contrast, IL-15-induced proliferation was unaffected by A-420983, suggesting that TCR-independent pathways of T cell activation were not impaired.  When mice were dosed orally, A-420983 inhibited TCR-mediated c-jun and ZAP-70 phosphorylation in CD4+ T cells and suppressed the disease course of established EAE.  Treatment with A-420983 for 7 days resulted in a block in thymocyte development at the CD4- CD8- stage, consistent with inhibition of Lck and Fyn in vivo.  These results demonstrate that a small mol. inhibitor of Lck and Fyn can block TCR-induced T cell activation in vitro and in vivo.  Furthermore, CNS demyelination mediated by activated encephalitogenic CD4+ T cells is dependent upon the kinase activity of these Src family members.  We conclude that inhibition of Src family kinases may represent a promising strategy for the treatment of T cell-mediated disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWKvht3SdgrVg90H21EOLACvtfcHk0lh7y84sBnsz9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlegtbg%253D&md5=7f1ee81f1bb64dd4a2441819e1c25478</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2004.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2004.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DMcRae%26aufirst%3DB.%2BL.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DDixon%26aufirst%3DK.%2BF.%26aulast%3DRoux%26aufirst%3DA.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DTracey%26aufirst%3DD.%2BE.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26atitle%3DSuppression%2520of%2520CD4%252B%2520T%2520cell%2520activation%2520by%2520a%2520novel%2520inhibitor%2520of%2520Src%2520family%2520kinases%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2005%26volume%3D5%26spage%3D667%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><div class="note"><p class="first last">This observation is consistent with results we have obtained from co-crystal structures of other protein−ligand systems. For a discussion of CH-O hydrogen bonds in protein−ligand complexes, see</p></div><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandretto, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span> </span><span class="NLM_article-title">Kinase inhibitors and the case for CH···O hydrogen bonds in protein−ligand binding</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=567-576&author=A.+C.+Pierceauthor=K.+L.+Sandrettoauthor=G.+W.+Bemis&title=Kinase+inhibitors+and+the+case+for+CH%C2%B7%C2%B7%C2%B7O+hydrogen+bonds+in+protein%E2%88%92ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DSandretto%26aufirst%3DK.%2BL.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26atitle%3DKinase%2520inhibitors%2520and%2520the%2520case%2520for%2520CH%25C2%25B7%25C2%25B7%25C2%25B7O%2520hydrogen%2520bonds%2520in%2520protein%25E2%2588%2592ligand%2520binding%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2002%26volume%3D49%26spage%3D567%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><div class="note"><p class="first last">The model of <b>3</b> and Lck was generated using MOE (Chemical Computing Group, Montreal, version 2006.08) based on the co-crystal structure of <b>1</b> and Lck</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+model+of+3+and+Lck+was+generated+using+MOE+%28Chemical+Computing+Group%2C+Montreal%2C+version+2006.08%29+based+on+the+co-crystal+structure+of+1+and+Lck."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">Because p38α also has threonine as its gatekeeper residue, we did not believe this would be an effective measure toward gaining selectivity over p38α</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Because+p38%CE%B1+also+has+threonine+as+its+gatekeeper+residue%2C+we+did+not+believe+this+would+be+an+effective+measure+toward+gaining+selectivity+over+p38%CE%B1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><div class="note"><p class="first last">For the synthesis of compounds containing an aniline substituted with <i>N</i>-methylpiperazine (such as <b>25</b>), it was necessary to run the reaction without acid to avoid the formation of unwanted side products.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+the+synthesis+of+compounds+containing+an+aniline+substituted+with+N-methylpiperazine+%28such+as+25%29%2C+it+was+necessary+to+run+the+reaction+without+acid+to+avoid+the+formation+of+unwanted+side+products."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2979</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.2174%2F092986705774462914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=16378500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2979-2994&author=M.+R.+Leeauthor=C.+Dominguez&title=MAP+kinase+p38+inhibitors%3A+Clinical+results+and+an+intimate+look+at+their+interactions+with+p38%CE%B1+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span></div><div class="casAuthors">Lee, Matthew R.; Dominguez, Celia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2979-2994</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes.  There are four isoforms p38α, p38β, p38γ, and p38δ.  The most thoroughly studied isoform is p38α, whose activation has been obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  Subsequently, p38α kinase has been shown to be involved in the biosynthesis of TNFα and IL-1β at the translational and transcriptional level.  MAP kinase p38α represents a point of convergence for multiple signaling processes that are activated in inflammation and thus a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and the pyridinyl-imidazole inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatment for inflammatory diseases.  Herein we provide a brief overview of recent reported clin. results for AMG 548, BIRB 796, VX 702, SCIO 469, and SCIO 323.  However, our focus will be on the binding modes of these inhibitors and other p38 inhibitors in the recent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSldsfUAO6bVg90H21EOLACvtfcHk0lh7y84sBnsz9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF&md5=eb21253fcc2df76280cd9a1812ed1015</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.2174%2F092986705774462914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774462914%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMAP%2520kinase%2520p38%2520inhibitors%253A%2520Clinical%2520results%2520and%2520an%2520intimate%2520look%2520at%2520their%2520interactions%2520with%2520p38%25CE%25B1%2520protein%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2979%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, T.</span><span> </span><span class="NLM_article-title">Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.2174%2F1568026054985939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=16178744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1017-1029&author=D.+M.+Goldsteinauthor=T.+Gabriel&title=Pathway+to+the+clinic%3A+Inhibition+of+p38+MAP+kinase.+A+review+of+ten+chemotypes+selected+for+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Pathway to the clinic: Inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span></div><div class="casAuthors">Goldstein, David M.; Gabriel, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 mitogen activated protein (MAP) kinase remains the most compelling therapeutic target for oral drug intervention for a wide range of autoimmune disorders based on the central role this enzyme plays in inflammatory cell signaling.  Efforts to discover inhibitors of p38 suitable for clin. investigation have continued to escalate in part due to the incredible diversity of unique chemotypes reported to inhibit the enzyme.  Since 1993, at least seventeen p38 inhibitors have been reported to have entered into clin. trials.  Next generation inhibitors have been disclosed with improved potency for p38 and enhanced selectivity vs. other protein kinases.  Over the last three years, there have been multiple reports of cytokine suppression in humans following oral administration of p38 inhibitors.  These results, in addn. to proof of concept studies in rheumatoid patients, have established p38 inhibition as an avenue for the future management of pro-inflammatory cytokine based diseases.  This review describes the discovery at Roche of novel p38 inhibitors which have advanced into clin. trials.  The pharmacol. of the Roche compds. is then compared with eight chem. distinct p38 inhibitors known to have entered clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve3HIFcxtSrVg90H21EOLACvtfcHk0lj7D4QJ7egEEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK&md5=a4acd0c62b42c1f2eb4dafd8f8b60306</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.2174%2F1568026054985939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985939%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DT.%26atitle%3DPathway%2520to%2520the%2520clinic%253A%2520Inhibition%2520of%2520p38%2520MAP%2520kinase.%2520A%2520review%2520of%2520ten%2520chemotypes%2520selected%2520for%2520development%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1017%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Small molecule p38 inhibitors: Novel structural features and advances from 2002–2005</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.2174%2F1568026054985920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=16178741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=967-985&author=J.+Hynesauthor=K.+Leftheris&title=Small+molecule+p38+inhibitors%3A+Novel+structural+features+and+advances+from+2002%E2%80%932005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule p38 inhibitors: Novel structural features and advances from 2002-2005</span></div><div class="casAuthors">Hynes, John, Jr.; Leftheris, Katerina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">967-985</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery and development of selective, efficacious, and safe small mol. p38 mitogen-activated protein kinase inhibitors for the treatment of inflammatory diseases remains the focus of many pharmaceutical research programs.  Advances in small mol. p38 inhibitor design in potency and oral efficacy have been accelerated with the large no. of available inhibitor-enzyme x-ray structures.  These advances have allowed for the discovery of diverse sets of inhibitors with the opportunity to map inhibitor interactions and design selective inhibitors.  This review covers recent compd. disclosures in the patent and published literature over the last three years.  Many disclosures represent new chemotypes as well as creative modifications of known structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXWto2uZjwJrVg90H21EOLACvtfcHk0lj7D4QJ7egEEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbP&md5=e8a3966e7f270b6171b95f306d3fc341</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.2174%2F1568026054985920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985920%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DSmall%2520molecule%2520p38%2520inhibitors%253A%2520Novel%2520structural%2520features%2520and%2520advances%2520from%25202002%25E2%2580%25932005%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D967%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeCouter, J.</span><span> </span><span class="NLM_article-title">The biology of VEGF and its receptor</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1038%2Fnm0603-669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=12778165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=669-676&author=N.+Ferraraauthor=H.+Gerberauthor=J.+LeCouter&title=The+biology+of+VEGF+and+its+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of VEGF and its receptors</span></div><div class="casAuthors">Ferrara, Napoleone; Gerber, Hans-Peter; LeCouter, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">669-676</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Vascular endothelial growth factor (VEGF) is a key regulator of physiol. angiogenesis during embryogenesis, skeletal growth and reproductive functions.  VEGF has also been implicated in pathol. angiogenesis assocd. with tumors, intraocular neovascular disorders and other conditions.  The biol. effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 and VEGFR-2, which differ considerably in signaling properties.  Non-signaling co-receptors also modulate VEGF RTK signaling.  Currently, several VEGF inhibitors are undergoing clin. testing in several malignancies.  VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp73RlVV-BkrVg90H21EOLACvtfcHk0lj7D4QJ7egEEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOnur4%253D&md5=7b3bc5510c26c80d75679920fbcb378e</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-669%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DGerber%26aufirst%3DH.%26aulast%3DLeCouter%26aufirst%3DJ.%26atitle%3DThe%2520biology%2520of%2520VEGF%2520and%2520its%2520receptor%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D669%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Angiogenesis in life, disease, and medicine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x">, </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=932-936&author=P.+Carmeliet&title=Angiogenesis+in+life%2C+disease%2C+and+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520life%252C%2520disease%252C%2520and%2520medicine%26jtitle%3DNature%26date%3D2005%26volume%3D438%26spage%3D932%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Angiogenesis in health and disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1038%2Fnm0603-653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=12778163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26c&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=653-660&author=P.+Carmeliet&title=Angiogenesis+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26cR"><div class="casContent"><span class="casTitleNuber">26c</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in health and disease</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-660</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Blood vessels constitute the first organ in the embryo and form the largest network in our body but, sadly, are also often deadly.  When dysregulated, the formation of new blood vessels contributes to numerous malignant, ischemic, inflammatory, infectious and immune disorders.  Mol. insights into these processes are being generated at a rapidly increasing pace, offering new therapeutic opportunities that are currently being evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVe6HXO3QPLbVg90H21EOLACvtfcHk0lj7D4QJ7egEEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D&md5=501ed35c48dbcc7c9d18b804c996284a</span></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-653%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D653%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ahmed, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, W. P.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor (VEGF) inhibition by small molecules</span> <span class="citation_source-journal">J. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26d&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=15688612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26d&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFantb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=59-63&author=S.+I.+Ahmedauthor=A.+L.+Thomasauthor=W.+P.+Steward&title=Vascular+endothelial+growth+factor+%28VEGF%29+inhibition+by+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26dR"><div class="casContent"><span class="casTitleNuber">26d</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor (VEGF) inhibition by small molecules</span></div><div class="casAuthors">Ahmed, S. I.; Thomas, A. L.; Steward, W. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemotherapy (Firenze, Italy)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">59-63</span>CODEN:
                <span class="NLM_cas:coden">JCHEEU</span>;
        ISSN:<span class="NLM_cas:issn">1120-009X</span>.
    
            (<span class="NLM_cas:orgname">E.S.I.F.T. srl</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is essential for primary tumors to grow and metastasise, and is driven by the prodn. of pos. angiogenic factors.  The Vascular Endothelial Growth Factor (VEGF) family is central to the process of angiogenesis and comprises 5 mols. designated A, B, C, D and E.  VEGF is overexpressed in several solid malignancies.  The actions of VEGF are mediated through receptors possessing tyrosine kinase activity: VEGFR-1 (Flt-1), VEGFR-2 (Kdr/Flk-1) and VEGFR-3 (Flt-4).  Anti-VEGF strategies include the use of antibodies to VEGF or its receptors, the use of ribozymes to decrease receptor expression, and the use of inhibitors of tyrosine kinase to reduce receptor activation and downstream signalling.  The focus of this review is small mol. inhibitors of VEGF receptors which target their intrinsic tyrosine kinase activity.  The clin. development of the following agents is discussed: SU5416, SU11248, SU6668, PTK/ZK, ZD6474.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvEoRDCaYsR7Vg90H21EOLACvtfcHk0lhqsjowxbU1qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFantb0%253D&md5=4646b63518c4ff1234ae9771927c1e87</span></div><a href="/servlet/linkout?suffix=cit26d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BI.%26aulast%3DThomas%26aufirst%3DA.%2BL.%26aulast%3DSteward%26aufirst%3DW.%2BP.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520inhibition%2520by%2520small%2520molecules%26jtitle%3DJ.%2520Chemother.%26date%3D2004%26volume%3D16%26spage%3D59%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Paz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhenping, Z.</span><span> </span><span class="NLM_article-title">Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.2741%2F1629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=15769635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26e&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVekurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1415-1439&author=K.+Pazauthor=Z.+Zhenping&title=Development+of+angiogenesis+inhibitors+to+vascular+endothelial+growth+factor+receptor+2.+Current+status+and+future+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26eR"><div class="casContent"><span class="casTitleNuber">26e</span><div class="casTitle"><span class="NLM_cas:atitle">Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective</span></div><div class="casAuthors">Paz, Keren; Zhu, Zhenping</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1415-1439</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Angiogenesis, the recruitment of new blood vessels is a crucial mechanism required for both tumor growth and metastasis.  Advances in the understanding of the mol. mechanisms underlying the angiogenesis process have led to the discovery of a variety of pharmaceutical agents with antiangiogenic activity.  The potential application of these angiogenesis inhibitors is currently under intense clin. investigation.  Decades of investigation suggest that vascular endothelial growth factor (VEGF) and its receptors, particularly VEGF receptor 2 (VEGFR2, or kinase insert domain-contg. receptor, KDR), play a crit. role in tumor-assocd. angiogenesis.  KDR, therefore, represents a good target for therapeutic intervention.  A no. of agents designed selectively for targeting KDR are being evaluated in various phases of clin. trials in cancer patients.  This Manuscript reviews briefly the biol. of VEGF family of ligands and receptors and of KDR in particular.  The attempts to develop effective KDR antagonists, including small mols., antibodies and others, for therapeutic purposes are discussed comprehensively with special emphasis on tumor angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWzpjh84lYrVg90H21EOLACvtfcHk0lhqsjowxbU1qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVekurg%253D&md5=8f8bdb8650b7822f55189835489f4edc</span></div><a href="/servlet/linkout?suffix=cit26e&amp;dbid=16384&amp;doi=10.2741%2F1629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1629%26sid%3Dliteratum%253Aachs%26aulast%3DPaz%26aufirst%3DK.%26aulast%3DZhenping%26aufirst%3DZ.%26atitle%3DDevelopment%2520of%2520angiogenesis%2520inhibitors%2520to%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%25202.%2520Current%2520status%2520and%2520future%2520perspective%26jtitle%3DFront.%2520Biosci.%26date%3D2005%26volume%3D10%26spage%3D1415%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">For example, see ref <a class="ref internalNav" href="#cit13d" aria-label="13d">13d</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+example%2C+see+ref+13d."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">For examples, see</p></div><span class="NLM_contrib-group">Tamayo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2409-2413&author=N.+Tamayoauthor=L.+Liaoauthor=M.+Goldbergauthor=D.+Powersauthor=Y.-Y.+Tudorauthor=V.+Yuauthor=L.+M.+Wongauthor=B.+Henkleauthor=S.+Middletonauthor=R.+Syedauthor=T.+Harveyauthor=G.+Jangauthor=R.+Hungateauthor=C.+Dominguez&title=Design+and+synthesis+of+potent+pyridazine+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamayo%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DL.%26aulast%3DGoldberg%26aufirst%3DM.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DTudor%26aufirst%3DY.-Y.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWong%26aufirst%3DL.%2BM.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DSyed%26aufirst%3DR.%26aulast%3DHarvey%26aufirst%3DT.%26aulast%3DJang%26aufirst%3DG.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520pyridazine%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2409%26epage%3D2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For examples, see</p></div><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=11896401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0lhqsjowxbU1qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkins, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulevitch, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span> </span><span class="NLM_article-title">The structure of mitogen-activated protein kinase p38 at 2.1-Å resolution</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">2327</span><span class="NLM_x">–</span> <span class="NLM_lpage">2332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1073%2Fpnas.94.6.2327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=9122194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2luro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=2327-2332&author=Z.+Wangauthor=P.+C.+Harkinsauthor=R.+J.+Ulevitchauthor=J.+Hanauthor=M.+H.+Cobbauthor=E.+J.+Goldsmith&title=The+structure+of+mitogen-activated+protein+kinase+p38+at+2.1-%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of mitogen-activated protein kinase p38 at 2.1-Å resolution</span></div><div class="casAuthors">Wang, Zhulun; Harkins, Paul C.; Ulevitch, Richard J.; Han, Jiahuai; Cobb, Melanie H.; Goldsmith, Elizabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2327-2332</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The structure of mitogen-activated protein (MAP) kinase p38 has been solved at 2.1-Å to an R factor of 21.0%, making p38 the second low activity MAP kinase solved to date.  Although p38 is topol. similar to the MAP kinase ERK2, the phosphorylation Lip (a regulatory loop near the active site) adopts a different fold in p38.  The peptide substrate binding site and the ATP binding site are also different from those of ERK2.  The results explain why MAP kinases are specific for different activating enzymes, substrates, and inhibitors.  A model presented for substrate and activator interactions has implications for the evolution of protein kinase cascades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFVQ00RJzP4bVg90H21EOLACvtfcHk0liqN_X_c7m8eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2luro%253D&md5=e437c9d7a133608665abc4f33a213790</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.6.2327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.6.2327%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHarkins%26aufirst%3DP.%2BC.%26aulast%3DUlevitch%26aufirst%3DR.%2BJ.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DCobb%26aufirst%3DM.%2BH.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26atitle%3DThe%2520structure%2520of%2520mitogen-activated%2520protein%2520kinase%2520p38%2520at%25202.1-%25C3%2585%2520resolution%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D2327%26epage%3D2332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wilson, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgibbon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaffrey, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. S.</span><span> </span><span class="NLM_article-title">Crystal structure of p38 mitogen-activated protein kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">27696</span><span class="NLM_x">–</span> <span class="NLM_lpage">27700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm701095m&amp;key=10.1074%2Fjbc.271.44.27696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Fjm701095m&amp;key=8910361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm701095m&amp;key=1%3ACAS%3A528%3ADyaK28XmvVWlur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=27696-27700&author=K.+P.+Wilsonauthor=M.+J.+Fitzgibbonauthor=P.+R.+Caronauthor=J.+P.+Griffithauthor=W.+Chenauthor=P.+G.+McCaffreyauthor=S.+P.+Chambersauthor=M.+S.+Su&title=Crystal+structure+of+p38+mitogen-activated+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of p38 mitogen-activated protein kinase</span></div><div class="casAuthors">Wilson, Keith P.; Fitzgibbon, Matthew J.; Caron, Paul R.; Griffith, James P.; Chen, Wenyong; McCaffrey, Patricia G.; Chambers, Stephen P.; Su, Michael S.-S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">27696-27700</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">MAP kinase p38 (I) is activated by environmental stress and cytokines and plays a role in transcriptional regulation and inflammatory responses.  Here, the crystal structure of unphosphorylated human apo-I was solved at 2.3 Å resoln.  The fold and topol. of I was similar to that previously reported for ERK2 kinase.  The relative orientation of the 2 domains of I was different from that obsd. in the active form of protein kinase A.  The twist resulted in a misalignment of the active site of I, suggesting that the orientation of the domains would have to change before catalysis could proceed.  The residues that were phosphorylated upon activation of I were located on a surface loop that occupied the peptide binding channel.  Occlusion of the active site by the loop, and misalignment of catalytic residues, may account for the low enzymic activity of unphosphorylated I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj36sU08J6cLVg90H21EOLACvtfcHk0liqN_X_c7m8eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVWlur4%253D&md5=eb8d3b9740f712aa829dfacda3ccf03f</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.44.27696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.44.27696%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DK.%2BP.%26aulast%3DFitzgibbon%26aufirst%3DM.%2BJ.%26aulast%3DCaron%26aufirst%3DP.%2BR.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DMcCaffrey%26aufirst%3DP.%2BG.%26aulast%3DChambers%26aufirst%3DS.%2BP.%26aulast%3DSu%26aufirst%3DM.%2BS.%26atitle%3DCrystal%2520structure%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D27696%26epage%3D27700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><div class="note"><p class="first last">All kinases were tested at their apparent <i>K</i><sub>m</sub> of ATP with respect to 1 µM of peptide substrate</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=All+kinases+were+tested+at+their+apparent+Km+of+ATP+with+respect+to+1+%C2%B5M+of+peptide+substrate."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Harmange, J. C.; Booker, S.; Buchanan, J. L.; Chaffee, S.; Novak, P. M.; van der Plas, S.; Zhu, X.</span> (Amgen, Inc.) <span> </span><span class="NLM_article-title">2,4-Disubstituted pyrimidinyl derivatives for use as anticancer agents.</span> WO 03018021,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=J.+C.+Harmange&author=S.+Booker&author=J.+L.+Buchanan&author=S.+Chaffee&author=P.+M.+Novak&author=S.+van+der+Plas&author=X.+Zhu&title=2%2C4-Disubstituted+pyrimidinyl+derivatives+for+use+as+anticancer+agents."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26atitle%3D2%252C4-Disubstituted%2520pyrimidinyl%2520derivatives%2520for%2520use%2520as%2520anticancer%2520agents.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i59"><a href="/doi/suppl/10.1021/jm701095m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83228"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis and HPLC purity data for the compounds synthesized and data collection and refinement statistics for the X-ray structures of compounds <b>1</b> and <b>25</b> bound to Lck. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701095m/suppl_file/jm701095m-file002.pdf">jm701095m-file002.pdf (193.49 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701095m&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-6%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm701095m%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701095m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667988514de4d1f3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
